ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,Count,ont,comparison,geneID,symbol
GO:0030198,extracellular matrix organization,6/18,348/18493,6.523355957691209e-7,5.916683853625927e-4,3.6736794077524184e-4,6,bp,NAC,1301/2335/3694/6696/2264/4316,COL11A1/FN1/ITGB6/SPP1/FGFR4/MMP7
GO:0043062,extracellular structure organization,6/18,402/18493,1.5124032626251329e-6,6.858748796004977e-4,4.258609186865506e-4,6,bp,NAC,1301/2335/3694/6696/2264/4316,COL11A1/FN1/ITGB6/SPP1/FGFR4/MMP7
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,3/18,29/18493,2.784746867711795e-6,8.41921803004866e-4,5.2275072779853e-4,3,bp,NAC,990/1869/898,CDC6/E2F1/CCNE1
GO:0008201,heparin binding,4/18,163/17632,1.946944118480378e-5,0.0024142107069156688,0.001434590403090805,4,mf,NAC,1301/2335/2264/4316,COL11A1/FN1/FGFR4/MMP7
hsa04151,PI3K-Akt signaling pathway,6/17,354/7844,6.562135605969266e-5,0.0026576649204175526,0.0017614153468654347,6,kg,NAC,2064/2335/3694/6696/898/2264,ERBB2/FN1/ITGB6/SPP1/CCNE1/FGFR4
hsa05165,Human papillomavirus infection,6/17,330/7844,4.422515151431319e-5,0.0026576649204175526,0.0017614153468654347,6,kg,NAC,6772/1869/2335/3694/6696/898,STAT1/E2F1/FN1/ITGB6/SPP1/CCNE1
hsa04110,Cell cycle,4/17,124/7844,1.2073868597180617e-4,0.0032599445212387664,0.002160587012127058,4,kg,NAC,990/1869/9088/898,CDC6/E2F1/PKMYT1/CCNE1
GO:0005539,glycosaminoglycan binding,4/18,222/17632,6.515833585296175e-5,0.003763173705082682,0.002236181318809743,4,mf,NAC,1301/2335/2264/4316,COL11A1/FN1/FGFR4/MMP7
GO:1901681,sulfur compound binding,4/18,242/17632,9.104452512296812e-5,0.003763173705082682,0.002236181318809743,4,mf,NAC,1301/2335/2264/4316,COL11A1/FN1/FGFR4/MMP7
GO:0048146,positive regulation of fibroblast proliferation,3/18,55/18493,1.9680006767751762e-5,0.004462441534587712,0.002770737794933472,3,bp,NAC,990/1869/2335,CDC6/E2F1/FN1
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,3/18,87/18493,7.797761535028623e-5,0.006041455281408087,0.003751150206642287,3,bp,NAC,990/9088/898,CDC6/PKMYT1/CCNE1
GO:0000280,nuclear division,5/18,416/18493,3.7828051109228236e-5,0.006041455281408087,0.003751150206642287,5,bp,NAC,990/83990/2175/9088/898,CDC6/BRIP1/FANCA/PKMYT1/CCNE1
GO:0048144,fibroblast proliferation,3/18,91/18493,8.915582886881212e-5,0.006041455281408087,0.003751150206642287,3,bp,NAC,990/1869/2335,CDC6/E2F1/FN1
GO:0048145,regulation of fibroblast proliferation,3/18,90/18493,8.626912519696272e-5,0.006041455281408087,0.003751150206642287,3,bp,NAC,990/1869/2335,CDC6/E2F1/FN1
GO:0048285,organelle fission,5/18,458/18493,5.981533842501425e-5,0.006041455281408087,0.003751150206642287,5,bp,NAC,990/83990/2175/9088/898,CDC6/BRIP1/FANCA/PKMYT1/CCNE1
GO:0051321,meiotic cell cycle,4/18,249/18493,8.462311872109383e-5,0.006041455281408087,0.003751150206642287,4,bp,NAC,83990/2175/9088/898,BRIP1/FANCA/PKMYT1/CCNE1
GO:0071900,regulation of protein serine/threonine kinase activity,5/18,496/18493,8.72606516762289e-5,0.006041455281408087,0.003751150206642287,5,bp,NAC,990/2146/2064/9088/898,CDC6/EZH2/ERBB2/PKMYT1/CCNE1
GO:0072160,nephron tubule epithelial cell differentiation,2/18,15/18493,9.325289298755591e-5,0.006041455281408087,0.003751150206642287,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0072182,regulation of nephron tubule epithelial cell differentiation,2/18,13/18493,6.935353959833934e-5,0.006041455281408087,0.003751150206642287,2,bp,NAC,6772/8842,STAT1/PROM1
GO:1904029,regulation of cyclin-dependent protein kinase activity,3/18,91/18493,8.915582886881212e-5,0.006041455281408087,0.003751150206642287,3,bp,NAC,990/9088/898,CDC6/PKMYT1/CCNE1
GO:0000082,G1/S transition of mitotic cell cycle,4/18,263/18493,1.0456222697616106e-4,0.006322529324491872,0.003925669574192714,4,bp,NAC,990/2146/1869/898,CDC6/EZH2/E2F1/CCNE1
GO:0044843,cell cycle G1/S phase transition,4/18,282/18493,1.3683459601608906e-4,0.007300528152152516,0.0045329107658580595,4,bp,NAC,990/2146/1869/898,CDC6/EZH2/E2F1/CCNE1
GO:2000696,regulation of epithelial cell differentiation involved in kidney development,2/18,18/18493,1.3564787196443406e-4,0.007300528152152516,0.0045329107658580595,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,2/18,24/17632,2.6808438484584484e-4,0.00831061593022119,0.004938396562949774,2,mf,NAC,6772/2146,STAT1/EZH2
hsa04510,Focal adhesion,4/17,199/7844,7.379817801709135e-4,0.009962754032307333,0.006602994875213437,4,kg,NAC,2064/2335/3694/6696,ERBB2/FN1/ITGB6/SPP1
hsa04512,ECM-receptor interaction,3/17,82/7844,6.736837183379979e-4,0.009962754032307333,0.006602994875213437,3,kg,NAC,2335/3694/6696,FN1/ITGB6/SPP1
hsa05212,Pancreatic cancer,3/17,75/7844,5.18513448574152e-4,0.009962754032307333,0.006602994875213437,3,kg,NAC,6772/2064/1869,STAT1/ERBB2/E2F1
hsa05215,Prostate cancer,3/17,97/7844,0.0010992502043806257,0.011129908319353834,0.007376547424133146,3,kg,NAC,2064/1869/898,ERBB2/E2F1/CCNE1
hsa05222,Small cell lung cancer,3/17,93/7844,9.726849066587479e-4,0.011129908319353834,0.007376547424133146,3,kg,NAC,1869/2335/898,E2F1/FN1/CCNE1
GO:1904385,cellular response to angiotensin,2/18,24/18493,2.438529034480684e-4,0.012287476857077668,0.007629315985071146,2,bp,NAC,990/83990,CDC6/BRIP1
GO:1990776,response to angiotensin,2/18,27/18493,3.0958130089731896e-4,0.014778433679677279,0.009175955455959317,2,bp,NAC,990/83990,CDC6/BRIP1
GO:0001046,core promoter sequence-specific DNA binding,2/18,38/17632,6.770823658849847e-4,0.016791642673947622,0.00997805591830504,2,mf,NAC,6772/2146,STAT1/EZH2
GO:0030856,regulation of epithelial cell differentiation,3/18,151/18493,3.979854702815596e-4,0.018048641077268727,0.011206432978980758,3,bp,NAC,6772/2146/8842,STAT1/EZH2/PROM1
GO:0001047,core promoter binding,2/18,47/17632,0.0010354985234279008,0.018343116700722816,0.010899984457135798,2,mf,NAC,6772/2146,STAT1/EZH2
GO:1990841,promoter-specific chromatin binding,2/18,46/17632,9.920340790531142e-4,0.018343116700722816,0.010899984457135798,2,mf,NAC,6772/2146,STAT1/EZH2
GO:0006270,DNA replication initiation,2/18,32/18493,4.3621175784675956e-4,0.018591514769555284,0.011543504209031602,2,bp,NAC,990/898,CDC6/CCNE1
GO:0031570,DNA integrity checkpoint,3/18,158/18493,4.54405213278692e-4,0.018591514769555284,0.011543504209031602,3,bp,NAC,990/83990/1869,CDC6/BRIP1/E2F1
GO:0045787,positive regulation of cell cycle,4/18,390/18493,4.714496578828794e-4,0.018591514769555284,0.011543504209031602,4,bp,NAC,990/2146/1869/898,CDC6/EZH2/E2F1/CCNE1
GO:2000045,regulation of G1/S transition of mitotic cell cycle,3/18,166/18493,5.249073576912197e-4,0.019837123892747343,0.012316905103719411,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
GO:0050839,cell adhesion molecule binding,4/18,486/17632,0.0012827953156606083,0.01988332739273943,0.0118152200126635,4,mf,NAC,6772/2335/3694/8842,STAT1/FN1/ITGB6/PROM1
GO:0050840,extracellular matrix binding,2/18,56/17632,0.0014671781415827821,0.020214454395140555,0.012011984784888277,2,mf,NAC,1301/6696,COL11A1/SPP1
GO:0140013,meiotic nuclear division,3/18,171/18493,5.723431850903485e-4,0.020764610755077847,0.01289278332729838,3,bp,NAC,83990/2175/898,BRIP1/FANCA/CCNE1
GO:0007088,regulation of mitotic nuclear division,3/18,177/18493,6.327940023295391e-4,0.022074775388957385,0.013706266852077062,3,bp,NAC,990/9088/898,CDC6/PKMYT1/CCNE1
GO:0007129,synapsis,2/18,46/18493,9.02925164964887e-4,0.022432483566762404,0.01392836848861822,2,bp,NAC,83990/898,BRIP1/CCNE1
GO:0030857,negative regulation of epithelial cell differentiation,2/18,46/18493,9.02925164964887e-4,0.022432483566762404,0.01392836848861822,2,bp,NAC,6772/2146,STAT1/EZH2
GO:0035850,epithelial cell differentiation involved in kidney development,2/18,44/18493,8.262339925594719e-4,0.022432483566762404,0.01392836848861822,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0035987,endodermal cell differentiation,2/18,45/18493,8.64165363289022e-4,0.022432483566762404,0.01392836848861822,2,bp,NAC,1301/2335,COL11A1/FN1
GO:0045023,G0 to G1 transition,2/18,46/18493,9.02925164964887e-4,0.022432483566762404,0.01392836848861822,2,bp,NAC,2146/1869,EZH2/E2F1
GO:0051783,regulation of nuclear division,3/18,201/18493,9.151068268690287e-4,0.022432483566762404,0.01392836848861822,3,bp,NAC,990/9088/898,CDC6/PKMYT1/CCNE1
GO:0070316,regulation of G0 to G1 transition,2/18,44/18493,8.262339925594719e-4,0.022432483566762404,0.01392836848861822,2,bp,NAC,2146/1869,EZH2/E2F1
GO:0070317,negative regulation of G0 to G1 transition,2/18,40/18493,6.828222302068905e-4,0.022432483566762404,0.01392836848861822,2,bp,NAC,2146/1869,EZH2/E2F1
GO:1901991,negative regulation of mitotic cell cycle phase transition,3/18,191/18493,7.893788660403587e-4,0.022432483566762404,0.01392836848861822,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
GO:1902806,regulation of cell cycle G1/S phase transition,3/18,185/18493,7.195546587044225e-4,0.022432483566762404,0.01392836848861822,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
GO:1903046,meiotic cell cycle process,3/18,188/18493,7.539496365971543e-4,0.022432483566762404,0.01392836848861822,3,bp,NAC,83990/2175/898,BRIP1/FANCA/CCNE1
GO:0009612,response to mechanical stimulus,3/18,204/18493,9.551619654338551e-4,0.022798207964434384,0.014155447410169322,3,bp,NAC,6772/1301/4316,STAT1/COL11A1/MMP7
GO:0001706,endoderm formation,2/18,50/18493,0.0010662193602317357,0.023586852676345957,0.014645118298433341,2,bp,NAC,1301/2335,COL11A1/FN1
GO:0031667,response to nutrient levels,4/18,481/18493,0.0010348748448159543,0.023586852676345957,0.014645118298433341,4,bp,NAC,6772/83990/6696/4316,STAT1/BRIP1/SPP1/MMP7
GO:1901988,negative regulation of cell cycle phase transition,3/18,211/18493,0.001052923043165522,0.023586852676345957,0.014645118298433341,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
GO:0004714,transmembrane receptor protein tyrosine kinase activity,2/18,64/17632,0.0019114106942163336,0.023701492608282537,0.014084078799488775,2,mf,NAC,2064/2264,ERBB2/FGFR4
GO:0000075,cell cycle checkpoint,3/18,216/18493,0.0011265034810462272,0.023761364123463444,0.014753472762784126,3,bp,NAC,990/83990/1869,CDC6/BRIP1/E2F1
GO:0007584,response to nutrient,3/18,216/18493,0.0011265034810462272,0.023761364123463444,0.014753472762784126,3,bp,NAC,6772/83990/6696,STAT1/BRIP1/SPP1
GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",2/18,68/17632,0.0021546071599591763,0.02424345306888404,0.014406126611391196,2,mf,NAC,2064/2264,ERBB2/FGFR4
GO:0052813,phosphatidylinositol bisphosphate kinase activity,2/18,71/17632,0.002346140619569423,0.02424345306888404,0.014406126611391196,2,mf,NAC,2064/2264,ERBB2/FGFR4
GO:0061005,cell differentiation involved in kidney development,2/18,54/18493,0.00124265138291236,0.024501843571771965,0.01521323775419022,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0090183,regulation of kidney development,2/18,54/18493,0.00124265138291236,0.024501843571771965,0.01521323775419022,2,bp,NAC,6772/8842,STAT1/PROM1
GO:1902808,positive regulation of cell cycle G1/S phase transition,2/18,53/18493,0.0011973168087694688,0.024501843571771965,0.01521323775419022,2,bp,NAC,990/2146,CDC6/EZH2
GO:0045143,homologous chromosome segregation,2/18,56/18493,0.0013357649472798363,0.02577742142942152,0.016005246288795353,2,bp,NAC,83990/898,BRIP1/CCNE1
GO:0019199,transmembrane receptor protein kinase activity,2/18,81/17632,0.0030405405710970316,0.026930502201145137,0.01600284511103701,2,mf,NAC,2064/2264,ERBB2/FGFR4
GO:0035004,phosphatidylinositol 3-kinase activity,2/18,79/17632,0.0028948214934126403,0.026930502201145137,0.01600284511103701,2,mf,NAC,2064/2264,ERBB2/FGFR4
hsa05206,MicroRNAs in cancer,4/17,299/7844,0.003322135766355743,0.02766250378858409,0.018333823173720454,4,kg,NAC,2146/2064/1869/898,EZH2/ERBB2/E2F1/CCNE1
hsa05219,Bladder cancer,2/17,41/7844,0.0034496698366836835,0.02766250378858409,0.018333823173720454,2,kg,NAC,2064/1869,ERBB2/E2F1
hsa05226,Gastric cancer,3/17,149/7844,0.0037566363169682098,0.02766250378858409,0.018333823173720454,3,kg,NAC,2064/1869/898,ERBB2/E2F1/CCNE1
GO:0060135,maternal process involved in female pregnancy,2/18,60/18493,0.0015317291680349337,0.028943299070993432,0.017970945282866,2,bp,NAC,6696/4316,SPP1/MMP7
GO:0070192,chromosome organization involved in meiotic cell cycle,2/18,64/18493,0.0017405991588463992,0.03221884565456498,0.020004737915850133,2,bp,NAC,83990/898,BRIP1/CCNE1
hsa05161,Hepatitis B,3/17,163/7844,0.0048350857331074725,0.03263682869847544,0.021630646700743963,3,kg,NAC,6772/1869/898,STAT1/E2F1/CCNE1
GO:0098813,nuclear chromosome segregation,3/18,258/18493,0.0018754873549608143,0.034021340618989176,0.02112391020850602,3,bp,NAC,990/83990/898,CDC6/BRIP1/CCNE1
GO:0042063,gliogenesis,3/18,266/18493,0.0020461501630487885,0.03638937642912257,0.022594227806627492,3,bp,NAC,2146/2064/1869,EZH2/ERBB2/E2F1
GO:0006260,DNA replication,3/18,268/18493,0.00209028227264321,0.036459346563219065,0.02263767238591331,3,bp,NAC,990/83990/898,CDC6/BRIP1/CCNE1
hsa03460,Fanconi anemia pathway,2/17,54/7844,0.0059213494385213575,0.03689456188617154,0.02445253614288172,2,kg,NAC,83990/2175,BRIP1/FANCA
GO:0007492,endoderm development,2/18,74/18493,0.0023186340779648646,0.0382363837948024,0.023741037927487132,2,bp,NAC,1301/2335,COL11A1/FN1
GO:0022617,extracellular matrix disassembly,2/18,74/18493,0.0023186340779648646,0.0382363837948024,0.023741037927487132,2,bp,NAC,2264/4316,FGFR4/MMP7
GO:0140014,mitotic nuclear division,3/18,277/18493,0.0022962496549739243,0.0382363837948024,0.023741037927487132,3,bp,NAC,990/9088/898,CDC6/PKMYT1/CCNE1
GO:0045930,negative regulation of mitotic cell cycle,3/18,281/18493,0.0023917097673295026,0.03873715641014034,0.024051968524836168,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
GO:0043235,receptor complex,4/18,396/19659,3.9665193697850724e-4,0.03887188982389371,0.02672181470170996,4,cc,NAC,2064/27092/3694/2264,ERBB2/CACNG4/ITGB6/FGFR4
GO:0090068,positive regulation of cell cycle process,3/18,286/18493,0.002514473784785887,0.04001101268071578,0.024842908122999996,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
GO:0010948,negative regulation of cell cycle process,3/18,304/18493,0.002988695714782037,0.04673701747081564,0.029019096323201266,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
hsa05169,Epstein-Barr virus infection,3/17,201/7844,0.008645879837055868,0.04720388323024926,0.03128522475299172,3,kg,NAC,6772/1869/898,STAT1/E2F1/CCNE1
hsa05223,Non-small cell lung cancer,2/17,66/7844,0.008741459857453567,0.04720388323024926,0.03128522475299172,2,kg,NAC,2064/1869,ERBB2/E2F1
GO:0071375,cellular response to peptide hormone stimulus,3/18,307/18493,0.0030727340244102366,0.04723677559559466,0.029329397021578538,3,bp,NAC,6772/990/83990,STAT1/CDC6/BRIP1
GO:0007059,chromosome segregation,3/18,312/18493,0.0032160291666379352,0.04861564090234346,0.030185536914935012,3,bp,NAC,990/83990/898,CDC6/BRIP1/CCNE1
GO:0033273,response to vitamin,2/18,89/18493,0.003332736260771989,0.04875470626645474,0.030271882844024014,2,bp,NAC,83990/6696,BRIP1/SPP1
GO:0045132,meiotic chromosome segregation,2/18,89/18493,0.003332736260771989,0.04875470626645474,0.030271882844024014,2,bp,NAC,83990/898,BRIP1/CCNE1
hsa04810,Regulation of actin cytoskeleton,3/17,214/7844,0.010263198257491134,0.04918268482942838,0.03259671119299347,3,kg,NAC,2335/3694/2264,FN1/ITGB6/FGFR4
hsa05166,Human T-cell leukemia virus 1 infection,3/17,219/7844,0.010929485517650751,0.04918268482942838,0.03259671119299347,3,kg,NAC,1869/898/4316,E2F1/CCNE1/MMP7
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),2/17,72/7844,0.010337307103345577,0.04918268482942838,0.03259671119299347,2,kg,NAC,27092/3694,CACNG4/ITGB6
GO:0070372,regulation of ERK1 and ERK2 cascade,3/18,324/18493,0.0035766287436465143,0.05068663486579418,0.03147142070817604,3,bp,NAC,2064/2335/2264,ERBB2/FN1/FGFR4
GO:0071902,positive regulation of protein serine/threonine kinase activity,3/18,323/18493,0.0035456697905989682,0.05068663486579418,0.03147142070817604,3,bp,NAC,990/2146/2064,CDC6/EZH2/ERBB2
GO:0072080,nephron tubule development,2/18,93/18493,0.0036324490256633094,0.05068663486579418,0.03147142070817604,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0061326,renal tubule development,2/18,95/18493,0.003786870937694705,0.05204078697710754,0.03231221613503457,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0070371,ERK1 and ERK2 cascade,3/18,341/18493,0.004128655490768048,0.055835896230940485,0.03466860614350741,3,bp,NAC,2064/2335/2264,ERBB2/FN1/FGFR4
GO:1901989,positive regulation of cell cycle phase transition,2/18,100/18493,0.004186153190412297,0.055835896230940485,0.03466860614350741,2,bp,NAC,990/2146,CDC6/EZH2
GO:0005178,integrin binding,2/18,126/17632,0.007192326752646456,0.05945656782187738,0.03533072790773698,2,mf,NAC,2335/3694,FN1/ITGB6
GO:0061387,regulation of extent of cell growth,2/18,105/18493,0.004604194353270006,0.060339341880818485,0.037464803465720294,2,bp,NAC,2335/6696,FN1/SPP1
GO:1901653,cellular response to peptide,3/18,356/18493,0.004656840056954018,0.060339341880818485,0.037464803465720294,3,bp,NAC,6772/990/83990,STAT1/CDC6/BRIP1
hsa05410,Hypertrophic cardiomyopathy (HCM),2/17,85/7844,0.014201942461169308,0.060545123123932315,0.040127372050949295,2,kg,NAC,27092/3694,CACNG4/ITGB6
GO:0044774,mitotic DNA integrity checkpoint,2/18,107/18493,0.004776624986192621,0.06101970228840432,0.0378872404390371,2,bp,NAC,990/1869,CDC6/E2F1
GO:0019838,growth factor binding,2/18,137/17632,0.008452203536731826,0.06165136697380861,0.03663493793010699,2,mf,NAC,2064/2264,ERBB2/FGFR4
GO:0019903,protein phosphatase binding,2/18,133/17632,0.007983302673236123,0.06165136697380861,0.03663493793010699,2,mf,NAC,6772/2064,STAT1/ERBB2
GO:0072009,nephron epithelium development,2/18,109/18493,0.00495201878908225,0.06238168113468889,0.03873289549940064,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0007127,meiosis I,2/18,113/18493,0.0053116524689800935,0.06364779356105515,0.039519026931079344,2,bp,NAC,83990/898,BRIP1/CCNE1
GO:0014013,regulation of gliogenesis,2/18,112/18493,0.00522064167576895,0.06364779356105515,0.039519026931079344,2,bp,NAC,2146/1869,EZH2/E2F1
GO:0046854,phosphatidylinositol phosphorylation,2/18,111/18493,0.005130364896233162,0.06364779356105515,0.039519026931079344,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:1901990,regulation of mitotic cell cycle phase transition,3/18,375/18493,0.005382672874514708,0.06364779356105515,0.039519026931079344,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,2/18,114/18493,0.005403395925249446,0.06364779356105515,0.039519026931079344,2,bp,NAC,2146/1869,EZH2/E2F1
hsa05414,Dilated cardiomyopathy (DCM),2/17,91/7844,0.016166940511192378,0.06547610907032912,0.04339547189846375,2,kg,NAC,27092/3694,CACNG4/ITGB6
GO:0001704,formation of primary germ layer,2/18,118/18493,0.005777669427438597,0.06633349583147857,0.041186584192933376,2,bp,NAC,1301/2335,COL11A1/FN1
GO:0061982,meiosis I cell cycle process,2/18,118/18493,0.005777669427438597,0.06633349583147857,0.041186584192933376,2,bp,NAC,83990/898,BRIP1/CCNE1
GO:0004386,helicase activity,2/18,151/17632,0.010188656946423603,0.06641206335065045,0.039463874656583464,2,mf,NAC,3070/83990,HELLS/BRIP1
GO:0005201,extracellular matrix structural constituent,2/18,155/17632,0.010711623121072652,0.06641206335065045,0.039463874656583464,2,mf,NAC,1301/2335,COL11A1/FN1
GO:0035257,nuclear hormone receptor binding,2/18,152/17632,0.010318291365416978,0.06641206335065045,0.039463874656583464,2,mf,NAC,6772/898,STAT1/CCNE1
GO:1905477,positive regulation of protein localization to membrane,2/18,119/18493,0.005873055998590334,0.06658577238401792,0.04134322314797144,2,bp,NAC,2064/1869,ERBB2/E2F1
GO:1902807,negative regulation of cell cycle G1/S phase transition,2/18,121/18493,0.006066001585943507,0.0679242399808736,0.04217428003222583,2,bp,NAC,2146/1869,EZH2/E2F1
hsa01522,Endocrine resistance,2/17,98/7844,0.018598890850180044,0.07113540180703314,0.047146270203491755,2,kg,NAC,2064/1869,ERBB2/E2F1
hsa04933,AGE-RAGE signaling pathway in diabetic complications,2/17,100/7844,0.01932072641672505,0.07113540180703314,0.047146270203491755,2,kg,NAC,6772/2335,STAT1/FN1
GO:0046834,lipid phosphorylation,2/18,125/18493,0.006460545110898159,0.07145993189737354,0.04436959735982691,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0045814,"negative regulation of gene expression, epigenetic",2/18,127/18493,0.006662121719991997,0.07280173975943062,0.04520272822061786,2,bp,NAC,3070/2146,HELLS/EZH2
hsa04620,Toll-like receptor signaling pathway,2/17,104/7844,0.020799713348662652,0.07325116440181195,0.04854853001289681,2,kg,NAC,6772/6696,STAT1/SPP1
GO:1901987,regulation of cell cycle phase transition,3/18,412/18493,0.006984368239404316,0.07541454753737756,0.046825025163926184,3,bp,NAC,990/2146/1869,CDC6/EZH2/E2F1
GO:0001558,regulation of cell growth,3/18,416/18493,0.007172796684301273,0.07564494949766525,0.04696808214617411,3,bp,NAC,2064/2335/6696,ERBB2/FN1/SPP1
GO:0008584,male gonad development,2/18,135/18493,0.007496879542064859,0.07564494949766525,0.04696808214617411,2,bp,NAC,83990/2175,BRIP1/FANCA
GO:0043434,response to peptide hormone,3/18,417/18493,0.007220376854935677,0.07564494949766525,0.04696808214617411,3,bp,NAC,6772/990/83990,STAT1/CDC6/BRIP1
GO:0045580,regulation of T cell differentiation,2/18,137/18493,0.007712629053547008,0.07564494949766525,0.04696808214617411,2,bp,NAC,2064/2175,ERBB2/FANCA
GO:0046546,development of primary male sexual characteristics,2/18,136/18493,0.007604403267841231,0.07564494949766525,0.04696808214617411,2,bp,NAC,83990/2175,BRIP1/FANCA
GO:0048608,reproductive structure development,3/18,428/18493,0.007756317864699966,0.07564494949766525,0.04696808214617411,3,bp,NAC,83990/2175/6696,BRIP1/FANCA/SPP1
GO:0060249,anatomical structure homeostasis,3/18,425/18493,0.007607861570582111,0.07564494949766525,0.04696808214617411,3,bp,NAC,6696/898/8842,SPP1/CCNE1/PROM1
GO:0072006,nephron development,2/18,136/18493,0.007604403267841231,0.07564494949766525,0.04696808214617411,2,bp,NAC,6772/8842,STAT1/PROM1
GO:1903706,regulation of hemopoiesis,3/18,418/18493,0.007268146653881241,0.07564494949766525,0.04696808214617411,3,bp,NAC,6772/2064/2175,STAT1/ERBB2/FANCA
GO:0061458,reproductive system development,3/18,431/18493,0.007906500200149416,0.07628931576101618,0.04736817029204858,3,bp,NAC,83990/2175/6696,BRIP1/FANCA/SPP1
GO:0072073,kidney epithelium development,2/18,140/18493,0.008041505671497366,0.07677521730576958,0.04766986741552456,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0042542,response to hydrogen peroxide,2/18,141/18493,0.00815252660638128,0.07702439199987314,0.047824580421205985,2,bp,NAC,6772/2146,STAT1/EZH2
GO:0004713,protein tyrosine kinase activity,2/18,177/17632,0.013795557786898525,0.07859309142546948,0.046702176568615146,2,mf,NAC,2064/2264,ERBB2/FGFR4
GO:0019902,phosphatase binding,2/18,178/17632,0.01394393557548652,0.07859309142546948,0.046702176568615146,2,mf,NAC,6772/2064,STAT1/ERBB2
GO:0008022,protein C-terminus binding,2/18,187/17632,0.015310733635601216,0.07910545711727296,0.04700663835491602,2,mf,NAC,2064/2335,ERBB2/FN1
GO:0051427,hormone receptor binding,2/18,185/17632,0.015002142973931485,0.07910545711727296,0.04700663835491602,2,mf,NAC,6772/898,STAT1/CCNE1
GO:0000077,DNA damage checkpoint,2/18,146/18493,0.008718038098134618,0.08151815005162988,0.05061476269671211,2,bp,NAC,83990/1869,BRIP1/E2F1
hsa04010,MAPK signaling pathway,3/17,295/7844,0.024209347071541053,0.08170654636645105,0.05415248687055236,3,kg,NAC,2064/27092/2264,ERBB2/CACNG4/FGFR4
GO:0007409,axonogenesis,3/18,449/18493,0.008844122088155824,0.08185325238731972,0.050822828326137125,3,bp,NAC,2064/2335/6696,ERBB2/FN1/SPP1
GO:0006261,DNA-dependent DNA replication,2/18,148/18493,0.008949074964773453,0.08198798982878304,0.050906487040444426,2,bp,NAC,990/898,CDC6/CCNE1
GO:0050769,positive regulation of neurogenesis,3/18,453/18493,0.009061052141608317,0.08218374292438743,0.051028030481688955,3,bp,NAC,2146/1869/2335,EZH2/E2F1/FN1
GO:0033314,mitotic DNA replication checkpoint,1/18,10/18493,0.009693239033567447,0.08294120569288371,0.05149834044646063,1,bp,NAC,990,CDC6
GO:0050910,detection of mechanical stimulus involved in sensory perception of sound,1/18,10/18493,0.009693239033567447,0.08294120569288371,0.05149834044646063,1,bp,NAC,1301,COL11A1
GO:0070341,fat cell proliferation,1/18,10/18493,0.009693239033567447,0.08294120569288371,0.05149834044646063,1,bp,NAC,1869,E2F1
GO:0070344,regulation of fat cell proliferation,1/18,10/18493,0.009693239033567447,0.08294120569288371,0.05149834044646063,1,bp,NAC,1869,E2F1
GO:0071104,response to interleukin-9,1/18,10/18493,0.009693239033567447,0.08294120569288371,0.05149834044646063,1,bp,NAC,6772,STAT1
GO:0072203,cell proliferation involved in metanephros development,1/18,10/18493,0.009693239033567447,0.08294120569288371,0.05149834044646063,1,bp,NAC,6772,STAT1
GO:0003337,mesenchymal to epithelial transition involved in metanephros morphogenesis,1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,6772,STAT1
GO:0007093,mitotic cell cycle checkpoint,2/18,166/18493,0.011150732717544187,0.08343397149053161,0.05180429959662788,2,bp,NAC,990/1869,CDC6/E2F1
GO:0008361,regulation of cell size,2/18,175/18493,0.012332634619643434,0.08343397149053161,0.05180429959662788,2,bp,NAC,2335/6696,FN1/SPP1
GO:0010975,regulation of neuron projection development,3/18,478/18493,0.010488422164620604,0.08343397149053161,0.05180429959662788,3,bp,NAC,2146/2335/6696,EZH2/FN1/SPP1
GO:0016049,cell growth,3/18,485/18493,0.010910404507019054,0.08343397149053161,0.05180429959662788,3,bp,NAC,2064/2335/6696,ERBB2/FN1/SPP1
GO:0030307,positive regulation of cell growth,2/18,163/18493,0.010768662137067179,0.08343397149053161,0.05180429959662788,2,bp,NAC,2064/2335,ERBB2/FN1
GO:0031507,heterochromatin assembly,1/18,12/18493,0.011621207828278024,0.08343397149053161,0.05180429959662788,1,bp,NAC,3070,HELLS
GO:0032785,"negative regulation of DNA-templated transcription, elongation",1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,2146,EZH2
GO:0034244,negative regulation of transcription elongation from RNA polymerase II promoter,1/18,11/18493,0.010657666978024172,0.08343397149053161,0.05180429959662788,1,bp,NAC,2146,EZH2
GO:0036294,cellular response to decreased oxygen levels,2/18,170/18493,0.01166944253898824,0.08343397149053161,0.05180429959662788,2,bp,NAC,83990/1869,BRIP1/E2F1
GO:0044849,estrous cycle,1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,4316,MMP7
GO:0045605,negative regulation of epidermal cell differentiation,1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,2146,EZH2
GO:0045619,regulation of lymphocyte differentiation,2/18,166/18493,0.011150732717544187,0.08343397149053161,0.05180429959662788,2,bp,NAC,2064/2175,ERBB2/FANCA
GO:0045945,positive regulation of transcription by RNA polymerase III,1/18,11/18493,0.010657666978024172,0.08343397149053161,0.05180429959662788,1,bp,NAC,2064,ERBB2
GO:0046661,male sex differentiation,2/18,157/18493,0.010022570850103388,0.08343397149053161,0.05180429959662788,2,bp,NAC,83990/2175,BRIP1/FANCA
GO:0048681,negative regulation of axon regeneration,1/18,12/18493,0.011621207828278024,0.08343397149053161,0.05180429959662788,1,bp,NAC,6696,SPP1
GO:0051897,positive regulation of protein kinase B signaling,2/18,168/18493,0.011408765779737822,0.08343397149053161,0.05180429959662788,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0055062,phosphate ion homeostasis,1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,2264,FGFR4
GO:0061564,axon development,3/18,493/18493,0.01140474394456421,0.08343397149053161,0.05180429959662788,3,bp,NAC,2064/2335/6696,ERBB2/FN1/SPP1
GO:0070106,interleukin-27-mediated signaling pathway,1/18,11/18493,0.010657666978024172,0.08343397149053161,0.05180429959662788,1,bp,NAC,6772,STAT1
GO:0070757,interleukin-35-mediated signaling pathway,1/18,11/18493,0.010657666978024172,0.08343397149053161,0.05180429959662788,1,bp,NAC,6772,STAT1
GO:0070857,regulation of bile acid biosynthetic process,1/18,11/18493,0.010657666978024172,0.08343397149053161,0.05180429959662788,1,bp,NAC,2264,FGFR4
GO:0071456,cellular response to hypoxia,2/18,160/18493,0.010392596749937389,0.08343397149053161,0.05180429959662788,2,bp,NAC,83990/1869,BRIP1/E2F1
GO:0072505,divalent inorganic anion homeostasis,1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,2264,FGFR4
GO:0072506,trivalent inorganic anion homeostasis,1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,2264,FGFR4
GO:0072520,seminiferous tubule development,1/18,12/18493,0.011621207828278024,0.08343397149053161,0.05180429959662788,1,bp,NAC,83990,BRIP1
GO:0098962,regulation of postsynaptic neurotransmitter receptor activity,1/18,12/18493,0.011621207828278024,0.08343397149053161,0.05180429959662788,1,bp,NAC,27092,CACNG4
GO:1900451,positive regulation of glutamate receptor signaling pathway,1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,27092,CACNG4
GO:1901652,response to peptide,3/18,481/18493,0.010668067729707947,0.08343397149053161,0.05180429959662788,3,bp,NAC,6772/990/83990,STAT1/CDC6/BRIP1
GO:1904251,regulation of bile acid metabolic process,1/18,13/18493,0.012583862352334663,0.08343397149053161,0.05180429959662788,1,bp,NAC,2264,FGFR4
GO:1905475,regulation of protein localization to membrane,2/18,177/18493,0.012602485219628258,0.08343397149053161,0.05180429959662788,2,bp,NAC,2064/1869,ERBB2/E2F1
GO:0005788,endoplasmic reticulum lumen,3/18,301/19659,0.0024452301395047477,0.08525799324910509,0.058609146809266655,3,cc,NAC,1301/2335/6696,COL11A1/FN1/SPP1
GO:0016324,apical plasma membrane,3/18,308/19659,0.002609938568850156,0.08525799324910509,0.058609146809266655,3,cc,NAC,2064/2335/8842,ERBB2/FN1/PROM1
GO:0003688,DNA replication origin binding,1/18,17/17632,0.017221545541893257,0.08541886588779056,0.05075823949189592,1,mf,NAC,990,CDC6
GO:0050770,regulation of axonogenesis,2/18,180/18493,0.013012130387753616,0.08552175551951109,0.05310060837107693,2,bp,NAC,2335/6696,FN1/SPP1
GO:0007369,gastrulation,2/18,181/18493,0.01314997227441262,0.08580593419346941,0.05327705540939609,2,bp,NAC,1301/2335,COL11A1/FN1
GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,1/18,14/18493,0.013545631317576357,0.08713395464568621,0.05410162564317545,1,bp,NAC,6772,STAT1
GO:0070571,negative regulation of neuron projection regeneration,1/18,14/18493,0.013545631317576357,0.08713395464568621,0.05410162564317545,1,bp,NAC,6696,SPP1
GO:0000790,nuclear chromatin,3/18,369/19659,0.00434098659601202,0.087686981051476,0.060278912860305726,3,cc,NAC,6772/2146/1869,STAT1/EZH2/E2F1
GO:0045177,apical part of cell,3/18,373/19659,0.004473825563850816,0.087686981051476,0.060278912860305726,3,cc,NAC,2064/2335/8842,ERBB2/FN1/PROM1
GO:0071453,cellular response to oxygen levels,2/18,187/18493,0.013990518596847258,0.08936197441789058,0.05548500703716296,2,bp,NAC,83990/1869,BRIP1/E2F1
GO:0031099,regeneration,2/18,188/18493,0.014132847295344579,0.08963980767047226,0.055657514192192496,2,bp,NAC,2146/6696,EZH2/SPP1
GO:0007565,female pregnancy,2/18,191/18493,0.014563644748507465,0.08985867882242361,0.055793411675270285,2,bp,NAC,6696/4316,SPP1/MMP7
GO:0010715,regulation of extracellular matrix disassembly,1/18,15/18493,0.014506515490760763,0.08985867882242361,0.055793411675270285,1,bp,NAC,2264,FGFR4
GO:0042447,hormone catabolic process,1/18,15/18493,0.014506515490760763,0.08985867882242361,0.055793411675270285,1,bp,NAC,6696,SPP1
GO:0072075,metanephric mesenchyme development,1/18,15/18493,0.014506515490760763,0.08985867882242361,0.055793411675270285,1,bp,NAC,6772,STAT1
GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,2/18,123/19659,0.005563964932917492,0.09087809390431903,0.06247258872047711,2,cc,NAC,2335/8842,FN1/PROM1
GO:0000076,DNA replication checkpoint,1/18,16/18493,0.015466515638026257,0.0935208645579321,0.05806726923750209,1,bp,NAC,990,CDC6
GO:0048385,regulation of retinoic acid receptor signaling pathway,1/18,16/18493,0.015466515638026257,0.0935208645579321,0.05806726923750209,1,bp,NAC,2146,EZH2
GO:0072283,metanephric renal vesicle morphogenesis,1/18,16/18493,0.015466515638026257,0.0935208645579321,0.05806726923750209,1,bp,NAC,6772,STAT1
GO:0000086,G2/M transition of mitotic cell cycle,2/18,199/18493,0.015740172623566445,0.09369841949730658,0.05817751341154648,2,bp,NAC,990/9088,CDC6/PKMYT1
GO:0045683,negative regulation of epidermis development,1/18,17/18493,0.016425632524886158,0.09369841949730658,0.05817751341154648,1,bp,NAC,2146,EZH2
GO:0045780,positive regulation of bone resorption,1/18,17/18493,0.016425632524886158,0.09369841949730658,0.05817751341154648,1,bp,NAC,6696,SPP1
GO:0046852,positive regulation of bone remodeling,1/18,17/18493,0.016425632524886158,0.09369841949730658,0.05817751341154648,1,bp,NAC,6696,SPP1
GO:0061318,renal filtration cell differentiation,1/18,17/18493,0.016425632524886158,0.09369841949730658,0.05817751341154648,1,bp,NAC,8842,PROM1
GO:0070102,interleukin-6-mediated signaling pathway,1/18,17/18493,0.016425632524886158,0.09369841949730658,0.05817751341154648,1,bp,NAC,6772,STAT1
GO:0070828,heterochromatin organization,1/18,17/18493,0.016425632524886158,0.09369841949730658,0.05817751341154648,1,bp,NAC,3070,HELLS
GO:0072112,glomerular visceral epithelial cell differentiation,1/18,17/18493,0.016425632524886158,0.09369841949730658,0.05817751341154648,1,bp,NAC,8842,PROM1
GO:0090185,negative regulation of kidney development,1/18,17/18493,0.016425632524886158,0.09369841949730658,0.05817751341154648,1,bp,NAC,6772,STAT1
GO:0001502,cartilage condensation,1/18,20/18493,0.019297691268864048,0.0938163761351605,0.058250752895387774,1,bp,NAC,1301,COL11A1
GO:0001894,tissue homeostasis,2/18,221/18493,0.019179241545844068,0.0938163761351605,0.058250752895387774,2,bp,NAC,6696/8842,SPP1/PROM1
GO:0006346,methylation-dependent chromatin silencing,1/18,20/18493,0.019297691268864048,0.0938163761351605,0.058250752895387774,1,bp,NAC,3070,HELLS
GO:0007160,cell-matrix adhesion,2/18,222/18493,0.019342516358627358,0.0938163761351605,0.058250752895387774,2,bp,NAC,2335/3694,FN1/ITGB6
GO:0007221,positive regulation of transcription of Notch receptor target,1/18,18/18493,0.017383866916234836,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0008406,gonad development,2/18,216/18493,0.01837183631798792,0.0938163761351605,0.058250752895387774,2,bp,NAC,83990/2175,BRIP1/FANCA
GO:0035458,cellular response to interferon-beta,1/18,20/18493,0.019297691268864048,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0044706,multi-multicellular organism process,2/18,221/18493,0.019179241545844068,0.0938163761351605,0.058250752895387774,2,bp,NAC,6696/4316,SPP1/MMP7
GO:0044839,cell cycle G2/M phase transition,2/18,218/18493,0.018692999920384305,0.0938163761351605,0.058250752895387774,2,bp,NAC,990/9088,CDC6/PKMYT1
GO:0045137,development of primary sexual characteristics,2/18,222/18493,0.019342516358627358,0.0938163761351605,0.058250752895387774,2,bp,NAC,83990/2175,BRIP1/FANCA
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,1/18,19/18493,0.01834121957634338,0.0938163761351605,0.058250752895387774,1,bp,NAC,990,CDC6
GO:0046697,decidualization,1/18,20/18493,0.019297691268864048,0.0938163761351605,0.058250752895387774,1,bp,NAC,6696,SPP1
GO:0048670,regulation of collateral sprouting,1/18,19/18493,0.01834121957634338,0.0938163761351605,0.058250752895387774,1,bp,NAC,6696,SPP1
GO:0048762,mesenchymal cell differentiation,2/18,210/18493,0.01742283769345341,0.0938163761351605,0.058250752895387774,2,bp,NAC,6772/2146,STAT1/EZH2
GO:0050663,cytokine secretion,2/18,210/18493,0.01742283769345341,0.0938163761351605,0.058250752895387774,2,bp,NAC,2335/3694,FN1/ITGB6
GO:0051767,nitric-oxide synthase biosynthetic process,1/18,18/18493,0.017383866916234836,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0051769,regulation of nitric-oxide synthase biosynthetic process,1/18,18/18493,0.017383866916234836,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0060219,camera-type eye photoreceptor cell differentiation,1/18,18/18493,0.017383866916234836,0.0938163761351605,0.058250752895387774,1,bp,NAC,8842,PROM1
GO:0060231,mesenchymal to epithelial transition,1/18,20/18493,0.019297691268864048,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0060252,positive regulation of glial cell proliferation,1/18,18/18493,0.017383866916234836,0.0938163761351605,0.058250752895387774,1,bp,NAC,1869,E2F1
GO:0070734,histone H3-K27 methylation,1/18,19/18493,0.01834121957634338,0.0938163761351605,0.058250752895387774,1,bp,NAC,2146,EZH2
GO:0072074,kidney mesenchyme development,1/18,19/18493,0.01834121957634338,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0072077,renal vesicle morphogenesis,1/18,19/18493,0.01834121957634338,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0072087,renal vesicle development,1/18,20/18493,0.019297691268864048,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0072111,cell proliferation involved in kidney development,1/18,19/18493,0.01834121957634338,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0072234,metanephric nephron tubule development,1/18,20/18493,0.019297691268864048,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0072311,glomerular epithelial cell differentiation,1/18,18/18493,0.017383866916234836,0.0938163761351605,0.058250752895387774,1,bp,NAC,8842,PROM1
GO:1905331,negative regulation of morphogenesis of an epithelium,1/18,19/18493,0.01834121957634338,0.0938163761351605,0.058250752895387774,1,bp,NAC,6772,STAT1
GO:0000302,response to reactive oxygen species,2/18,224/18493,0.01967085032641861,0.09458206590851286,0.05872617102193974,2,bp,NAC,6772/2146,STAT1/EZH2
GO:0033622,integrin activation,1/18,21/18493,0.02025328275682814,0.09458206590851286,0.05872617102193974,1,bp,NAC,2335,FN1
GO:0046777,protein autophosphorylation,2/18,227/18493,0.02016779452385229,0.09458206590851286,0.05872617102193974,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0048588,developmental cell growth,2/18,226/18493,0.020001555588090424,0.09458206590851286,0.05872617102193974,2,bp,NAC,2335/6696,FN1/SPP1
GO:0051896,regulation of protein kinase B signaling,2/18,228/18493,0.020334622769746423,0.09458206590851286,0.05872617102193974,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0060560,developmental growth involved in morphogenesis,2/18,227/18493,0.02016779452385229,0.09458206590851286,0.05872617102193974,2,bp,NAC,2335/6696,FN1/SPP1
GO:0072010,glomerular epithelium development,1/18,21/18493,0.02025328275682814,0.09458206590851286,0.05872617102193974,1,bp,NAC,8842,PROM1
GO:0098743,cell aggregation,1/18,21/18493,0.02025328275682814,0.09458206590851286,0.05872617102193974,1,bp,NAC,1301,COL11A1
hsa04114,Oocyte meiosis,2/17,125/7844,0.029307014223436012,0.09495472608393268,0.06293295685874681,2,kg,NAC,9088/898,PKMYT1/CCNE1
GO:0005583,fibrillar collagen trimer,1/18,11/19659,0.010028279536503648,0.0960907778280358,0.06605595897953051,1,cc,NAC,1301,COL11A1
GO:0031012,extracellular matrix,3/18,490/19659,0.009503463254320676,0.0960907778280358,0.06605595897953051,3,cc,NAC,1301/2335/4316,COL11A1/FN1/MMP7
GO:0042622,photoreceptor outer segment membrane,1/18,14/19659,0.01274673583433128,0.0960907778280358,0.06605595897953051,1,cc,NAC,8842,PROM1
GO:0043240,Fanconi anaemia nuclear complex,1/18,13/19659,0.011841368055903412,0.0960907778280358,0.06605595897953051,1,cc,NAC,2175,FANCA
GO:0098643,banded collagen fibril,1/18,11/19659,0.010028279536503648,0.0960907778280358,0.06605595897953051,1,cc,NAC,1301,COL11A1
GO:0098802,plasma membrane receptor complex,2/18,184/19659,0.012080257447264263,0.0960907778280358,0.06605595897953051,2,cc,NAC,27092/3694,CACNG4/ITGB6
GO:1990454,L-type voltage-gated calcium channel complex,1/18,12/19659,0.010935216169663642,0.0960907778280358,0.06605595897953051,1,cc,NAC,27092,CACNG4
GO:0008045,motor neuron axon guidance,1/18,22/18493,0.02120799480264768,0.09617825643000723,0.05971724852324479,1,bp,NAC,2064,ERBB2
GO:0010842,retina layer formation,1/18,22/18493,0.02120799480264768,0.09617825643000723,0.05971724852324479,1,bp,NAC,8842,PROM1
GO:0032727,positive regulation of interferon-alpha production,1/18,22/18493,0.02120799480264768,0.09617825643000723,0.05971724852324479,1,bp,NAC,6772,STAT1
GO:0045943,positive regulation of transcription by RNA polymerase I,1/18,22/18493,0.02120799480264768,0.09617825643000723,0.05971724852324479,1,bp,NAC,2064,ERBB2
GO:0046488,phosphatidylinositol metabolic process,2/18,233/18493,0.021177562823712512,0.09617825643000723,0.05971724852324479,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0030217,T cell differentiation,2/18,234/18493,0.02134790245479588,0.09633108222139236,0.05981213832582245,2,bp,NAC,2064/2175,ERBB2/FANCA
GO:0072170,metanephric tubule development,1/18,23/18493,0.02216182816811496,0.09805257633405011,0.06088101704719644,1,bp,NAC,6772,STAT1
GO:0072215,regulation of metanephros development,1/18,23/18493,0.02216182816811496,0.09805257633405011,0.06088101704719644,1,bp,NAC,6772,STAT1
GO:0072243,metanephric nephron epithelium development,1/18,23/18493,0.02216182816811496,0.09805257633405011,0.06088101704719644,1,bp,NAC,6772,STAT1
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,1/18,23/18493,0.02216182816811496,0.09805257633405011,0.06088101704719644,1,bp,NAC,990,CDC6
GO:0006359,regulation of transcription by RNA polymerase III,1/18,24/18493,0.023114783614405,0.09889202235030818,0.06140223055465083,1,bp,NAC,2064,ERBB2
GO:0033081,regulation of T cell differentiation in thymus,1/18,24/18493,0.023114783614405,0.09889202235030818,0.06140223055465083,1,bp,NAC,2064,ERBB2
GO:0048679,regulation of axon regeneration,1/18,24/18493,0.023114783614405,0.09889202235030818,0.06140223055465083,1,bp,NAC,6696,SPP1
GO:0099632,protein transport within plasma membrane,1/18,24/18493,0.023114783614405,0.09889202235030818,0.06140223055465083,1,bp,NAC,27092,CACNG4
GO:0099637,neurotransmitter receptor transport,1/18,24/18493,0.023114783614405,0.09889202235030818,0.06140223055465083,1,bp,NAC,27092,CACNG4
GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/18,24/18493,0.023114783614405,0.09889202235030818,0.06140223055465083,1,bp,NAC,1869,E2F1
GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/18,24/18493,0.023114783614405,0.09889202235030818,0.06140223055465083,1,bp,NAC,1869,E2F1
GO:0070374,positive regulation of ERK1 and ERK2 cascade,2/18,245/18493,0.023259741389486117,0.09904500206696672,0.06149721592970138,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0000729,DNA double-strand break processing,1/18,26/18493,0.02501806379105742,0.09908901248248507,0.061524542074078245,1,bp,NAC,83990,BRIP1
GO:0002053,positive regulation of mesenchymal cell proliferation,1/18,26/18493,0.02501806379105742,0.09908901248248507,0.061524542074078245,1,bp,NAC,6772,STAT1
GO:0002230,positive regulation of defense response to virus by host,1/18,25/18493,0.024066861902072745,0.09908901248248507,0.061524542074078245,1,bp,NAC,6772,STAT1
GO:0043491,protein kinase B signaling,2/18,253/18493,0.024693464433761383,0.09908901248248507,0.061524542074078245,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0048668,collateral sprouting,1/18,26/18493,0.02501806379105742,0.09908901248248507,0.061524542074078245,1,bp,NAC,6696,SPP1
GO:0048872,homeostasis of number of cells,2/18,248/18493,0.023793154997460483,0.09908901248248507,0.061524542074078245,2,bp,NAC,6772/2146,STAT1/EZH2
GO:0050974,detection of mechanical stimulus involved in sensory perception,1/18,26/18493,0.02501806379105742,0.09908901248248507,0.061524542074078245,1,bp,NAC,1301,COL11A1
GO:0055083,monovalent inorganic anion homeostasis,1/18,25/18493,0.024066861902072745,0.09908901248248507,0.061524542074078245,1,bp,NAC,2264,FGFR4
GO:0060330,regulation of response to interferon-gamma,1/18,25/18493,0.024066861902072745,0.09908901248248507,0.061524542074078245,1,bp,NAC,6772,STAT1
GO:0060334,regulation of interferon-gamma-mediated signaling pathway,1/18,25/18493,0.024066861902072745,0.09908901248248507,0.061524542074078245,1,bp,NAC,6772,STAT1
GO:0071168,protein localization to chromatin,1/18,26/18493,0.02501806379105742,0.09908901248248507,0.061524542074078245,1,bp,NAC,2146,EZH2
GO:0072202,cell differentiation involved in metanephros development,1/18,26/18493,0.02501806379105742,0.09908901248248507,0.061524542074078245,1,bp,NAC,6772,STAT1
GO:0072273,metanephric nephron morphogenesis,1/18,26/18493,0.02501806379105742,0.09908901248248507,0.061524542074078245,1,bp,NAC,6772,STAT1
GO:0090596,sensory organ morphogenesis,2/18,251/18493,0.024331654460812903,0.09908901248248507,0.061524542074078245,2,bp,NAC,1301/8842,COL11A1/PROM1
GO:0099590,neurotransmitter receptor internalization,1/18,26/18493,0.02501806379105742,0.09908901248248507,0.061524542074078245,1,bp,NAC,27092,CACNG4
GO:2000311,regulation of AMPA receptor activity,1/18,25/18493,0.024066861902072745,0.09908901248248507,0.061524542074078245,1,bp,NAC,27092,CACNG4
GO:0043406,positive regulation of MAP kinase activity,2/18,258/18493,0.025607759543080342,0.10098364306771249,0.06270092153568872,2,bp,NAC,2146/2064,EZH2/ERBB2
GO:0035098,ESC/E(Z) complex,1/18,16/19659,0.014555121621752098,0.10099318725596824,0.06942603635211565,1,cc,NAC,2146,EZH2
GO:0045120,pronucleus,1/18,17/19659,0.015458140906525752,0.10099318725596824,0.06942603635211565,1,cc,NAC,2146,EZH2
GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/18,28/18493,0.026917841409641707,0.10150538843784235,0.0630248741533635,1,bp,NAC,1869,E2F1
GO:0006706,steroid catabolic process,1/18,27/18493,0.02596839004067908,0.10150538843784235,0.0630248741533635,1,bp,NAC,6696,SPP1
GO:0006929,substrate-dependent cell migration,1/18,29/18493,0.027866418656033898,0.10150538843784235,0.0630248741533635,1,bp,NAC,2335,FN1
GO:0007548,sex differentiation,2/18,268/18493,0.027477744318943186,0.10150538843784235,0.0630248741533635,2,bp,NAC,83990/2175,BRIP1/FANCA
GO:0008209,androgen metabolic process,1/18,28/18493,0.026917841409641707,0.10150538843784235,0.0630248741533635,1,bp,NAC,6696,SPP1
GO:0010976,positive regulation of neuron projection development,2/18,269/18493,0.027667745622417167,0.10150538843784235,0.0630248741533635,2,bp,NAC,2146/2335,EZH2/FN1
GO:0032607,interferon-alpha production,1/18,29/18493,0.027866418656033898,0.10150538843784235,0.0630248741533635,1,bp,NAC,6772,STAT1
GO:0032647,regulation of interferon-alpha production,1/18,28/18493,0.026917841409641707,0.10150538843784235,0.0630248741533635,1,bp,NAC,6772,STAT1
GO:0032943,mononuclear cell proliferation,2/18,266/18493,0.027099370715866787,0.10150538843784235,0.0630248741533635,2,bp,NAC,3070/2064,HELLS/ERBB2
GO:0034243,regulation of transcription elongation from RNA polymerase II promoter,1/18,29/18493,0.027866418656033898,0.10150538843784235,0.0630248741533635,1,bp,NAC,2146,EZH2
GO:0035456,response to interferon-beta,1/18,28/18493,0.026917841409641707,0.10150538843784235,0.0630248741533635,1,bp,NAC,6772,STAT1
GO:0045927,positive regulation of growth,2/18,267/18493,0.027288285646955863,0.10150538843784235,0.0630248741533635,2,bp,NAC,2064/2335,ERBB2/FN1
GO:0046651,lymphocyte proliferation,2/18,264/18493,0.026723176521205184,0.10150538843784235,0.0630248741533635,2,bp,NAC,3070/2064,HELLS/ERBB2
GO:0051984,positive regulation of chromosome segregation,1/18,28/18493,0.026917841409641707,0.10150538843784235,0.0630248741533635,1,bp,NAC,990,CDC6
GO:0060485,mesenchyme development,2/18,269/18493,0.027667745622417167,0.10150538843784235,0.0630248741533635,2,bp,NAC,6772/2146,STAT1/EZH2
GO:0070570,regulation of neuron projection regeneration,1/18,28/18493,0.026917841409641707,0.10150538843784235,0.0630248741533635,1,bp,NAC,6696,SPP1
GO:0071295,cellular response to vitamin,1/18,29/18493,0.027866418656033898,0.10150538843784235,0.0630248741533635,1,bp,NAC,83990,BRIP1
GO:0072207,metanephric epithelium development,1/18,27/18493,0.02596839004067908,0.10150538843784235,0.0630248741533635,1,bp,NAC,6772,STAT1
GO:1902105,regulation of leukocyte differentiation,2/18,265/18493,0.02691100063652228,0.10150538843784235,0.0630248741533635,2,bp,NAC,2064/2175,ERBB2/FANCA
GO:0001822,kidney development,2/18,271/18493,0.028049371693344417,0.10176312050345354,0.06318490044606007,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0048384,retinoic acid receptor signaling pathway,1/18,30/18493,0.028814122537326514,0.10370797278315536,0.06439246264607221,1,bp,NAC,2146,EZH2
GO:0090314,positive regulation of protein targeting to membrane,1/18,30/18493,0.028814122537326514,0.10370797278315536,0.06439246264607221,1,bp,NAC,2064,ERBB2
GO:0001893,maternal placenta development,1/18,31/18493,0.02976095381037691,0.10381994271543023,0.06446198497389331,1,bp,NAC,6696,SPP1
GO:0038128,ERBB2 signaling pathway,1/18,31/18493,0.02976095381037691,0.10381994271543023,0.06446198497389331,1,bp,NAC,2064,ERBB2
GO:0044818,mitotic G2/M transition checkpoint,1/18,31/18493,0.02976095381037691,0.10381994271543023,0.06446198497389331,1,bp,NAC,990,CDC6
GO:0045589,regulation of regulatory T cell differentiation,1/18,31/18493,0.02976095381037691,0.10381994271543023,0.06446198497389331,1,bp,NAC,2175,FANCA
GO:0045648,positive regulation of erythrocyte differentiation,1/18,31/18493,0.02976095381037691,0.10381994271543023,0.06446198497389331,1,bp,NAC,6772,STAT1
GO:0048511,rhythmic process,2/18,276/18493,0.02901285553842553,0.10381994271543023,0.06446198497389331,2,bp,NAC,2146/4316,EZH2/MMP7
GO:0051204,protein insertion into mitochondrial membrane,1/18,31/18493,0.02976095381037691,0.10381994271543023,0.06446198497389331,1,bp,NAC,1869,E2F1
GO:0051968,"positive regulation of synaptic transmission, glutamatergic",1/18,31/18493,0.02976095381037691,0.10381994271543023,0.06446198497389331,1,bp,NAC,27092,CACNG4
GO:0003299,muscle hypertrophy in response to stress,1/18,33/18493,0.03165200155610148,0.10439405604139654,0.06481845294742314,1,bp,NAC,2146,EZH2
GO:0003338,metanephros morphogenesis,1/18,33/18493,0.03165200155610148,0.10439405604139654,0.06481845294742314,1,bp,NAC,6772,STAT1
GO:0006356,regulation of transcription by RNA polymerase I,1/18,32/18493,0.030706913231426047,0.10439405604139654,0.06481845294742314,1,bp,NAC,2064,ERBB2
GO:0009410,response to xenobiotic stimulus,2/18,282/18493,0.030186639852830637,0.10439405604139654,0.06481845294742314,2,bp,NAC,27092/1869,CACNG4/E2F1
GO:0014887,cardiac muscle adaptation,1/18,33/18493,0.03165200155610148,0.10439405604139654,0.06481845294742314,1,bp,NAC,2146,EZH2
GO:0014898,cardiac muscle hypertrophy in response to stress,1/18,33/18493,0.03165200155610148,0.10439405604139654,0.06481845294742314,1,bp,NAC,2146,EZH2
GO:0030522,intracellular receptor signaling pathway,2/18,288/18493,0.03137940529932533,0.10439405604139654,0.06481845294742314,2,bp,NAC,2146/898,EZH2/CCNE1
GO:0032594,protein transport within lipid bilayer,1/18,32/18493,0.030706913231426047,0.10439405604139654,0.06481845294742314,1,bp,NAC,27092,CACNG4
GO:0045066,regulatory T cell differentiation,1/18,33/18493,0.03165200155610148,0.10439405604139654,0.06481845294742314,1,bp,NAC,2175,FANCA
GO:0060251,regulation of glial cell proliferation,1/18,33/18493,0.03165200155610148,0.10439405604139654,0.06481845294742314,1,bp,NAC,1869,E2F1
GO:0070661,leukocyte proliferation,2/18,283/18493,0.03038412230887589,0.10439405604139654,0.06481845294742314,2,bp,NAC,3070/2064,HELLS/ERBB2
GO:0071103,DNA conformation change,2/18,283/18493,0.03038412230887589,0.10439405604139654,0.06481845294742314,2,bp,NAC,3070/83990,HELLS/BRIP1
GO:0071354,cellular response to interleukin-6,1/18,33/18493,0.03165200155610148,0.10439405604139654,0.06481845294742314,1,bp,NAC,6772,STAT1
GO:0072001,renal system development,2/18,286/18493,0.030979722300683837,0.10439405604139654,0.06481845294742314,2,bp,NAC,6772/8842,STAT1/PROM1
GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1/18,32/18493,0.030706913231426047,0.10439405604139654,0.06481845294742314,1,bp,NAC,1869,E2F1
GO:0010464,regulation of mesenchymal cell proliferation,1/18,34/18493,0.03259621953941627,0.10483961390868993,0.06509510061062974,1,bp,NAC,6772,STAT1
GO:0010769,regulation of cell morphogenesis involved in differentiation,2/18,293/18493,0.03238770691691519,0.10483961390868993,0.06509510061062974,2,bp,NAC,2335/6696,FN1/SPP1
GO:0030258,lipid modification,2/18,291/18493,0.0319828326688233,0.10483961390868993,0.06509510061062974,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0043276,anoikis,1/18,34/18493,0.03259621953941627,0.10483961390868993,0.06509510061062974,1,bp,NAC,1869,E2F1
GO:0043403,skeletal muscle tissue regeneration,1/18,34/18493,0.03259621953941627,0.10483961390868993,0.06509510061062974,1,bp,NAC,2146,EZH2
GO:0071634,regulation of transforming growth factor beta production,1/18,34/18493,0.03259621953941627,0.10483961390868993,0.06509510061062974,1,bp,NAC,3694,ITGB6
GO:0097421,liver regeneration,1/18,34/18493,0.03259621953941627,0.10483961390868993,0.06509510061062974,1,bp,NAC,2146,EZH2
GO:0098644,complex of collagen trimers,1/18,19/19659,0.017261835443999285,0.10572874209449562,0.07268141239578646,1,cc,NAC,1301,COL11A1
GO:0033280,response to vitamin D,1/18,35/18493,0.03353956793576973,0.10711404266810967,0.06650729742637809,1,bp,NAC,6696,SPP1
GO:0110111,negative regulation of animal organ morphogenesis,1/18,35/18493,0.03353956793576973,0.10711404266810967,0.06650729742637809,1,bp,NAC,6772,STAT1
GO:0006699,bile acid biosynthetic process,1/18,36/18493,0.0344820474989489,0.10747497278882011,0.06673139957293421,1,bp,NAC,2264,FGFR4
GO:0010742,macrophage derived foam cell differentiation,1/18,36/18493,0.0344820474989489,0.10747497278882011,0.06673139957293421,1,bp,NAC,6772,STAT1
GO:0048255,mRNA stabilization,1/18,36/18493,0.0344820474989489,0.10747497278882011,0.06673139957293421,1,bp,NAC,1869,E2F1
GO:0050691,regulation of defense response to virus by host,1/18,36/18493,0.0344820474989489,0.10747497278882011,0.06673139957293421,1,bp,NAC,6772,STAT1
GO:0071604,transforming growth factor beta production,1/18,36/18493,0.0344820474989489,0.10747497278882011,0.06673139957293421,1,bp,NAC,3694,ITGB6
GO:0090077,foam cell differentiation,1/18,36/18493,0.0344820474989489,0.10747497278882011,0.06673139957293421,1,bp,NAC,6772,STAT1
GO:0090313,regulation of protein targeting to membrane,1/18,36/18493,0.0344820474989489,0.10747497278882011,0.06673139957293421,1,bp,NAC,2064,ERBB2
GO:0050863,regulation of T cell activation,2/18,305/18493,0.034859943159363055,0.1082807138545969,0.06723168561737289,2,bp,NAC,2064/2175,ERBB2/FANCA
GO:0032467,positive regulation of cytokinesis,1/18,37/18493,0.03542365898212674,0.10854479289455726,0.06739565275760245,1,bp,NAC,990,CDC6
GO:0045494,photoreceptor cell maintenance,1/18,37/18493,0.03542365898212674,0.10854479289455726,0.06739565275760245,1,bp,NAC,8842,PROM1
GO:0070741,response to interleukin-6,1/18,37/18493,0.03542365898212674,0.10854479289455726,0.06739565275760245,1,bp,NAC,6772,STAT1
GO:2000273,positive regulation of signaling receptor activity,1/18,37/18493,0.03542365898212674,0.10854479289455726,0.06739565275760245,1,bp,NAC,27092,CACNG4
hsa05162,Measles,2/17,138/7844,0.03516419651572469,0.10954999683744998,0.0726062357207271,2,kg,NAC,6772/898,STAT1/CCNE1
GO:0005721,pericentric heterochromatin,1/18,21/19659,0.019062408847433043,0.10988918041461401,0.07554143444183993,1,cc,NAC,3070,HELLS
GO:0045124,regulation of bone resorption,1/18,38/18493,0.03636440313786593,0.11067957599343758,0.06872114333718923,1,bp,NAC,6696,SPP1
GO:0061462,protein localization to lysosome,1/18,38/18493,0.03636440313786593,0.11067957599343758,0.06872114333718923,1,bp,NAC,27092,CACNG4
GO:0017134,fibroblast growth factor binding,1/18,23/17632,0.023232574928299776,0.11080151119650662,0.06584130546481719,1,mf,NAC,2264,FGFR4
GO:0000983,"transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding",1/18,24/17632,0.02423103103888502,0.11128325366006454,0.0661275700866258,1,mf,NAC,6772,STAT1
GO:0001666,response to hypoxia,2/18,314/18493,0.03676171511370422,0.11150709499810545,0.06923495134217654,2,bp,NAC,83990/1869,BRIP1/E2F1
GO:0008156,negative regulation of DNA replication,1/18,39/18493,0.037304280718116534,0.11150709499810545,0.06923495134217654,1,bp,NAC,990,CDC6
GO:0008202,steroid metabolic process,2/18,318/18493,0.03761981374798265,0.11150709499810545,0.06923495134217654,2,bp,NAC,6696/2264,SPP1/FGFR4
GO:0045773,positive regulation of axon extension,1/18,39/18493,0.037304280718116534,0.11150709499810545,0.06923495134217654,1,bp,NAC,2335,FN1
GO:0051154,negative regulation of striated muscle cell differentiation,1/18,39/18493,0.037304280718116534,0.11150709499810545,0.06923495134217654,1,bp,NAC,2146,EZH2
GO:0090150,establishment of protein localization to membrane,2/18,317/18493,0.03740455305249374,0.11150709499810545,0.06923495134217654,2,bp,NAC,2064/1869,ERBB2/E2F1
GO:1903053,regulation of extracellular matrix organization,1/18,39/18493,0.037304280718116534,0.11150709499810545,0.06923495134217654,1,bp,NAC,2264,FGFR4
GO:1903829,positive regulation of cellular protein localization,2/18,318/18493,0.03761981374798265,0.11150709499810545,0.06923495134217654,2,bp,NAC,2064/1869,ERBB2/E2F1
GO:0001655,urogenital system development,2/18,322/18493,0.03848573573032034,0.11246064973197421,0.06982701515302758,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0030574,collagen catabolic process,1/18,41/18493,0.03918143915689509,0.11246064973197421,0.06982701515302758,1,bp,NAC,4316,MMP7
GO:0033574,response to testosterone,1/18,41/18493,0.03918143915689509,0.11246064973197421,0.06982701515302758,1,bp,NAC,6696,SPP1
GO:0036293,response to decreased oxygen levels,2/18,325/18493,0.039140271384026364,0.11246064973197421,0.06982701515302758,2,bp,NAC,83990/1869,BRIP1/E2F1
GO:0043489,RNA stabilization,1/18,41/18493,0.03918143915689509,0.11246064973197421,0.06982701515302758,1,bp,NAC,1869,E2F1
GO:0046677,response to antibiotic,2/18,323/18493,0.038703430845209566,0.11246064973197421,0.06982701515302758,2,bp,NAC,6772/2146,STAT1/EZH2
GO:0050982,detection of mechanical stimulus,1/18,41/18493,0.03918143915689509,0.11246064973197421,0.06982701515302758,1,bp,NAC,1301,COL11A1
GO:0072210,metanephric nephron development,1/18,41/18493,0.03918143915689509,0.11246064973197421,0.06982701515302758,1,bp,NAC,6772,STAT1
GO:0090184,positive regulation of kidney development,1/18,40/18493,0.03824329247421665,0.11246064973197421,0.06982701515302758,1,bp,NAC,8842,PROM1
GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1/18,41/18493,0.03918143915689509,0.11246064973197421,0.06982701515302758,1,bp,NAC,1869,E2F1
GO:0031528,microvillus membrane,1/18,23/19659,0.02085986620049307,0.11357038264712895,0.07807201384979863,1,cc,NAC,8842,PROM1
GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,1/18,42/18493,0.040118721516269606,0.11371150129767667,0.07060367108948765,1,bp,NAC,6772,STAT1
GO:0045581,negative regulation of T cell differentiation,1/18,42/18493,0.040118721516269606,0.11371150129767667,0.07060367108948765,1,bp,NAC,2064,ERBB2
GO:0071496,cellular response to external stimulus,2/18,328/18493,0.03979914251386587,0.11371150129767667,0.07060367108948765,2,bp,NAC,83990/4316,BRIP1/MMP7
GO:0072666,establishment of protein localization to vacuole,1/18,42/18493,0.040118721516269606,0.11371150129767667,0.07060367108948765,1,bp,NAC,27092,CACNG4
GO:0004003,ATP-dependent DNA helicase activity,1/18,38/17632,0.038108596284166296,0.11423926649972455,0.06788411421885161,1,mf,NAC,83990,BRIP1
GO:0004693,cyclin-dependent protein serine/threonine kinase activity,1/18,36/17632,0.03613756395450851,0.11423926649972455,0.06788411421885161,1,mf,NAC,898,CCNE1
GO:0005085,guanyl-nucleotide exchange factor activity,2/18,327/17632,0.04314646453825145,0.11423926649972455,0.06788411421885161,2,mf,NAC,2064/2264,ERBB2/FGFR4
GO:0005088,Ras guanyl-nucleotide exchange factor activity,2/18,254/17632,0.02717199131483573,0.11423926649972455,0.06788411421885161,2,mf,NAC,2064/2264,ERBB2/FGFR4
GO:0005164,tumor necrosis factor receptor binding,1/18,31/17632,0.03119328138606481,0.11423926649972455,0.06788411421885161,1,mf,NAC,6772,STAT1
GO:0005245,voltage-gated calcium channel activity,1/18,48/17632,0.04790678917730384,0.11423926649972455,0.06788411421885161,1,mf,NAC,27092,CACNG4
GO:0005246,calcium channel regulator activity,1/18,44/17632,0.04399887814257508,0.11423926649972455,0.06788411421885161,1,mf,NAC,27092,CACNG4
GO:0015485,cholesterol binding,1/18,44/17632,0.04399887814257508,0.11423926649972455,0.06788411421885161,1,mf,NAC,8842,PROM1
GO:0016303,1-phosphatidylinositol-3-kinase activity,1/18,46/17632,0.045954723418757615,0.11423926649972455,0.06788411421885161,1,mf,NAC,2264,FGFR4
GO:0016504,peptidase activator activity,1/18,39/17632,0.03909268434071289,0.11423926649972455,0.06788411421885161,1,mf,NAC,2335,FN1
GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,1/18,48/17632,0.04790678917730384,0.11423926649972455,0.06788411421885161,1,mf,NAC,898,CCNE1
GO:0018024,histone-lysine N-methyltransferase activity,1/18,45/17632,0.04497727365050319,0.11423926649972455,0.06788411421885161,1,mf,NAC,2146,EZH2
GO:0030020,extracellular matrix structural constituent conferring tensile strength,1/18,37/17632,0.03712355644421128,0.11423926649972455,0.06788411421885161,1,mf,NAC,1301,COL11A1
GO:0032813,tumor necrosis factor receptor superfamily binding,1/18,46/17632,0.045954723418757615,0.11423926649972455,0.06788411421885161,1,mf,NAC,6772,STAT1
GO:0035035,histone acetyltransferase binding,1/18,29/17632,0.029208869405630167,0.11423926649972455,0.06788411421885161,1,mf,NAC,6772,STAT1
GO:0035254,glutamate receptor binding,1/18,48/17632,0.04790678917730384,0.11423926649972455,0.06788411421885161,1,mf,NAC,27092,CACNG4
GO:0035255,ionotropic glutamate receptor binding,1/18,32/17632,0.032184050145513066,0.11423926649972455,0.06788411421885161,1,mf,NAC,27092,CACNG4
GO:0042805,actinin binding,1/18,39/17632,0.03909268434071289,0.11423926649972455,0.06788411421885161,1,mf,NAC,8842,PROM1
GO:0045296,cadherin binding,2/18,323/17632,0.04219657757175503,0.11423926649972455,0.06788411421885161,2,mf,NAC,6772/8842,STAT1/PROM1
GO:0048020,CCR chemokine receptor binding,1/18,43/17632,0.04301953603379194,0.11423926649972455,0.06788411421885161,1,mf,NAC,6772,STAT1
GO:0050681,androgen receptor binding,1/18,44/17632,0.04399887814257508,0.11423926649972455,0.06788411421885161,1,mf,NAC,898,CCNE1
GO:0051539,"4 iron, 4 sulfur cluster binding",1/18,41/17632,0.041058008565252546,0.11423926649972455,0.06788411421885161,1,mf,NAC,83990,BRIP1
GO:0051721,protein phosphatase 2A binding,1/18,29/17632,0.029208869405630167,0.11423926649972455,0.06788411421885161,1,mf,NAC,6772,STAT1
GO:0097472,cyclin-dependent protein kinase activity,1/18,37/17632,0.03712355644421128,0.11423926649972455,0.06788411421885161,1,mf,NAC,898,CCNE1
GO:0097718,disordered domain specific binding,1/18,32/17632,0.032184050145513066,0.11423926649972455,0.06788411421885161,1,mf,NAC,2335,FN1
GO:0003678,DNA helicase activity,1/18,50/17632,0.04985508229299218,0.11448204082094501,0.06802837739784509,1,mf,NAC,83990,BRIP1
GO:0032934,sterol binding,1/18,50/17632,0.04985508229299218,0.11448204082094501,0.06802837739784509,1,mf,NAC,8842,PROM1
GO:0014009,glial cell proliferation,1/18,43/18493,0.04105514030184754,0.11513799624132598,0.07148938430814067,1,bp,NAC,1869,E2F1
GO:0048638,regulation of developmental growth,2/18,334/18493,0.0411297803552256,0.11513799624132598,0.07148938430814067,2,bp,NAC,2335/6696,FN1/SPP1
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,1/18,43/18493,0.04105514030184754,0.11513799624132598,0.07148938430814067,1,bp,NAC,990,CDC6
GO:1902373,negative regulation of mRNA catabolic process,1/18,43/18493,0.04105514030184754,0.11513799624132598,0.07148938430814067,1,bp,NAC,1869,E2F1
GO:0043405,regulation of MAP kinase activity,2/18,335/18493,0.0413532130550612,0.11540727458750925,0.07165657970674572,2,bp,NAC,2146/2064,EZH2/ERBB2
GO:0031589,cell-substrate adhesion,2/18,338/18493,0.04202633604693897,0.11585983828137886,0.07193757729999153,2,bp,NAC,2335/3694,FN1/ITGB6
GO:0034105,positive regulation of tissue remodeling,1/18,44/18493,0.04199069626252905,0.11585983828137886,0.07193757729999153,1,bp,NAC,6696,SPP1
GO:0046850,regulation of bone remodeling,1/18,44/18493,0.04199069626252905,0.11585983828137886,0.07193757729999153,1,bp,NAC,6696,SPP1
GO:0071364,cellular response to epidermal growth factor stimulus,1/18,44/18493,0.04199069626252905,0.11585983828137886,0.07193757729999153,1,bp,NAC,2064,ERBB2
GO:0001754,eye photoreceptor cell differentiation,1/18,45/18493,0.04292539014660257,0.11726906284026667,0.0728125673063804,1,bp,NAC,8842,PROM1
GO:0002063,chondrocyte development,1/18,45/18493,0.04292539014660257,0.11726906284026667,0.0728125673063804,1,bp,NAC,1301,COL11A1
GO:0010463,mesenchymal cell proliferation,1/18,45/18493,0.04292539014660257,0.11726906284026667,0.0728125673063804,1,bp,NAC,6772,STAT1
GO:0006953,acute-phase response,1/18,47/18493,0.044792194675044805,0.11741768950943826,0.07290484986659256,1,bp,NAC,2335,FN1
GO:0007140,male meiotic nuclear division,1/18,46/18493,0.04385922270175002,0.11741768950943826,0.07290484986659256,1,bp,NAC,2175,FANCA
GO:0007528,neuromuscular junction development,1/18,47/18493,0.044792194675044805,0.11741768950943826,0.07290484986659256,1,bp,NAC,2064,ERBB2
GO:0008206,bile acid metabolic process,1/18,46/18493,0.04385922270175002,0.11741768950943826,0.07290484986659256,1,bp,NAC,2264,FGFR4
GO:0019731,antibacterial humoral response,1/18,47/18493,0.044792194675044805,0.11741768950943826,0.07290484986659256,1,bp,NAC,4316,MMP7
GO:0022412,cellular process involved in reproduction in multicellular organism,2/18,350/18493,0.044760716454860155,0.11741768950943826,0.07290484986659256,2,bp,NAC,83990/2175,BRIP1/FANCA
GO:0030098,lymphocyte differentiation,2/18,344/18493,0.04338520293980766,0.11741768950943826,0.07290484986659256,2,bp,NAC,2064/2175,ERBB2/FANCA
GO:0031103,axon regeneration,1/18,46/18493,0.04385922270175002,0.11741768950943826,0.07290484986659256,1,bp,NAC,6696,SPP1
GO:0045646,regulation of erythrocyte differentiation,1/18,47/18493,0.044792194675044805,0.11741768950943826,0.07290484986659256,1,bp,NAC,6772,STAT1
GO:0051205,protein insertion into membrane,1/18,47/18493,0.044792194675044805,0.11741768950943826,0.07290484986659256,1,bp,NAC,1869,E2F1
GO:0055010,ventricular cardiac muscle tissue morphogenesis,1/18,47/18493,0.044792194675044805,0.11741768950943826,0.07290484986659256,1,bp,NAC,1301,COL11A1
GO:0060042,retina morphogenesis in camera-type eye,1/18,47/18493,0.044792194675044805,0.11741768950943826,0.07290484986659256,1,bp,NAC,8842,PROM1
GO:0070482,response to oxygen levels,2/18,349/18493,0.04453031737509816,0.11741768950943826,0.07290484986659256,2,bp,NAC,83990/1869,BRIP1/E2F1
GO:1901185,negative regulation of ERBB signaling pathway,1/18,47/18493,0.044792194675044805,0.11741768950943826,0.07290484986659256,1,bp,NAC,2064,ERBB2
GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,1/18,48/18493,0.045724306812952586,0.11748426708030593,0.07294618799740461,1,bp,NAC,990,CDC6
GO:0021695,cerebellar cortex development,1/18,48/18493,0.045724306812952586,0.11748426708030593,0.07294618799740461,1,bp,NAC,2146,EZH2
GO:0031055,chromatin remodeling at centromere,1/18,48/18493,0.045724306812952586,0.11748426708030593,0.07294618799740461,1,bp,NAC,3070,HELLS
GO:0032784,"regulation of DNA-templated transcription, elongation",1/18,48/18493,0.045724306812952586,0.11748426708030593,0.07294618799740461,1,bp,NAC,2146,EZH2
GO:0045862,positive regulation of proteolysis,2/18,352/18493,0.04522288282526116,0.11748426708030593,0.07294618799740461,2,bp,NAC,2335/2264,FN1/FGFR4
GO:0070849,response to epidermal growth factor,1/18,48/18493,0.045724306812952586,0.11748426708030593,0.07294618799740461,1,bp,NAC,2064,ERBB2
GO:1900449,regulation of glutamate receptor signaling pathway,1/18,48/18493,0.045724306812952586,0.11748426708030593,0.07294618799740461,1,bp,NAC,27092,CACNG4
GO:0045666,positive regulation of neuron differentiation,2/18,356/18493,0.04615266058359037,0.11824989590202391,0.07342156827897964,2,bp,NAC,2146/2335,EZH2/FN1
hsa05224,Breast cancer,2/17,147/7844,0.03946691588848095,0.11840074766544284,0.07847223042154107,2,kg,NAC,2064/1869,ERBB2/E2F1
GO:0010718,positive regulation of epithelial to mesenchymal transition,1/18,49/18493,0.04665555986133274,0.1185338733731899,0.07359789039013127,1,bp,NAC,2146,EZH2
GO:0045599,negative regulation of fat cell differentiation,1/18,49/18493,0.04665555986133274,0.1185338733731899,0.07359789039013127,1,bp,NAC,1869,E2F1
GO:1990090,cellular response to nerve growth factor stimulus,1/18,49/18493,0.04665555986133274,0.1185338733731899,0.07359789039013127,1,bp,NAC,1869,E2F1
GO:0043687,post-translational protein modification,2/18,361/18493,0.04732501052625371,0.11989016886347548,0.07444001664476226,2,bp,NAC,2335/6696,FN1/SPP1
GO:0097120,receptor localization to synapse,1/18,50/18493,0.047585954565436794,0.11989016886347548,0.07444001664476226,1,bp,NAC,27092,CACNG4
GO:1902369,negative regulation of RNA catabolic process,1/18,50/18493,0.047585954565436794,0.11989016886347548,0.07444001664476226,1,bp,NAC,1869,E2F1
GO:0006650,glycerophospholipid metabolic process,2/18,367/18493,0.048746522071797124,0.1208008074292896,0.0750054337314106,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0030071,regulation of mitotic metaphase/anaphase transition,1/18,51/18493,0.048515491669911204,0.1208008074292896,0.0750054337314106,1,bp,NAC,990,CDC6
GO:0032535,regulation of cellular component size,2/18,367/18493,0.048746522071797124,0.1208008074292896,0.0750054337314106,2,bp,NAC,2335/6696,FN1/SPP1
GO:0036297,interstrand cross-link repair,1/18,51/18493,0.048515491669911204,0.1208008074292896,0.0750054337314106,1,bp,NAC,2175,FANCA
GO:0045620,negative regulation of lymphocyte differentiation,1/18,51/18493,0.048515491669911204,0.1208008074292896,0.0750054337314106,1,bp,NAC,2064,ERBB2
GO:0097345,mitochondrial outer membrane permeabilization,1/18,51/18493,0.048515491669911204,0.1208008074292896,0.0750054337314106,1,bp,NAC,1869,E2F1
GO:0007566,embryo implantation,1/18,52/18493,0.049444171918796576,0.12087833943490159,0.0750535734900161,1,bp,NAC,6696,SPP1
GO:0030199,collagen fibril organization,1/18,52/18493,0.049444171918796576,0.12087833943490159,0.0750535734900161,1,bp,NAC,1301,COL11A1
GO:0042220,response to cocaine,1/18,52/18493,0.049444171918796576,0.12087833943490159,0.0750535734900161,1,bp,NAC,27092,CACNG4
GO:0050678,regulation of epithelial cell proliferation,2/18,368/18493,0.04898498515667651,0.12087833943490159,0.0750535734900161,2,bp,NAC,6772/2064,STAT1/ERBB2
GO:1990089,response to nerve growth factor,1/18,52/18493,0.049444171918796576,0.12087833943490159,0.0750535734900161,1,bp,NAC,1869,E2F1
GO:0007131,reciprocal meiotic recombination,1/18,53/18493,0.050371996055527446,0.12099318108112088,0.07512487887007448,1,bp,NAC,83990,BRIP1
GO:0030900,forebrain development,2/18,374/18493,0.05042494206026868,0.12099318108112088,0.07512487887007448,2,bp,NAC,2146/1869,EZH2/E2F1
GO:0031346,positive regulation of cell projection organization,2/18,371/18493,0.049703002630089005,0.12099318108112088,0.07512487887007448,2,bp,NAC,2146/2335,EZH2/FN1
GO:0035825,homologous recombination,1/18,53/18493,0.050371996055527446,0.12099318108112088,0.07512487887007448,1,bp,NAC,83990,BRIP1
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,1/18,53/18493,0.050371996055527446,0.12099318108112088,0.07512487887007448,1,bp,NAC,2264,FGFR4
GO:0043392,negative regulation of DNA binding,1/18,53/18493,0.050371996055527446,0.12099318108112088,0.07512487887007448,1,bp,NAC,1869,E2F1
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,1/18,53/18493,0.050371996055527446,0.12099318108112088,0.07512487887007448,1,bp,NAC,990,CDC6
GO:0052742,phosphatidylinositol kinase activity,1/18,54/17632,0.05374037803630327,0.12116012502730192,0.07199667870892305,1,mf,NAC,2264,FGFR4
hsa04934,Cushing syndrome,2/17,155/7844,0.04345392223911399,0.12137130004718046,0.08044101757512935,2,kg,NAC,1869/898,E2F1/CCNE1
hsa05160,Hepatitis C,2/17,155/7844,0.04345392223911399,0.12137130004718046,0.08044101757512935,2,kg,NAC,6772/1869,STAT1/E2F1
GO:0003229,ventricular cardiac muscle tissue development,1/18,54/18493,0.0512989648229355,0.12244252919579605,0.07602478166279916,1,bp,NAC,1301,COL11A1
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,1/18,54/18493,0.0512989648229355,0.12244252919579605,0.07602478166279916,1,bp,NAC,990,CDC6
GO:0001503,ossification,2/18,380/18493,0.05188048247456958,0.12290969634664929,0.07631484656816269,2,bp,NAC,1301/6696,COL11A1/SPP1
GO:0006383,transcription by RNA polymerase III,1/18,56/18493,0.05315033921808232,0.12290969634664929,0.07631484656816269,1,bp,NAC,2064,ERBB2
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",1/18,56/18493,0.05315033921808232,0.12290969634664929,0.07631484656816269,1,bp,NAC,1869,E2F1
GO:0008333,endosome to lysosome transport,1/18,57/18493,0.054074746328461765,0.12290969634664929,0.07631484656816269,1,bp,NAC,27092,CACNG4
GO:0010965,regulation of mitotic sister chromatid separation,1/18,57/18493,0.054074746328461765,0.12290969634664929,0.07631484656816269,1,bp,NAC,990,CDC6
GO:0018108,peptidyl-tyrosine phosphorylation,2/18,387/18493,0.053598031920170236,0.12290969634664929,0.07631484656816269,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0018212,peptidyl-tyrosine modification,2/18,390/18493,0.05434045009372257,0.12290969634664929,0.07631484656816269,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0031102,neuron projection regeneration,1/18,55/18493,0.0522250789632458,0.12290969634664929,0.07631484656816269,1,bp,NAC,6696,SPP1
GO:0034508,centromere complex assembly,1/18,56/18493,0.05315033921808232,0.12290969634664929,0.07631484656816269,1,bp,NAC,3070,HELLS
GO:0042130,negative regulation of T cell proliferation,1/18,56/18493,0.05315033921808232,0.12290969634664929,0.07631484656816269,1,bp,NAC,2064,ERBB2
GO:0044784,metaphase/anaphase transition of cell cycle,1/18,56/18493,0.05315033921808232,0.12290969634664929,0.07631484656816269,1,bp,NAC,990,CDC6
GO:0045765,regulation of angiogenesis,2/18,381/18493,0.052124573006349414,0.12290969634664929,0.07631484656816269,2,bp,NAC,6772/2064,STAT1/ERBB2
GO:0048545,response to steroid hormone,2/18,390/18493,0.05434045009372257,0.12290969634664929,0.07631484656816269,2,bp,NAC,6696/898,SPP1/CCNE1
GO:0055081,anion homeostasis,1/18,56/18493,0.05315033921808232,0.12290969634664929,0.07631484656816269,1,bp,NAC,2264,FGFR4
GO:0071398,cellular response to fatty acid,1/18,55/18493,0.0522250789632458,0.12290969634664929,0.07631484656816269,1,bp,NAC,1869,E2F1
GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,1/18,57/18493,0.054074746328461765,0.12290969634664929,0.07631484656816269,1,bp,NAC,1869,E2F1
GO:0072665,protein localization to vacuole,1/18,57/18493,0.054074746328461765,0.12290969634664929,0.07631484656816269,1,bp,NAC,27092,CACNG4
GO:0099601,regulation of neurotransmitter receptor activity,1/18,56/18493,0.05315033921808232,0.12290969634664929,0.07631484656816269,1,bp,NAC,27092,CACNG4
GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,1/18,57/18493,0.054074746328461765,0.12290969634664929,0.07631484656816269,1,bp,NAC,1869,E2F1
GO:1902400,intracellular signal transduction involved in G1 DNA damage checkpoint,1/18,57/18493,0.054074746328461765,0.12290969634664929,0.07631484656816269,1,bp,NAC,1869,E2F1
GO:1903749,positive regulation of establishment of protein localization to mitochondrion,1/18,56/18493,0.05315033921808232,0.12290969634664929,0.07631484656816269,1,bp,NAC,1869,E2F1
GO:0043175,RNA polymerase core enzyme binding,1/18,56/17632,0.055677394354933796,0.12328565892878199,0.07325972941438658,1,mf,NAC,2064,ERBB2
GO:0014888,striated muscle adaptation,1/18,58/18493,0.0549983010348023,0.1234739085113012,0.07666516689322364,1,bp,NAC,2146,EZH2
GO:0045453,bone resorption,1/18,58/18493,0.0549983010348023,0.1234739085113012,0.07666516689322364,1,bp,NAC,6696,SPP1
GO:0045604,regulation of epidermal cell differentiation,1/18,58/18493,0.0549983010348023,0.1234739085113012,0.07666516689322364,1,bp,NAC,2146,EZH2
GO:0032370,positive regulation of lipid transport,1/18,59/18493,0.055921004076916025,0.12401063740284311,0.07699842280568801,1,bp,NAC,6696,SPP1
GO:0072413,signal transduction involved in mitotic cell cycle checkpoint,1/18,59/18493,0.055921004076916025,0.12401063740284311,0.07699842280568801,1,bp,NAC,1869,E2F1
GO:1902402,signal transduction involved in mitotic DNA damage checkpoint,1/18,59/18493,0.055921004076916025,0.12401063740284311,0.07699842280568801,1,bp,NAC,1869,E2F1
GO:1902403,signal transduction involved in mitotic DNA integrity checkpoint,1/18,59/18493,0.055921004076916025,0.12401063740284311,0.07699842280568801,1,bp,NAC,1869,E2F1
GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,1/18,59/18493,0.055921004076916025,0.12401063740284311,0.07699842280568801,1,bp,NAC,1869,E2F1
GO:0045785,positive regulation of cell adhesion,2/18,397/18493,0.05608733107044593,0.12407612019730357,0.07703908118790392,2,bp,NAC,2064/2335,ERBB2/FN1
GO:0003407,neural retina development,1/18,60/18493,0.056842856194015634,0.12423245919993298,0.07713615234952027,1,bp,NAC,8842,PROM1
GO:0018149,peptide cross-linking,1/18,60/18493,0.056842856194015634,0.12423245919993298,0.07713615234952027,1,bp,NAC,2335,FN1
GO:0032835,glomerulus development,1/18,60/18493,0.056842856194015634,0.12423245919993298,0.07713615234952027,1,bp,NAC,8842,PROM1
GO:0051306,mitotic sister chromatid separation,1/18,60/18493,0.056842856194015634,0.12423245919993298,0.07713615234952027,1,bp,NAC,990,CDC6
GO:1902750,negative regulation of cell cycle G2/M phase transition,1/18,60/18493,0.056842856194015634,0.12423245919993298,0.07713615234952027,1,bp,NAC,990,CDC6
hsa04218,Cellular senescence,2/17,160/7844,0.04602073660647097,0.12425598883747163,0.08235289708526385,2,kg,NAC,1869/898,E2F1/CCNE1
GO:0042054,histone methyltransferase activity,1/18,58/17632,0.057610665412758943,0.12532846510845805,0.0744736210321907,1,mf,NAC,2146,EZH2
GO:0035794,positive regulation of mitochondrial membrane permeability,1/18,61/18493,0.057763858124710965,0.12594187336325205,0.07819753060911026,1,bp,NAC,1869,E2F1
GO:0032281,AMPA glutamate receptor complex,1/18,27/19659,0.024445453051358368,0.1260870736333221,0.08667639863085513,1,cc,NAC,27092,CACNG4
GO:0043547,positive regulation of GTPase activity,2/18,405/18493,0.05810840897353903,0.12638927323501173,0.0784753219761287,2,bp,NAC,2146/2064,EZH2/ERBB2
GO:0046530,photoreceptor cell differentiation,1/18,62/18493,0.058684010607011006,0.12672951814418804,0.07868658063847342,1,bp,NAC,8842,PROM1
GO:0051148,negative regulation of muscle cell differentiation,1/18,62/18493,0.058684010607011006,0.12672951814418804,0.07868658063847342,1,bp,NAC,2146,EZH2
GO:1905818,regulation of chromosome separation,1/18,62/18493,0.058684010607011006,0.12672951814418804,0.07868658063847342,1,bp,NAC,990,CDC6
GO:0016278,lysine N-methyltransferase activity,1/18,62/17632,0.06146599899972638,0.12690180784212637,0.0754085445581396,1,mf,NAC,2146,EZH2
GO:0016279,protein-lysine N-methyltransferase activity,1/18,61/17632,0.06050356454305206,0.12690180784212637,0.0754085445581396,1,mf,NAC,2146,EZH2
GO:0051536,iron-sulfur cluster binding,1/18,63/17632,0.062427502244917,0.12690180784212637,0.0754085445581396,1,mf,NAC,83990,BRIP1
GO:0051540,metal cluster binding,1/18,63/17632,0.062427502244917,0.12690180784212637,0.0754085445581396,1,mf,NAC,83990,BRIP1
GO:0006360,transcription by RNA polymerase I,1/18,63/18493,0.059603314378324446,0.12720048503797712,0.0789790048109067,1,bp,NAC,2064,ERBB2
GO:0031571,mitotic G1 DNA damage checkpoint,1/18,63/18493,0.059603314378324446,0.12720048503797712,0.0789790048109067,1,bp,NAC,1869,E2F1
GO:0044819,mitotic G1/S transition checkpoint,1/18,63/18493,0.059603314378324446,0.12720048503797712,0.0789790048109067,1,bp,NAC,1869,E2F1
GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,1/18,63/18493,0.059603314378324446,0.12720048503797712,0.0789790048109067,1,bp,NAC,1869,E2F1
GO:1905710,positive regulation of membrane permeability,1/18,63/18493,0.059603314378324446,0.12720048503797712,0.0789790048109067,1,bp,NAC,1869,E2F1
GO:0051052,regulation of DNA metabolic process,2/18,412/18493,0.059898055959207885,0.12723076523419566,0.07899780583797911,2,bp,NAC,990/2264,CDC6/FGFR4
GO:0051090,regulation of DNA-binding transcription factor activity,2/18,412/18493,0.059898055959207885,0.12723076523419566,0.07899780583797911,2,bp,NAC,2146/2175,EZH2/FANCA
GO:0044783,G1 DNA damage checkpoint,1/18,64/18493,0.0605217701754589,0.12795628333133152,0.07944828130013622,1,bp,NAC,1869,E2F1
GO:0050710,negative regulation of cytokine secretion,1/18,64/18493,0.0605217701754589,0.12795628333133152,0.07944828130013622,1,bp,NAC,2335,FN1
GO:0032481,positive regulation of type I interferon production,1/18,65/18493,0.061439378734623684,0.12839980763203615,0.07972366631827232,1,bp,NAC,6772,STAT1
GO:0033627,cell adhesion mediated by integrin,1/18,65/18493,0.061439378734623684,0.12839980763203615,0.07972366631827232,1,bp,NAC,3694,ITGB6
GO:0042246,tissue regeneration,1/18,65/18493,0.061439378734623684,0.12839980763203615,0.07972366631827232,1,bp,NAC,2146,EZH2
GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,1/18,65/18493,0.061439378734623684,0.12839980763203615,0.07972366631827232,1,bp,NAC,27092,CACNG4
GO:2001259,positive regulation of cation channel activity,1/18,65/18493,0.061439378734623684,0.12839980763203615,0.07972366631827232,1,bp,NAC,27092,CACNG4
GO:0014015,positive regulation of gliogenesis,1/18,66/18493,0.06235614079142726,0.1285386811314194,0.07980989311821433,1,bp,NAC,1869,E2F1
GO:0030858,positive regulation of epithelial cell differentiation,1/18,66/18493,0.06235614079142726,0.1285386811314194,0.07980989311821433,1,bp,NAC,8842,PROM1
GO:0032508,DNA duplex unwinding,1/18,66/18493,0.06235614079142726,0.1285386811314194,0.07980989311821433,1,bp,NAC,83990,BRIP1
GO:0050673,epithelial cell proliferation,2/18,420/18493,0.06196717583645318,0.1285386811314194,0.07980989311821433,2,bp,NAC,6772/2064,STAT1/ERBB2
GO:1901342,regulation of vasculature development,2/18,421/18493,0.0622275795596731,0.1285386811314194,0.07980989311821433,2,bp,NAC,6772/2064,STAT1/ERBB2
GO:2000573,positive regulation of DNA biosynthetic process,1/18,66/18493,0.06235614079142726,0.1285386811314194,0.07980989311821433,1,bp,NAC,2264,FGFR4
GO:0051966,"regulation of synaptic transmission, glutamatergic",1/18,67/18493,0.06327205708088046,0.13013096547020087,0.08079854526380488,1,bp,NAC,27092,CACNG4
GO:0005518,collagen binding,1/18,67/17632,0.06626422006098176,0.13042481408828155,0.07750201176723014,1,mf,NAC,2335,FN1
GO:0042379,chemokine receptor binding,1/18,66/17632,0.06530643318846607,0.13042481408828155,0.07750201176723014,1,mf,NAC,6772,STAT1
GO:0031670,cellular response to nutrient,1/18,68/18493,0.06418712833739548,0.1308263492180173,0.08123031025548572,1,bp,NAC,83990,BRIP1
GO:0033047,regulation of mitotic sister chromatid segregation,1/18,68/18493,0.06418712833739548,0.1308263492180173,0.08123031025548572,1,bp,NAC,990,CDC6
GO:0042698,ovulation cycle,1/18,68/18493,0.06418712833739548,0.1308263492180173,0.08123031025548572,1,bp,NAC,4316,MMP7
GO:0050688,regulation of defense response to virus,1/18,68/18493,0.06418712833739548,0.1308263492180173,0.08123031025548572,1,bp,NAC,6772,STAT1
GO:0033077,T cell differentiation in thymus,1/18,69/18493,0.06510135529478622,0.1315076375331205,0.08165332336821154,1,bp,NAC,2064,ERBB2
GO:0050771,negative regulation of axonogenesis,1/18,69/18493,0.06510135529478622,0.1315076375331205,0.08165332336821154,1,bp,NAC,6696,SPP1
GO:0055008,cardiac muscle tissue morphogenesis,1/18,69/18493,0.06510135529478622,0.1315076375331205,0.08165332336821154,1,bp,NAC,1301,COL11A1
GO:1900006,positive regulation of dendrite development,1/18,69/18493,0.06510135529478622,0.1315076375331205,0.08165332336821154,1,bp,NAC,2146,EZH2
GO:0030521,androgen receptor signaling pathway,1/18,70/18493,0.06601473868626972,0.13188407045913358,0.08188705123383794,1,bp,NAC,898,CCNE1
GO:0032945,negative regulation of mononuclear cell proliferation,1/18,70/18493,0.06601473868626972,0.13188407045913358,0.08188705123383794,1,bp,NAC,2064,ERBB2
GO:0048678,response to axon injury,1/18,70/18493,0.06601473868626972,0.13188407045913358,0.08188705123383794,1,bp,NAC,6696,SPP1
GO:0050672,negative regulation of lymphocyte proliferation,1/18,70/18493,0.06601473868626972,0.13188407045913358,0.08188705123383794,1,bp,NAC,2064,ERBB2
GO:1903747,regulation of establishment of protein localization to mitochondrion,1/18,70/18493,0.06601473868626972,0.13188407045913358,0.08188705123383794,1,bp,NAC,1869,E2F1
GO:0006305,DNA alkylation,1/18,71/18493,0.06692727924446595,0.132250636764119,0.08211465289712026,1,bp,NAC,2146,EZH2
GO:0006306,DNA methylation,1/18,71/18493,0.06692727924446595,0.132250636764119,0.08211465289712026,1,bp,NAC,2146,EZH2
GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,1/18,71/18493,0.06692727924446595,0.132250636764119,0.08211465289712026,1,bp,NAC,4316,MMP7
GO:1903312,negative regulation of mRNA metabolic process,1/18,71/18493,0.06692727924446595,0.132250636764119,0.08211465289712026,1,bp,NAC,1869,E2F1
GO:1904951,positive regulation of establishment of protein localization,2/18,437/18493,0.06644631828871767,0.132250636764119,0.08211465289712026,2,bp,NAC,2064/1869,ERBB2/E2F1
GO:0001618,virus receptor activity,1/18,74/17632,0.07294282000932373,0.1327936031533407,0.07890961138144184,1,mf,NAC,3694,ITGB6
GO:0008026,ATP-dependent helicase activity,1/18,75/17632,0.07389321465790732,0.1327936031533407,0.07890961138144184,1,mf,NAC,83990,BRIP1
GO:0070035,purine NTP-dependent helicase activity,1/18,75/17632,0.07389321465790732,0.1327936031533407,0.07890961138144184,1,mf,NAC,83990,BRIP1
GO:0070063,RNA polymerase binding,1/18,73/17632,0.07199150427818923,0.1327936031533407,0.07890961138144184,1,mf,NAC,2064,ERBB2
GO:0070491,repressing transcription factor binding,1/18,74/17632,0.07294282000932373,0.1327936031533407,0.07890961138144184,1,mf,NAC,6772,STAT1
GO:0104005,hijacked molecular function,1/18,74/17632,0.07294282000932373,0.1327936031533407,0.07890961138144184,1,mf,NAC,3694,ITGB6
GO:0000982,"transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding",2/18,447/17632,0.07511609548555638,0.1330627977172713,0.07906957419532251,2,mf,NAC,6772/1869,STAT1/E2F1
GO:0006979,response to oxidative stress,2/18,441/18493,0.06751612843361975,0.1331241923680285,0.08265704510752075,2,bp,NAC,6772/2146,STAT1/EZH2
GO:0003208,cardiac ventricle morphogenesis,1/18,72/18493,0.06783897770139768,0.13318171596356645,0.08269276160913139,1,bp,NAC,1301,COL11A1
GO:0019226,transmission of nerve impulse,1/18,72/18493,0.06783897770139768,0.13318171596356645,0.08269276160913139,1,bp,NAC,27092,CACNG4
GO:0004674,protein serine/threonine kinase activity,2/18,455/17632,0.07746238876563791,0.1337918652956915,0.07950280620287271,2,mf,NAC,9088/898,PKMYT1/CCNE1
GO:0043178,alcohol binding,1/18,79/17632,0.0776855992039499,0.1337918652956915,0.07950280620287271,1,mf,NAC,8842,PROM1
GO:0001895,retina homeostasis,1/18,73/18493,0.0687498347884925,0.13381137371923327,0.0830837172167235,1,bp,NAC,8842,PROM1
GO:0046902,regulation of mitochondrial membrane permeability,1/18,73/18493,0.0687498347884925,0.13381137371923327,0.0830837172167235,1,bp,NAC,1869,E2F1
GO:0072401,signal transduction involved in DNA integrity checkpoint,1/18,73/18493,0.0687498347884925,0.13381137371923327,0.0830837172167235,1,bp,NAC,1869,E2F1
GO:0072422,signal transduction involved in DNA damage checkpoint,1/18,73/18493,0.0687498347884925,0.13381137371923327,0.0830837172167235,1,bp,NAC,1869,E2F1
GO:0008305,integrin complex,1/18,32/19659,0.028909999081823123,0.13455594708781624,0.09249818059742469,1,cc,NAC,3694,ITGB6
GO:0009925,basal plasma membrane,1/18,34/19659,0.030690408682011228,0.13455594708781624,0.09249818059742469,1,cc,NAC,2064,ERBB2
GO:0051233,spindle midzone,1/18,34/19659,0.030690408682011228,0.13455594708781624,0.09249818059742469,1,cc,NAC,990,CDC6
GO:0098636,protein complex involved in cell adhesion,1/18,35/19659,0.031579456969589526,0.13455594708781624,0.09249818059742469,1,cc,NAC,3694,ITGB6
GO:0072347,response to anesthetic,1/18,74/18493,0.06965985123658214,0.1350031732298718,0.08382370762836583,1,bp,NAC,27092,CACNG4
GO:0072395,signal transduction involved in cell cycle checkpoint,1/18,74/18493,0.06965985123658214,0.1350031732298718,0.08382370762836583,1,bp,NAC,1869,E2F1
GO:0001937,negative regulation of endothelial cell proliferation,1/18,75/18493,0.07056902777590246,0.1356061614253041,0.08419810405911644,1,bp,NAC,6772,STAT1
GO:0007422,peripheral nervous system development,1/18,75/18493,0.07056902777590246,0.1356061614253041,0.08419810405911644,1,bp,NAC,2064,ERBB2
GO:0042110,T cell activation,2/18,451/18493,0.07021650297611969,0.1356061614253041,0.08419810405911644,2,bp,NAC,2064/2175,ERBB2/FANCA
GO:0070664,negative regulation of leukocyte proliferation,1/18,75/18493,0.07056902777590246,0.1356061614253041,0.08419810405911644,1,bp,NAC,2064,ERBB2
GO:0032392,DNA geometric change,1/18,76/18493,0.0714773651360957,0.13648414774408169,0.08474324730816887,1,bp,NAC,83990,BRIP1
GO:0072088,nephron epithelium morphogenesis,1/18,76/18493,0.0714773651360957,0.13648414774408169,0.08474324730816887,1,bp,NAC,6772,STAT1
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,1/18,76/18493,0.0714773651360957,0.13648414774408169,0.08474324730816887,1,bp,NAC,1869,E2F1
GO:0046486,glycerolipid metabolic process,2/18,459/18493,0.07240292837416142,0.1379610420911017,0.08566025360498974,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0021766,hippocampus development,1/18,78/18493,0.07329152523469451,0.13849044455805817,0.0859889605275473,1,bp,NAC,2146,EZH2
GO:0031100,animal organ regeneration,1/18,78/18493,0.07329152523469451,0.13849044455805817,0.0859889605275473,1,bp,NAC,2146,EZH2
GO:0071260,cellular response to mechanical stimulus,1/18,78/18493,0.07329152523469451,0.13849044455805817,0.0859889605275473,1,bp,NAC,4316,MMP7
GO:0072028,nephron morphogenesis,1/18,78/18493,0.07329152523469451,0.13849044455805817,0.0859889605275473,1,bp,NAC,6772,STAT1
GO:0000307,cyclin-dependent protein kinase holoenzyme complex,1/18,41/19659,0.036897595082190704,0.1392918839503618,0.09575381925696193,1,cc,NAC,898,CCNE1
GO:0005891,voltage-gated calcium channel complex,1/18,43/19659,0.03866416983072407,0.1392918839503618,0.09575381925696193,1,cc,NAC,27092,CACNG4
GO:0008328,ionotropic glutamate receptor complex,1/18,52/19659,0.04657595277126869,0.1392918839503618,0.09575381925696193,1,cc,NAC,27092,CACNG4
GO:0030315,T-tubule,1/18,51/19659,0.04569991229908332,0.1392918839503618,0.09575381925696193,1,cc,NAC,27092,CACNG4
GO:0031519,PcG protein complex,1/18,48/19659,0.04306722731831214,0.1392918839503618,0.09575381925696193,1,cc,NAC,2146,EZH2
GO:0044420,extracellular matrix component,1/18,49/19659,0.043945550193651206,0.1392918839503618,0.09575381925696193,1,cc,NAC,1301,COL11A1
GO:0045178,basal part of cell,1/18,51/19659,0.04569991229908332,0.1392918839503618,0.09575381925696193,1,cc,NAC,2064,ERBB2
GO:0062023,collagen-containing extracellular matrix,2/18,332/19659,0.03640576022565357,0.1392918839503618,0.09575381925696193,2,cc,NAC,1301/2335,COL11A1/FN1
GO:0098878,neurotransmitter receptor complex,1/18,54/19659,0.04832575565624797,0.1392918839503618,0.09575381925696193,1,cc,NAC,27092,CACNG4
GO:0099061,integral component of postsynaptic density membrane,1/18,51/19659,0.04569991229908332,0.1392918839503618,0.09575381925696193,1,cc,NAC,27092,CACNG4
GO:0099146,intrinsic component of postsynaptic density membrane,1/18,54/19659,0.04832575565624797,0.1392918839503618,0.09575381925696193,1,cc,NAC,27092,CACNG4
GO:1905954,positive regulation of lipid localization,1/18,79/18493,0.07419734942941503,0.1399105944542192,0.08687073409505863,1,bp,NAC,6696,SPP1
GO:0016569,covalent chromatin modification,2/18,470/18493,0.07544630794255898,0.14040302688320347,0.08717648625603652,2,bp,NAC,3070/2146,HELLS/EZH2
GO:0033045,regulation of sister chromatid segregation,1/18,80/18493,0.07510233735763638,0.14040302688320347,0.08717648625603652,1,bp,NAC,990,CDC6
GO:0034502,protein localization to chromosome,1/18,81/18493,0.07600648974603408,0.14040302688320347,0.08717648625603652,1,bp,NAC,2146,EZH2
GO:0045682,regulation of epidermis development,1/18,81/18493,0.07600648974603408,0.14040302688320347,0.08717648625603652,1,bp,NAC,2146,EZH2
GO:0048871,multicellular organismal homeostasis,2/18,471/18493,0.0757250715209526,0.14040302688320347,0.08717648625603652,2,bp,NAC,6696/8842,SPP1/PROM1
GO:0050772,positive regulation of axonogenesis,1/18,81/18493,0.07600648974603408,0.14040302688320347,0.08717648625603652,1,bp,NAC,2335,FN1
GO:0051249,regulation of lymphocyte activation,2/18,472/18493,0.07600418019941108,0.14040302688320347,0.08717648625603652,2,bp,NAC,2064/2175,ERBB2/FANCA
GO:0051702,interaction with symbiont,1/18,80/18493,0.07510233735763638,0.14040302688320347,0.08717648625603652,1,bp,NAC,2335,FN1
GO:0090559,regulation of membrane permeability,1/18,81/18493,0.07600648974603408,0.14040302688320347,0.08717648625603652,1,bp,NAC,1869,E2F1
GO:1903533,regulation of protein targeting,1/18,81/18493,0.07600648974603408,0.14040302688320347,0.08717648625603652,1,bp,NAC,2064,ERBB2
GO:0006644,phospholipid metabolic process,2/18,473/18493,0.07628363313167237,0.14062856758216838,0.08731652487258178,2,bp,NAC,2064/2264,ERBB2/FGFR4
GO:0022604,regulation of cell morphogenesis,2/18,474/18493,0.07656342947262831,0.14085807410075837,0.08745902587350518,2,bp,NAC,2335/6696,FN1/SPP1
GO:0060415,muscle tissue morphogenesis,1/18,82/18493,0.0769098073206903,0.14092362674720427,0.08749972762694168,1,bp,NAC,1301,COL11A1
GO:0071158,positive regulation of cell cycle arrest,1/18,82/18493,0.0769098073206903,0.14092362674720427,0.08749972762694168,1,bp,NAC,1869,E2F1
GO:0006368,transcription elongation from RNA polymerase II promoter,1/18,84/18493,0.07871394093015338,0.14193547599135015,0.08812798660172035,1,bp,NAC,2146,EZH2
GO:0032465,regulation of cytokinesis,1/18,84/18493,0.07871394093015338,0.14193547599135015,0.08812798660172035,1,bp,NAC,990,CDC6
GO:0034103,regulation of tissue remodeling,1/18,84/18493,0.07871394093015338,0.14193547599135015,0.08812798660172035,1,bp,NAC,6696,SPP1
GO:0043087,regulation of GTPase activity,2/18,481/18493,0.07853154855541299,0.14193547599135015,0.08812798660172035,2,bp,NAC,2146/2064,EZH2/ERBB2
GO:0046849,bone remodeling,1/18,83/18493,0.07781229080709662,0.14193547599135015,0.08812798660172035,1,bp,NAC,6696,SPP1
GO:0051781,positive regulation of cell division,1/18,84/18493,0.07871394093015338,0.14193547599135015,0.08812798660172035,1,bp,NAC,990,CDC6
GO:0070542,response to fatty acid,1/18,84/18493,0.07871394093015338,0.14193547599135015,0.08812798660172035,1,bp,NAC,1869,E2F1
GO:1903035,negative regulation of response to wounding,1/18,84/18493,0.07871394093015338,0.14193547599135015,0.08812798660172035,1,bp,NAC,6696,SPP1
GO:1901992,positive regulation of mitotic cell cycle phase transition,1/18,85/18493,0.07961475841416998,0.1432749719874051,0.08895968202084575,1,bp,NAC,990,CDC6
GO:0005496,steroid binding,1/18,89/17632,0.0871024948306438,0.14364286213759964,0.08535653947056006,1,mf,NAC,8842,PROM1
GO:0008094,DNA-dependent ATPase activity,1/18,87/17632,0.08522641082625815,0.14364286213759964,0.08535653947056006,1,mf,NAC,83990,BRIP1
GO:0008276,protein methyltransferase activity,1/18,89/17632,0.0871024948306438,0.14364286213759964,0.08535653947056006,1,mf,NAC,2146,EZH2
GO:0035258,steroid hormone receptor binding,1/18,90/17632,0.08803917356820623,0.14364286213759964,0.08535653947056006,1,mf,NAC,898,CCNE1
GO:0006029,proteoglycan metabolic process,1/18,86/18493,0.08051474398286518,0.14460766889595786,0.08978715587458651,1,bp,NAC,1301,COL11A1
GO:0034446,substrate adhesion-dependent cell spreading,1/18,87/18493,0.08141389835936952,0.1456457708322449,0.09043171519207453,1,bp,NAC,2335,FN1
GO:0048709,oligodendrocyte differentiation,1/18,87/18493,0.08141389835936952,0.1456457708322449,0.09043171519207453,1,bp,NAC,2064,ERBB2
GO:0010717,regulation of epithelial to mesenchymal transition,1/18,88/18493,0.08231222226622215,0.14667423496161786,0.09107029037830391,1,bp,NAC,2146,EZH2
GO:0048644,muscle organ morphogenesis,1/18,88/18493,0.08231222226622215,0.14667423496161786,0.09107029037830391,1,bp,NAC,1301,COL11A1
GO:0001656,metanephros development,1/18,89/18493,0.08320971642537456,0.14683115330314148,0.09116772125245833,1,bp,NAC,6772,STAT1
GO:0051304,chromosome separation,1/18,89/18493,0.08320971642537456,0.14683115330314148,0.09116772125245833,1,bp,NAC,990,CDC6
GO:0060337,type I interferon signaling pathway,1/18,89/18493,0.08320971642537456,0.14683115330314148,0.09116772125245833,1,bp,NAC,6772,STAT1
GO:0071357,cellular response to type I interferon,1/18,89/18493,0.08320971642537456,0.14683115330314148,0.09116772125245833,1,bp,NAC,6772,STAT1
GO:0090066,regulation of anatomical structure size,2/18,497/18493,0.08309159951500142,0.14683115330314148,0.09116772125245833,2,bp,NAC,2335/6696,FN1/SPP1
GO:0007215,glutamate receptor signaling pathway,1/18,90/18493,0.08410638155819061,0.14698359937047953,0.0912623752837075,1,bp,NAC,27092,CACNG4
GO:0035249,"synaptic transmission, glutamatergic",1/18,90/18493,0.08410638155819061,0.14698359937047953,0.0912623752837075,1,bp,NAC,27092,CACNG4
GO:0051899,membrane depolarization,1/18,90/18493,0.08410638155819061,0.14698359937047953,0.0912623752837075,1,bp,NAC,27092,CACNG4
GO:0060333,interferon-gamma-mediated signaling pathway,1/18,90/18493,0.08410638155819061,0.14698359937047953,0.0912623752837075,1,bp,NAC,6772,STAT1
GO:1901184,regulation of ERBB signaling pathway,1/18,90/18493,0.08410638155819061,0.14698359937047953,0.0912623752837075,1,bp,NAC,2064,ERBB2
GO:0030516,regulation of axon extension,1/18,91/18493,0.08500221838544453,0.14741302500114375,0.09152900641282646,1,bp,NAC,2335,FN1
GO:0045639,positive regulation of myeloid cell differentiation,1/18,91/18493,0.08500221838544453,0.14741302500114375,0.09152900641282646,1,bp,NAC,6772,STAT1
GO:0048525,negative regulation of viral process,1/18,91/18493,0.08500221838544453,0.14741302500114375,0.09152900641282646,1,bp,NAC,6772,STAT1
GO:0050810,regulation of steroid biosynthetic process,1/18,91/18493,0.08500221838544453,0.14741302500114375,0.09152900641282646,1,bp,NAC,2264,FGFR4
GO:0042632,cholesterol homeostasis,1/18,92/18493,0.08589722762732344,0.14868088827859227,0.09231622495102058,1,bp,NAC,2264,FGFR4
GO:0044728,DNA methylation or demethylation,1/18,93/18493,0.08679141000342883,0.14909054710816277,0.09257058283858538,1,bp,NAC,2146,EZH2
GO:0048704,embryonic skeletal system morphogenesis,1/18,93/18493,0.08679141000342883,0.14909054710816277,0.09257058283858538,1,bp,NAC,1301,COL11A1
GO:0055092,sterol homeostasis,1/18,93/18493,0.08679141000342883,0.14909054710816277,0.09257058283858538,1,bp,NAC,2264,FGFR4
GO:1901655,cellular response to ketone,1/18,93/18493,0.08679141000342883,0.14909054710816277,0.09257058283858538,1,bp,NAC,6696,SPP1
GO:0034340,response to type I interferon,1/18,94/18493,0.08768476623277299,0.1497741675576744,0.09299504397766589,1,bp,NAC,6772,STAT1
GO:0060993,kidney morphogenesis,1/18,94/18493,0.08768476623277299,0.1497741675576744,0.09299504397766589,1,bp,NAC,6772,STAT1
GO:0070301,cellular response to hydrogen peroxide,1/18,94/18493,0.08768476623277299,0.1497741675576744,0.09299504397766589,1,bp,NAC,2146,EZH2
GO:0007044,cell-substrate junction assembly,1/18,95/18493,0.08857729703378447,0.15101430152188441,0.09376504533651504,1,bp,NAC,2335,FN1
GO:0010771,negative regulation of cell morphogenesis involved in differentiation,1/18,96/18493,0.08946900312430517,0.1513962422271358,0.09400219299195457,1,bp,NAC,6696,SPP1
GO:0021549,cerebellum development,1/18,96/18493,0.08946900312430517,0.1513962422271358,0.09400219299195457,1,bp,NAC,2146,EZH2
GO:0032414,positive regulation of ion transmembrane transporter activity,1/18,96/18493,0.08946900312430517,0.1513962422271358,0.09400219299195457,1,bp,NAC,27092,CACNG4
GO:0042472,inner ear morphogenesis,1/18,96/18493,0.08946900312430517,0.1513962422271358,0.09400219299195457,1,bp,NAC,1301,COL11A1
GO:0008170,N-methyltransferase activity,1/18,97/17632,0.09457055438747963,0.1522954382343828,0.09049813816983698,1,mf,NAC,2146,EZH2
GO:0006354,"DNA-templated transcription, elongation",1/18,98/18493,0.09124994404231324,0.15241933562868898,0.09463743348383753,1,bp,NAC,2146,EZH2
GO:0008585,female gonad development,1/18,98/18493,0.09124994404231324,0.15241933562868898,0.09463743348383753,1,bp,NAC,2175,FANCA
GO:0042752,regulation of circadian rhythm,1/18,97/18493,0.09035988522159055,0.15241933562868898,0.09463743348383753,1,bp,NAC,2146,EZH2
GO:0044773,mitotic DNA damage checkpoint,1/18,98/18493,0.09124994404231324,0.15241933562868898,0.09463743348383753,1,bp,NAC,1869,E2F1
GO:0048661,positive regulation of smooth muscle cell proliferation,1/18,98/18493,0.09124994404231324,0.15241933562868898,0.09463743348383753,1,bp,NAC,6772,STAT1
GO:0051591,response to cAMP,1/18,98/18493,0.09124994404231324,0.15241933562868898,0.09463743348383753,1,bp,NAC,6772,STAT1
GO:1902106,negative regulation of leukocyte differentiation,1/18,98/18493,0.09124994404231324,0.15241933562868898,0.09463743348383753,1,bp,NAC,2064,ERBB2
GO:0007229,integrin-mediated signaling pathway,1/18,99/18493,0.09213918030255974,0.15362175833533398,0.09538401985655856,1,bp,NAC,3694,ITGB6
GO:0007041,lysosomal transport,1/18,101/18493,0.09391518800305543,0.1560092958219254,0.09686644607988175,1,bp,NAC,27092,CACNG4
GO:0010923,negative regulation of phosphatase activity,1/18,101/18493,0.09391518800305543,0.1560092958219254,0.09686644607988175,1,bp,NAC,9088,PKMYT1
GO:0051087,chaperone binding,1/18,101/17632,0.09828291078704143,0.15624462740504022,0.09284485499450608,1,mf,NAC,2335,FN1
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,1/18,102/18493,0.09480196087256099,0.15719447625486804,0.09760232669454467,1,bp,NAC,1869,E2F1
hsa05167,Kaposi sarcoma-associated herpesvirus infection,2/17,186/7844,0.0602407605411715,0.15740327754306102,0.1043218603599235,2,kg,NAC,6772/1869,STAT1/E2F1
GO:0046545,development of primary female sexual characteristics,1/18,103/18493,0.09568791404010446,0.15808549733037294,0.09815556324696749,1,bp,NAC,2175,FANCA
GO:0051983,regulation of chromosome segregation,1/18,103/18493,0.09568791404010446,0.15808549733037294,0.09815556324696749,1,bp,NAC,990,CDC6
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",1/18,104/18493,0.09657304821885804,0.15868071509873957,0.098525135005890635,1,bp,NAC,1869,E2F1
GO:0032411,positive regulation of transporter activity,1/18,104/18493,0.09657304821885804,0.15868071509873957,0.098525135005890635,1,bp,NAC,27092,CACNG4
GO:2000278,regulation of DNA biosynthetic process,1/18,104/18493,0.09657304821885804,0.15868071509873957,0.098525135005890635,1,bp,NAC,2264,FGFR4
GO:0021761,limbic system development,1/18,105/18493,0.09745736412141148,0.15955564848036138,0.09906838268089523,1,bp,NAC,2146,EZH2
GO:0022037,metencephalon development,1/18,105/18493,0.09745736412141148,0.15955564848036138,0.09906838268089523,1,bp,NAC,2146,EZH2
GO:0003300,cardiac muscle hypertrophy,1/18,107/18493,0.09922354394537425,0.16013479423212534,0.09942797529645107,1,bp,NAC,2146,EZH2
GO:0006275,regulation of DNA replication,1/18,107/18493,0.09922354394537425,0.16013479423212534,0.09942797529645107,1,bp,NAC,990,CDC6
GO:0031623,receptor internalization,1/18,107/18493,0.09922354394537425,0.16013479423212534,0.09942797529645107,1,bp,NAC,27092,CACNG4
GO:0032963,collagen metabolic process,1/18,106/18493,0.09834086245977458,0.16013479423212534,0.09942797529645107,1,bp,NAC,4316,MMP7
GO:0043279,response to alkaloid,1/18,106/18493,0.09834086245977458,0.16013479423212534,0.09942797529645107,1,bp,NAC,27092,CACNG4
GO:0048640,negative regulation of developmental growth,1/18,107/18493,0.09922354394537425,0.16013479423212534,0.09942797529645107,1,bp,NAC,6696,SPP1
GO:0050868,negative regulation of T cell activation,1/18,106/18493,0.09834086245977458,0.16013479423212534,0.09942797529645107,1,bp,NAC,2064,ERBB2
GO:0071156,regulation of cell cycle arrest,1/18,107/18493,0.09922354394537425,0.16013479423212534,0.09942797529645107,1,bp,NAC,1869,E2F1
GO:0048593,camera-type eye morphogenesis,1/18,108/18493,0.10010540928905898,0.1609851174205257,0.09995594245921345,1,bp,NAC,8842,PROM1
GO:1904019,epithelial cell apoptotic process,1/18,108/18493,0.10010540928905898,0.1609851174205257,0.09995594245921345,1,bp,NAC,1869,E2F1
GO:0099106,ion channel regulator activity,1/18,106/17632,0.10290314236525755,0.161518856370784,0.09597894690963396,1,mf,NAC,27092,CACNG4
GO:0006289,nucleotide-excision repair,1/18,109/18493,0.10098645920109572,0.16182812455016576,0.10047936706822805,1,bp,NAC,83990,BRIP1
GO:0014897,striated muscle hypertrophy,1/18,109/18493,0.10098645920109572,0.16182812455016576,0.10047936706822805,1,bp,NAC,2146,EZH2
GO:0034704,calcium channel complex,1/18,65/19659,0.057895584127017896,0.1621076355556501,0.11143811681591415,1,cc,NAC,27092,CACNG4
GO:0031093,platelet alpha granule lumen,1/18,67/19659,0.05962575894337507,0.16231456601252103,0.11158036761333347,1,cc,NAC,2335,FN1
GO:0006342,chromatin silencing,1/18,110/18493,0.10186669439117291,0.16266389403660886,0.10099829781185603,1,bp,NAC,3070,HELLS
GO:0034968,histone lysine methylation,1/18,110/18493,0.10186669439117291,0.16266389403660886,0.10099829781185603,1,bp,NAC,2146,EZH2
GO:0014896,muscle hypertrophy,1/18,111/18493,0.10274611556839952,0.16320617656836842,0.10133500198929625,1,bp,NAC,2146,EZH2
GO:0030218,erythrocyte differentiation,1/18,111/18493,0.10274611556839952,0.16320617656836842,0.10133500198929625,1,bp,NAC,6772,STAT1
GO:0035305,negative regulation of dephosphorylation,1/18,111/18493,0.10274611556839952,0.16320617656836842,0.10133500198929625,1,bp,NAC,9088,PKMYT1
GO:0006304,DNA modification,1/18,112/18493,0.10362472344130613,0.164027267297146,0.10184481866648074,1,bp,NAC,2146,EZH2
GO:0010822,positive regulation of mitochondrion organization,1/18,112/18493,0.10362472344130613,0.164027267297146,0.10184481866648074,1,bp,NAC,1869,E2F1
GO:0008543,fibroblast growth factor receptor signaling pathway,1/18,113/18493,0.10450251871784522,0.16455518138382919,0.10217260145110965,1,bp,NAC,2264,FGFR4
GO:0032479,regulation of type I interferon production,1/18,113/18493,0.10450251871784522,0.16455518138382919,0.10217260145110965,1,bp,NAC,6772,STAT1
GO:0051153,regulation of striated muscle cell differentiation,1/18,113/18493,0.10450251871784522,0.16455518138382919,0.10217260145110965,1,bp,NAC,2146,EZH2
GO:0032606,type I interferon production,1/18,114/18493,0.10537950210538993,0.16536195226572434,0.10267352691018689,1,bp,NAC,6772,STAT1
GO:0042552,myelination,1/18,114/18493,0.10537950210538993,0.16536195226572434,0.10267352691018689,1,bp,NAC,2064,ERBB2
GO:0000792,heterochromatin,1/18,76/19659,0.06737447587289591,0.16537763902752878,0.11368602468057834,1,cc,NAC,3070,HELLS
GO:0001750,photoreceptor outer segment,1/18,84/19659,0.07421156295717835,0.16537763902752878,0.11368602468057834,1,cc,NAC,8842,PROM1
GO:0005581,collagen trimer,1/18,87/19659,0.07676324463931317,0.16537763902752878,0.11368602468057834,1,cc,NAC,1301,COL11A1
GO:0005604,basement membrane,1/18,92/19659,0.08100129258491207,0.16537763902752878,0.11368602468057834,1,cc,NAC,2335,FN1
GO:0005902,microvillus,1/18,83/19659,0.07335952328713213,0.16537763902752878,0.11368602468057834,1,cc,NAC,8842,PROM1
GO:0031091,platelet alpha granule,1/18,91/19659,0.08015515566759879,0.16537763902752878,0.11368602468057834,1,cc,NAC,2335,FN1
GO:0035097,histone methyltransferase complex,1/18,88/19659,0.07761232810530994,0.16537763902752878,0.11368602468057834,1,cc,NAC,2146,EZH2
GO:0060170,ciliary membrane,1/18,89/19659,0.07846067403010215,0.16537763902752878,0.11368602468057834,1,cc,NAC,8842,PROM1
GO:0098839,postsynaptic density membrane,1/18,75/19659,0.06651649470994547,0.16537763902752878,0.11368602468057834,1,cc,NAC,27092,CACNG4
GO:0098948,intrinsic component of postsynaptic specialization membrane,1/18,77/19659,0.0682317122224998,0.16537763902752878,0.11368602468057834,1,cc,NAC,27092,CACNG4
GO:0099060,integral component of postsynaptic specialization membrane,1/18,74/19659,0.0656577681246121,0.16537763902752878,0.11368602468057834,1,cc,NAC,27092,CACNG4
GO:1902554,serine/threonine protein kinase complex,1/18,87/19659,0.07676324463931317,0.16537763902752878,0.11368602468057834,1,cc,NAC,898,CCNE1
GO:0034754,cellular hormone metabolic process,1/18,115/18493,0.10625567431073857,0.16644887150231413,0.10334839697526614,1,bp,NAC,6696,SPP1
GO:0007272,ensheathment of neurons,1/18,116/18493,0.10713103604011087,0.1666686958634315,0.10348488630759109,1,bp,NAC,2064,ERBB2
GO:0008366,axon ensheathment,1/18,116/18493,0.10713103604011087,0.1666686958634315,0.10348488630759109,1,bp,NAC,2064,ERBB2
GO:0042471,ear morphogenesis,1/18,116/18493,0.10713103604011087,0.1666686958634315,0.10348488630759109,1,bp,NAC,1301,COL11A1
GO:0048675,axon extension,1/18,116/18493,0.10713103604011087,0.1666686958634315,0.10348488630759109,1,bp,NAC,2335,FN1
GO:0002062,chondrocyte differentiation,1/18,117/18493,0.10800558799915139,0.16774155533429846,0.10415102663941239,1,bp,NAC,1301,COL11A1
GO:0010811,positive regulation of cell-substrate adhesion,1/18,118/18493,0.10887933089292645,0.16794821959163997,0.10427934484016409,1,bp,NAC,2335,FN1
GO:0019730,antimicrobial humoral response,1/18,118/18493,0.10887933089292645,0.16794821959163997,0.10427934484016409,1,bp,NAC,4316,MMP7
GO:0043488,regulation of mRNA stability,1/18,118/18493,0.10887933089292645,0.16794821959163997,0.10427934484016409,1,bp,NAC,1869,E2F1
GO:0046660,female sex differentiation,1/18,118/18493,0.10887933089292645,0.16794821959163997,0.10427934484016409,1,bp,NAC,2175,FANCA
GO:0019218,regulation of steroid metabolic process,1/18,119/18493,0.1097522654259292,0.16872085549375895,0.10475907583028034,1,bp,NAC,2264,FGFR4
GO:0033209,tumor necrosis factor-mediated signaling pathway,1/18,119/18493,0.1097522654259292,0.16872085549375895,0.10475907583028034,1,bp,NAC,6772,STAT1
GO:0034101,erythrocyte homeostasis,1/18,120/18493,0.11062439230207655,0.169201220603682,0.10505733537163568,1,bp,NAC,6772,STAT1
GO:0043500,muscle adaptation,1/18,120/18493,0.11062439230207655,0.169201220603682,0.10505733537163568,1,bp,NAC,2146,EZH2
GO:0045727,positive regulation of translation,1/18,120/18493,0.11062439230207655,0.169201220603682,0.10505733537163568,1,bp,NAC,2064,ERBB2
GO:0004222,metalloendopeptidase activity,1/18,113/17632,0.10933391722256791,0.16946757169498028,0.10070229217868097,1,mf,NAC,4316,MMP7
GO:0008637,apoptotic mitochondrial changes,1/18,121/18493,0.11149571222471089,0.16996069073581976,0.10552889171202182,1,bp,NAC,1869,E2F1
GO:0046718,viral entry into host cell,1/18,121/18493,0.11149571222471089,0.16996069073581976,0.10552889171202182,1,bp,NAC,3694,ITGB6
GO:0032368,regulation of lipid transport,1/18,122/18493,0.11236622589660072,0.17042837272277067,0.10581927628002356,1,bp,NAC,6696,SPP1
GO:0051101,regulation of DNA binding,1/18,122/18493,0.11236622589660072,0.17042837272277067,0.10581927628002356,1,bp,NAC,1869,E2F1
GO:1903038,negative regulation of leukocyte cell-cell adhesion,1/18,122/18493,0.11236622589660072,0.17042837272277067,0.10581927628002356,1,bp,NAC,2064,ERBB2
GO:0010565,regulation of cellular ketone metabolic process,1/18,125/18493,0.11497293642687689,0.17351156961593567,0.10773363865203457,1,bp,NAC,2264,FGFR4
GO:0018022,peptidyl-lysine methylation,1/18,125/18493,0.11497293642687689,0.17351156961593567,0.10773363865203457,1,bp,NAC,2146,EZH2
GO:0048706,embryonic skeletal system development,1/18,125/18493,0.11497293642687689,0.17351156961593567,0.10773363865203457,1,bp,NAC,1301,COL11A1
GO:0003231,cardiac ventricle development,1/18,126/18493,0.11584023211199856,0.17424061447028638,0.10818630388394736,1,bp,NAC,1301,COL11A1
GO:0043487,regulation of RNA stability,1/18,126/18493,0.11584023211199856,0.17424061447028638,0.10818630388394736,1,bp,NAC,1869,E2F1
hsa05205,Proteoglycans in cancer,2/17,201/7844,0.0690614520140573,0.17481180041058256,0.11585967278674089,2,kg,NAC,2064/2335,ERBB2/FN1
GO:0002576,platelet degranulation,1/18,128/18493,0.11757241594506584,0.17481669059372903,0.10854399056188134,1,bp,NAC,2335,FN1
GO:0031644,regulation of neurological system process,1/18,127/18493,0.11670672505161794,0.17481669059372903,0.10854399056188134,1,bp,NAC,27092,CACNG4
GO:0032355,response to estradiol,1/18,127/18493,0.11670672505161794,0.17481669059372903,0.10854399056188134,1,bp,NAC,2146,EZH2
GO:0045598,regulation of fat cell differentiation,1/18,128/18493,0.11757241594506584,0.17481669059372903,0.10854399056188134,1,bp,NAC,1869,E2F1
GO:0046887,positive regulation of hormone secretion,1/18,128/18493,0.11757241594506584,0.17481669059372903,0.10854399056188134,1,bp,NAC,6696,SPP1
GO:0050709,negative regulation of protein secretion,1/18,128/18493,0.11757241594506584,0.17481669059372903,0.10854399056188134,1,bp,NAC,2335,FN1
GO:0060359,response to ammonium ion,1/18,128/18493,0.11757241594506584,0.17481669059372903,0.10854399056188134,1,bp,NAC,27092,CACNG4
GO:0031490,chromatin DNA binding,1/18,119/17632,0.1148113332860522,0.1757605595984009,0.10444175867477135,1,mf,NAC,2146,EZH2
GO:0003206,cardiac chamber morphogenesis,1/18,129/18493,0.11843730549110398,0.17581446167010034,0.10916350837753579,1,bp,NAC,1301,COL11A1
GO:0002831,regulation of response to biotic stimulus,1/18,130/18493,0.11930139438792176,0.1762318643482818,0.10942267443431879,1,bp,NAC,6772,STAT1
GO:0009581,detection of external stimulus,1/18,130/18493,0.11930139438792176,0.1762318643482818,0.10942267443431879,1,bp,NAC,1301,COL11A1
GO:0042770,signal transduction in response to DNA damage,1/18,130/18493,0.11930139438792176,0.1762318643482818,0.10942267443431879,1,bp,NAC,1869,E2F1
GO:0007006,mitochondrial membrane organization,1/18,131/18493,0.12016468333313857,0.17693079185577382,0.10985663975261303,1,bp,NAC,1869,E2F1
GO:0007034,vacuolar transport,1/18,131/18493,0.12016468333313857,0.17693079185577382,0.10985663975261303,1,bp,NAC,27092,CACNG4
GO:0009582,detection of abiotic stimulus,1/18,133/18493,0.12188886415639921,0.1780244763121644,0.11053571035456156,1,bp,NAC,1301,COL11A1
GO:0030260,entry into host cell,1/18,133/18493,0.12188886415639921,0.1780244763121644,0.11053571035456156,1,bp,NAC,3694,ITGB6
GO:0044409,entry into host,1/18,133/18493,0.12188886415639921,0.1780244763121644,0.11053571035456156,1,bp,NAC,3694,ITGB6
GO:0051806,entry into cell of other organism involved in symbiotic interaction,1/18,133/18493,0.12188886415639921,0.1780244763121644,0.11053571035456156,1,bp,NAC,3694,ITGB6
GO:0051828,entry into other organism involved in symbiotic interaction,1/18,133/18493,0.12188886415639921,0.1780244763121644,0.11053571035456156,1,bp,NAC,3694,ITGB6
GO:0099634,postsynaptic specialization membrane,1/18,102/19659,0.08942232853664656,0.1788446570732931,0.12294369551762362,1,cc,NAC,27092,CACNG4
GO:1905330,regulation of morphogenesis of an epithelium,1/18,134/18493,0.12274975742683403,0.17899361734105862,0.11113745172339856,1,bp,NAC,6772,STAT1
GO:0001837,epithelial to mesenchymal transition,1/18,135/18493,0.12360985353045151,0.1790960657382101,0.11120106211332026,1,bp,NAC,2146,EZH2
GO:0002792,negative regulation of peptide secretion,1/18,135/18493,0.12360985353045151,0.1790960657382101,0.11120106211332026,1,bp,NAC,2335,FN1
GO:0016571,histone methylation,1/18,135/18493,0.12360985353045151,0.1790960657382101,0.11120106211332026,1,bp,NAC,2146,EZH2
GO:0072655,establishment of protein localization to mitochondrion,1/18,135/18493,0.12360985353045151,0.1790960657382101,0.11120106211332026,1,bp,NAC,1869,E2F1
GO:0005262,calcium channel activity,1/18,123/17632,0.11844525295852615,0.17911233374216148,0.1064334750590094,1,mf,NAC,27092,CACNG4
GO:0097731,9+0 non-motile cilium,1/18,109/19659,0.09527363411654843,0.17955415660426435,0.12343142881496154,1,cc,NAC,8842,PROM1
GO:0097733,photoreceptor cell cilium,1/18,108/19659,0.09443991299916266,0.17955415660426435,0.12343142881496154,1,cc,NAC,8842,PROM1
GO:1902911,protein kinase complex,1/18,107/19659,0.09360546631307587,0.17955415660426435,0.12343142881496154,1,cc,NAC,898,CCNE1
GO:0002020,protease binding,1/18,125/17632,0.12025692485997808,0.1796609479835817,0.1067594767304815,1,mf,NAC,2335,FN1
GO:0014065,phosphatidylinositol 3-kinase signaling,1/18,136/18493,0.12446915316202667,0.17976675464643024,0.11161749403567595,1,bp,NAC,2064,ERBB2
GO:1904064,positive regulation of cation transmembrane transport,1/18,136/18493,0.12446915316202667,0.17976675464643024,0.11161749403567595,1,bp,NAC,27092,CACNG4
GO:0001889,liver development,1/18,137/18493,0.12532765701576531,0.18014609336497486,0.11185302611299433,1,bp,NAC,2146,EZH2
GO:0046683,response to organophosphorus,1/18,137/18493,0.12532765701576531,0.18014609336497486,0.11185302611299433,1,bp,NAC,6772,STAT1
GO:0051250,negative regulation of lymphocyte activation,1/18,137/18493,0.12532765701576531,0.18014609336497486,0.11185302611299433,1,bp,NAC,2064,ERBB2
GO:0043021,ribonucleoprotein complex binding,1/18,128/17632,0.12296784090053181,0.1815239556150708,0.10786652710572966,1,mf,NAC,2146,EZH2
GO:0050773,regulation of dendrite development,1/18,139/18493,0.12704228016372598,0.18203372528988856,0.11302506009411059,1,bp,NAC,2146,EZH2
GO:0070585,protein localization to mitochondrion,1/18,139/18493,0.12704228016372598,0.18203372528988856,0.11302506009411059,1,bp,NAC,1869,E2F1
GO:0034250,positive regulation of cellular amide metabolic process,1/18,140/18493,0.12789840084352577,0.1823959898821979,0.11324999081642882,1,bp,NAC,2064,ERBB2
GO:0061008,hepaticobiliary system development,1/18,140/18493,0.12789840084352577,0.1823959898821979,0.11324999081642882,1,bp,NAC,2146,EZH2
GO:0061013,regulation of mRNA catabolic process,1/18,140/18493,0.12789840084352577,0.1823959898821979,0.11324999081642882,1,bp,NAC,1869,E2F1
GO:0060041,retina development in camera-type eye,1/18,141/18493,0.12875372851664835,0.1830401751796239,0.11364996660024232,1,bp,NAC,8842,PROM1
GO:0071236,cellular response to antibiotic,1/18,141/18493,0.12875372851664835,0.1830401751796239,0.11364996660024232,1,bp,NAC,2146,EZH2
GO:0007605,sensory perception of sound,1/18,142/18493,0.1296082638744679,0.1833926604276792,0.11386882531051865,1,bp,NAC,1301,COL11A1
GO:0030518,intracellular steroid hormone receptor signaling pathway,1/18,142/18493,0.1296082638744679,0.1833926604276792,0.11386882531051865,1,bp,NAC,898,CCNE1
GO:0044344,cellular response to fibroblast growth factor stimulus,1/18,142/18493,0.1296082638744679,0.1833926604276792,0.11386882531051865,1,bp,NAC,2264,FGFR4
GO:0038127,ERBB signaling pathway,1/18,143/18493,0.13046200760779347,0.1840265021777118,0.11426237876756899,1,bp,NAC,2064,ERBB2
GO:0051668,localization within membrane,1/18,143/18493,0.13046200760779347,0.1840265021777118,0.11426237876756899,1,bp,NAC,27092,CACNG4
GO:0055088,lipid homeostasis,1/18,144/18493,0.1313149604068704,0.18494203274694324,0.11483083330774056,1,bp,NAC,2264,FGFR4
GO:0034708,methyltransferase complex,1/18,116/19659,0.10108941583779651,0.18496112346263174,0.12714835554896275,1,cc,NAC,2146,EZH2
GO:0099055,integral component of postsynaptic membrane,1/18,117/19659,0.10191735374471544,0.18496112346263174,0.12714835554896275,1,cc,NAC,27092,CACNG4
GO:0048592,eye morphogenesis,1/18,145/18493,0.13216712296137845,0.18585361321855853,0.11539683522535696,1,bp,NAC,8842,PROM1
GO:0002262,myeloid cell homeostasis,1/18,146/18493,0.13301849596043525,0.18618483925326354,0.11560249405268495,1,bp,NAC,6772,STAT1
GO:0006661,phosphatidylinositol biosynthetic process,1/18,146/18493,0.13301849596043525,0.18618483925326354,0.11560249405268495,1,bp,NAC,2264,FGFR4
GO:0007286,spermatid development,1/18,146/18493,0.13301849596043525,0.18618483925326354,0.11560249405268495,1,bp,NAC,83990,BRIP1
GO:0007259,JAK-STAT cascade,1/18,147/18493,0.13386908009259435,0.18622585221469798,0.11562795907255084,1,bp,NAC,6772,STAT1
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1/18,147/18493,0.13386908009259435,0.18622585221469798,0.11562795907255084,1,bp,NAC,2335,FN1
GO:0030902,hindbrain development,1/18,147/18493,0.13386908009259435,0.18622585221469798,0.11562795907255084,1,bp,NAC,2146,EZH2
GO:0098727,maintenance of cell number,1/18,147/18493,0.13386908009259435,0.18622585221469798,0.11562795907255084,1,bp,NAC,2146,EZH2
GO:0010977,negative regulation of neuron projection development,1/18,148/18493,0.13471887604584443,0.18654964973065788,0.11582900551952877,1,bp,NAC,6696,SPP1
GO:0034767,positive regulation of ion transmembrane transport,1/18,148/18493,0.13471887604584443,0.18654964973065788,0.11582900551952877,1,bp,NAC,27092,CACNG4
GO:0071774,response to fibroblast growth factor,1/18,148/18493,0.13471887604584443,0.18654964973065788,0.11582900551952877,1,bp,NAC,2264,FGFR4
GO:0001890,placenta development,1/18,149/18493,0.13556788450761448,0.1874391330006194,0.11638128724578588,1,bp,NAC,6696,SPP1
GO:0031214,biomineral tissue development,1/18,150/18493,0.1364161061647704,0.1880386144246911,0.11675350631603293,1,bp,NAC,6696,SPP1
GO:1903707,negative regulation of hemopoiesis,1/18,150/18493,0.1364161061647704,0.1880386144246911,0.11675350631603293,1,bp,NAC,2064,ERBB2
GO:0008360,regulation of cell shape,1/18,151/18493,0.1372635417036152,0.1883480065433873,0.11694560842652146,1,bp,NAC,2335,FN1
GO:0014074,response to purine-containing compound,1/18,151/18493,0.1372635417036152,0.1883480065433873,0.11694560842652146,1,bp,NAC,6772,STAT1
GO:0097696,STAT cascade,1/18,151/18493,0.1372635417036152,0.1883480065433873,0.11694560842652146,1,bp,NAC,6772,STAT1
GO:0048515,spermatid differentiation,1/18,152/18493,0.13811019180989248,0.1886535300776694,0.11713530852614536,1,bp,NAC,83990,BRIP1
GO:0051053,negative regulation of DNA metabolic process,1/18,152/18493,0.13811019180989248,0.1886535300776694,0.11713530852614536,1,bp,NAC,990,CDC6
GO:1905952,regulation of lipid localization,1/18,152/18493,0.13811019180989248,0.1886535300776694,0.11713530852614536,1,bp,NAC,6696,SPP1
GO:0098936,intrinsic component of postsynaptic membrane,1/18,122/19659,0.10604625145605362,0.18895513895805918,0.12989397307535755,1,cc,NAC,27092,CACNG4
GO:0000070,mitotic sister chromatid segregation,1/18,153/18493,0.13895605716878368,0.1889552381590507,0.11732263960435457,1,bp,NAC,990,CDC6
GO:0010389,regulation of G2/M transition of mitotic cell cycle,1/18,153/18493,0.13895605716878368,0.1889552381590507,0.11732263960435457,1,bp,NAC,990,CDC6
GO:0042129,regulation of T cell proliferation,1/18,153/18493,0.13895605716878368,0.1889552381590507,0.11732263960435457,1,bp,NAC,2064,ERBB2
GO:0001959,regulation of cytokine-mediated signaling pathway,1/18,155/18493,0.14064543638233373,0.19096618383050404,0.11857123930751427,1,bp,NAC,6772,STAT1
GO:0000723,telomere maintenance,1/18,157/18493,0.14233168481452096,0.19267886287577687,0.11963464473804986,1,bp,NAC,898,CCNE1
GO:0045931,positive regulation of mitotic cell cycle,1/18,157/18493,0.14233168481452096,0.19267886287577687,0.11963464473804986,1,bp,NAC,990,CDC6
GO:0090316,positive regulation of intracellular protein transport,1/18,158/18493,0.14317363669461136,0.19352978909390833,0.12016298632303254,1,bp,NAC,2064,ERBB2
GO:0015085,calcium ion transmembrane transporter activity,1/18,139/17632,0.13284051952064413,0.1937908755359985,0.11515586831510947,1,mf,NAC,27092,CACNG4
GO:0016247,channel regulator activity,1/18,141/17632,0.13462423709107607,0.19410936510806315,0.11534512357864536,1,mf,NAC,27092,CACNG4
GO:0050806,positive regulation of synaptic transmission,1/18,159/18493,0.1440148079266539,0.19437712915100458,0.12068910125432306,1,bp,NAC,27092,CACNG4
GO:0022843,voltage-gated cation channel activity,1/18,143/17632,0.13640448905492797,0.1944155935955295,0.11552709296848104,1,mf,NAC,27092,CACNG4
GO:0043433,negative regulation of DNA-binding transcription factor activity,1/18,160/18493,0.14485519919191614,0.19493125469891387,0.12103315878131367,1,bp,NAC,2146,EZH2
GO:1903034,regulation of response to wounding,1/18,160/18493,0.14485519919191614,0.19493125469891387,0.12103315878131367,1,bp,NAC,6696,SPP1
GO:0034614,cellular response to reactive oxygen species,1/18,162/18493,0.14653364454438633,0.19545002294376235,0.12135526289666672,1,bp,NAC,2146,EZH2
GO:0050680,negative regulation of epithelial cell proliferation,1/18,162/18493,0.14653364454438633,0.19545002294376235,0.12135526289666672,1,bp,NAC,6772,STAT1
GO:0050954,sensory perception of mechanical stimulus,1/18,161/18493,0.1456948111711095,0.19545002294376235,0.12135526289666672,1,bp,NAC,1301,COL11A1
GO:0051302,regulation of cell division,1/18,162/18493,0.14653364454438633,0.19545002294376235,0.12135526289666672,1,bp,NAC,990,CDC6
GO:1990138,neuron projection extension,1/18,161/18493,0.1456948111711095,0.19545002294376235,0.12135526289666672,1,bp,NAC,2335,FN1
GO:2001257,regulation of cation channel activity,1/18,162/18493,0.14653364454438633,0.19545002294376235,0.12135526289666672,1,bp,NAC,27092,CACNG4
GO:0000910,cytokinesis,1/18,163/18493,0.14737169999134514,0.1962791951426579,0.12187009737285674,1,bp,NAC,990,CDC6
GO:0002695,negative regulation of leukocyte activation,1/18,164/18493,0.14820897819102619,0.1968163151087273,0.12220359610418283,1,bp,NAC,2064,ERBB2
GO:0048015,phosphatidylinositol-mediated signaling,1/18,164/18493,0.14820897819102619,0.1968163151087273,0.12220359610418283,1,bp,NAC,2064,ERBB2
GO:0006338,chromatin remodeling,1/18,165/18493,0.14904547982191518,0.19706158921060798,0.12235588722529481,1,bp,NAC,3070,HELLS
GO:0051100,negative regulation of binding,1/18,165/18493,0.14904547982191518,0.19706158921060798,0.12235588722529481,1,bp,NAC,1869,E2F1
GO:0060759,regulation of response to cytokine stimulus,1/18,165/18493,0.14904547982191518,0.19706158921060798,0.12235588722529481,1,bp,NAC,6772,STAT1
GO:0031497,chromatin assembly,1/18,166/18493,0.14988120556194162,0.19787809817275262,0.122862859075521,1,bp,NAC,3070,HELLS
GO:0003205,cardiac chamber development,1/18,167/18493,0.1507161560884811,0.19840283537337064,0.12318866932600628,1,bp,NAC,1301,COL11A1
GO:0048017,inositol lipid-mediated signaling,1/18,167/18493,0.1507161560884811,0.19840283537337064,0.12318866932600628,1,bp,NAC,2064,ERBB2
GO:0021543,pallium development,1/18,169/18493,0.15238373420782647,0.19909346902495642,0.12361748497458562,1,bp,NAC,2146,EZH2
GO:0022408,negative regulation of cell-cell adhesion,1/18,170/18493,0.15321636315261256,0.19909346902495642,0.12361748497458562,1,bp,NAC,2064,ERBB2
GO:0032200,telomere organization,1/18,170/18493,0.15321636315261256,0.19909346902495642,0.12361748497458562,1,bp,NAC,898,CCNE1
GO:0043901,negative regulation of multi-organism process,1/18,169/18493,0.15238373420782647,0.19909346902495642,0.12361748497458562,1,bp,NAC,6772,STAT1
GO:0048659,smooth muscle cell proliferation,1/18,170/18493,0.15321636315261256,0.19909346902495642,0.12361748497458562,1,bp,NAC,6772,STAT1
GO:0048660,regulation of smooth muscle cell proliferation,1/18,168/18493,0.15155033207835344,0.19909346902495642,0.12361748497458562,1,bp,NAC,6772,STAT1
GO:0048771,tissue remodeling,1/18,170/18493,0.15321636315261256,0.19909346902495642,0.12361748497458562,1,bp,NAC,6696,SPP1
GO:1902749,regulation of cell cycle G2/M phase transition,1/18,170/18493,0.15321636315261256,0.19909346902495642,0.12361748497458562,1,bp,NAC,990,CDC6
GO:2001235,positive regulation of apoptotic signaling pathway,1/18,170/18493,0.15321636315261256,0.19909346902495642,0.12361748497458562,1,bp,NAC,1869,E2F1
GO:0071466,cellular response to xenobiotic stimulus,1/18,171/18493,0.15404821958787174,0.19988803314191653,0.12411083123185211,1,bp,NAC,1869,E2F1
GO:0010921,regulation of phosphatase activity,1/18,172/18493,0.15487930418821105,0.20067932699815347,0.12460214697848562,1,bp,NAC,9088,PKMYT1
GO:0042383,sarcolemma,1/18,133/19659,0.11506680745443698,0.20136691304526472,0.1384262345316535,1,cc,NAC,27092,CACNG4
GO:0006479,protein methylation,1/18,174/18493,0.15653916057979822,0.20225216331321508,0.1255787238119539,1,bp,NAC,2146,EZH2
GO:0008213,protein alkylation,1/18,174/18493,0.15653916057979822,0.20225216331321508,0.1255787238119539,1,bp,NAC,2146,EZH2
GO:0001936,regulation of endothelial cell proliferation,1/18,175/18493,0.15736793371750024,0.2030337352514548,0.12606400320260933,1,bp,NAC,6772,STAT1
GO:0010821,regulation of mitochondrion organization,1/18,176/18493,0.15819593771319207,0.2035230007175393,0.1263677889907544,1,bp,NAC,1869,E2F1
GO:0035637,multicellular organismal signaling,1/18,176/18493,0.15819593771319207,0.2035230007175393,0.1263677889907544,1,bp,NAC,27092,CACNG4
GO:0050792,regulation of viral process,1/18,177/18493,0.15902317323872373,0.20429747610130652,0.12684866211826035,1,bp,NAC,6772,STAT1
GO:0016525,negative regulation of angiogenesis,1/18,178/18493,0.15984964096539422,0.2044903023351376,0.12696838826588364,1,bp,NAC,6772,STAT1
GO:0042098,T cell proliferation,1/18,178/18493,0.15984964096539422,0.2044903023351376,0.12696838826588364,1,bp,NAC,2064,ERBB2
GO:0071346,cellular response to interferon-gamma,1/18,178/18493,0.15984964096539422,0.2044903023351376,0.12696838826588364,1,bp,NAC,6772,STAT1
GO:0031345,negative regulation of cell projection organization,1/18,179/18493,0.16067534156395424,0.20525709126550212,0.12744448886095705,1,bp,NAC,6696,SPP1
GO:0048639,positive regulation of developmental growth,1/18,180/18493,0.16150027570460335,0.2057313905394315,0.12773898211407866,1,bp,NAC,2335,FN1
GO:2000181,negative regulation of blood vessel morphogenesis,1/18,180/18493,0.16150027570460335,0.2057313905394315,0.12773898211407866,1,bp,NAC,6772,STAT1
GO:0051224,negative regulation of protein transport,1/18,181/18493,0.16232444405699342,0.2064912633375779,0.12821078847049752,1,bp,NAC,2335,FN1
GO:0030308,negative regulation of cell growth,1/18,184/18493,0.16479236107289663,0.20701755054448373,0.12853756112261222,1,bp,NAC,6696,SPP1
GO:0043112,receptor metabolic process,1/18,184/18493,0.16479236107289663,0.20701755054448373,0.12853756112261222,1,bp,NAC,27092,CACNG4
GO:0046890,regulation of lipid biosynthetic process,1/18,183/18493,0.16397048607285925,0.20701755054448373,0.12853756112261222,1,bp,NAC,2264,FGFR4
GO:0048839,inner ear development,1/18,183/18493,0.16397048607285925,0.20701755054448373,0.12853756112261222,1,bp,NAC,1301,COL11A1
GO:0050707,regulation of cytokine secretion,1/18,184/18493,0.16479236107289663,0.20701755054448373,0.12853756112261222,1,bp,NAC,2335,FN1
GO:0050866,negative regulation of cell activation,1/18,184/18493,0.16479236107289663,0.20701755054448373,0.12853756112261222,1,bp,NAC,2064,ERBB2
GO:0051147,regulation of muscle cell differentiation,1/18,182/18493,0.1631478472902268,0.20701755054448373,0.12853756112261222,1,bp,NAC,2146,EZH2
GO:1903708,positive regulation of hemopoiesis,1/18,183/18493,0.16397048607285925,0.20701755054448373,0.12853756112261222,1,bp,NAC,6772,STAT1
GO:1904950,negative regulation of establishment of protein localization,1/18,184/18493,0.16479236107289663,0.20701755054448373,0.12853756112261222,1,bp,NAC,2335,FN1
GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,1/18,155/17632,0.14701357726883613,0.20715549524245092,0.1230974929284513,1,mf,NAC,2146,EZH2
GO:0000819,sister chromatid segregation,1/18,185/18493,0.1656134729577995,0.20776130010058663,0.12899935652969752,1,bp,NAC,990,CDC6
hsa03440,Homologous recombination,1/17,41/7844,0.08532090747504206,0.2094240456205578,0.13879956239959,1,kg,NAC,83990,BRIP1
GO:0097730,non-motile cilium,1/18,142/19659,0.1223832497222831,0.21041330654006568,0.14464502275579164,1,cc,NAC,8842,PROM1
GO:0007219,Notch signaling pathway,1/18,189/18493,0.16889030267612937,0.21099656270970985,0.1310081367721172,1,bp,NAC,6772,STAT1
GO:0010952,positive regulation of peptidase activity,1/18,189/18493,0.16889030267612937,0.21099656270970985,0.1310081367721172,1,bp,NAC,2335,FN1
GO:0071897,DNA biosynthetic process,1/18,189/18493,0.16889030267612937,0.21099656270970985,0.1310081367721172,1,bp,NAC,2264,FGFR4
GO:0001935,endothelial cell proliferation,1/18,190/18493,0.16970760897813086,0.21114513215797628,0.1311003838037687,1,bp,NAC,6772,STAT1
GO:0042180,cellular ketone metabolic process,1/18,190/18493,0.16970760897813086,0.21114513215797628,0.1311003838037687,1,bp,NAC,2264,FGFR4
GO:1901654,response to ketone,1/18,190/18493,0.16970760897813086,0.21114513215797628,0.1311003838037687,1,bp,NAC,6696,SPP1
GO:0043401,steroid hormone mediated signaling pathway,1/18,191/18493,0.17052415615828664,0.21187042415830956,0.1315507188820236,1,bp,NAC,898,CCNE1
GO:0006333,chromatin assembly or disassembly,1/18,192/18493,0.17133994488023785,0.21201272852165856,0.13163907591143428,1,bp,NAC,3070,HELLS
GO:0034764,positive regulation of transmembrane transport,1/18,192/18493,0.17133994488023785,0.21201272852165856,0.13163907591143428,1,bp,NAC,27092,CACNG4
GO:1901343,negative regulation of vasculature development,1/18,192/18493,0.17133994488023785,0.21201272852165856,0.13163907591143428,1,bp,NAC,6772,STAT1
GO:0006694,steroid biosynthetic process,1/18,193/18493,0.1721549758070805,0.21244158239050615,0.13190535203263598,1,bp,NAC,2264,FGFR4
GO:0007623,circadian rhythm,1/18,193/18493,0.1721549758070805,0.21244158239050615,0.13190535203263598,1,bp,NAC,2146,EZH2
GO:0010001,glial cell differentiation,1/18,194/18493,0.17296924960136928,0.21315639862560043,0.13234918268983492,1,bp,NAC,2064,ERBB2
GO:0072562,blood microparticle,1/18,147/19659,0.12642321564368786,0.21361164022554155,0.14684366245364833,1,cc,NAC,2335,FN1
GO:1903531,negative regulation of secretion by cell,1/18,196/18493,0.17459552843977766,0.21486858113280644,0.13341227981901174,1,bp,NAC,2335,FN1
GO:0000922,spindle pole,1/18,154/19659,0.13204966874600066,0.21568112561846775,0.14826629473235162,1,cc,NAC,990,CDC6
GO:0099699,integral component of synaptic membrane,1/18,154/19659,0.13204966874600066,0.21568112561846775,0.14826629473235162,1,cc,NAC,27092,CACNG4
GO:0006612,protein targeting to membrane,1/18,198/18493,0.17621878668503355,0.2162793498285865,0.134288228582712,1,bp,NAC,2064,ERBB2
GO:0034341,response to interferon-gamma,1/18,198/18493,0.17621878668503355,0.2162793498285865,0.134288228582712,1,bp,NAC,6772,STAT1
GO:0030666,endocytic vesicle membrane,1/18,163/19659,0.1392333993983319,0.21658528795296075,0.14888784563898483,1,cc,NAC,27092,CACNG4
GO:0043209,myelin sheath,1/18,162/19659,0.1384379890173667,0.21658528795296075,0.14888784563898483,1,cc,NAC,2064,ERBB2
GO:0090575,RNA polymerase II transcription factor complex,1/18,161/19659,0.13764188448976444,0.21658528795296075,0.14888784563898483,1,cc,NAC,1869,E2F1
GO:0099240,intrinsic component of synaptic membrane,1/18,166/19659,0.14161547135595054,0.21684869051379926,0.14906891721679005,1,cc,NAC,27092,CACNG4
GO:0001078,"proximal promoter DNA-binding transcription repressor activity, RNA polymerase II-specific",1/18,169/17632,0.159235263399642,0.21939080735061786,0.13036805190613965,1,mf,NAC,1869,E2F1
GO:0030674,"protein binding, bridging",1/18,168/17632,0.15836780006943452,0.21939080735061786,0.13036805190613965,1,mf,NAC,1301,COL11A1
GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",1/18,203/18493,0.18026375183774035,0.22064672458411672,0.13699993924737708,1,bp,NAC,6772,STAT1
GO:0050679,positive regulation of epithelial cell proliferation,1/18,203/18493,0.18026375183774035,0.22064672458411672,0.13699993924737708,1,bp,NAC,2064,ERBB2
GO:0032869,cellular response to insulin stimulus,1/18,204/18493,0.18107049062762148,0.22103759757638314,0.13724263297552952,1,bp,NAC,6772,STAT1
GO:0032886,regulation of microtubule-based process,1/18,204/18493,0.18107049062762148,0.22103759757638314,0.13724263297552952,1,bp,NAC,2064,ERBB2
GO:0032944,regulation of mononuclear cell proliferation,1/18,206/18493,0.18268171922277232,0.22151379590247927,0.13753830535348044,1,bp,NAC,2064,ERBB2
GO:0035303,regulation of dephosphorylation,1/18,206/18493,0.18268171922277232,0.22151379590247927,0.13753830535348044,1,bp,NAC,9088,PKMYT1
GO:0050670,regulation of lymphocyte proliferation,1/18,205/18493,0.18187647953727737,0.22151379590247927,0.13753830535348044,1,bp,NAC,2064,ERBB2
GO:0051216,cartilage development,1/18,206/18493,0.18268171922277232,0.22151379590247927,0.13753830535348044,1,bp,NAC,1301,COL11A1
GO:0071229,cellular response to acid chemical,1/18,206/18493,0.18268171922277232,0.22151379590247927,0.13753830535348044,1,bp,NAC,1869,E2F1
GO:0006323,DNA packaging,1/18,209/18493,0.18509294948685018,0.22294728444166417,0.13842836090789803,1,bp,NAC,3070,HELLS
GO:0007601,visual perception,1/18,209/18493,0.18509294948685018,0.22294728444166417,0.13842836090789803,1,bp,NAC,1301,COL11A1
GO:0010810,regulation of cell-substrate adhesion,1/18,209/18493,0.18509294948685018,0.22294728444166417,0.13842836090789803,1,bp,NAC,2335,FN1
GO:0051701,interaction with host,1/18,209/18493,0.18509294948685018,0.22294728444166417,0.13842836090789803,1,bp,NAC,3694,ITGB6
GO:2000027,regulation of animal organ morphogenesis,1/18,208/18493,0.18428995354283995,0.22294728444166417,0.13842836090789803,1,bp,NAC,6772,STAT1
GO:0043583,ear development,1/18,210/18493,0.1858951988255746,0.2236166383750612,0.13884396394203885,1,bp,NAC,1301,COL11A1
GO:0002526,acute inflammatory response,1/18,211/18493,0.1866967022123901,0.22428332305514942,0.13925790963210696,1,bp,NAC,2335,FN1
GO:0050953,sensory perception of light stimulus,1/18,213/18493,0.18829747374111827,0.22590715434284958,0.14026614933374865,1,bp,NAC,1301,COL11A1
GO:0001649,osteoblast differentiation,1/18,214/18493,0.18909674318710612,0.22626747502731565,0.1404898730802691,1,bp,NAC,6696,SPP1
GO:0032388,positive regulation of intracellular transport,1/18,214/18493,0.18909674318710612,0.22626747502731565,0.1404898730802691,1,bp,NAC,2064,ERBB2
GO:0070663,regulation of leukocyte proliferation,1/18,216/18493,0.190693052698504,0.22787694176224393,0.14148919380583824,1,bp,NAC,2064,ERBB2
GO:0045444,fat cell differentiation,1/18,217/18493,0.19149009406477935,0.22822800961465817,0.1417071724526689,1,bp,NAC,1869,E2F1
GO:0045665,negative regulation of neuron differentiation,1/18,217/18493,0.19149009406477935,0.22822800961465817,0.1417071724526689,1,bp,NAC,6696,SPP1
GO:0016358,dendrite development,1/18,218/18493,0.19228639403779513,0.22827717197942432,0.14173769745139214,1,bp,NAC,2146,EZH2
GO:0042445,hormone metabolic process,1/18,218/18493,0.19228639403779513,0.22827717197942432,0.14173769745139214,1,bp,NAC,6696,SPP1
GO:0072331,signal transduction by p53 class mediator,1/18,218/18493,0.19228639403779513,0.22827717197942432,0.14173769745139214,1,bp,NAC,1869,E2F1
GO:0051054,positive regulation of DNA metabolic process,1/18,220/18493,0.1938767723999103,0.22986435629636423,0.1427231829844541,1,bp,NAC,2264,FGFR4
GO:0019887,protein kinase regulator activity,1/18,180/17632,0.1687217953001473,0.2299066221672337,0.13661683829971444,1,mf,NAC,898,CCNE1
GO:0051048,negative regulation of secretion,1/18,222/18493,0.19546419297125328,0.2314438942884161,0.1437039209009489,1,bp,NAC,2335,FN1
GO:0048738,cardiac muscle tissue development,1/18,224/18493,0.19704866092971585,0.2330158219859873,0.14467993357221987,1,bp,NAC,1301,COL11A1
GO:0140097,"catalytic activity, acting on DNA",1/18,185/17632,0.17300035414429826,0.233174390368402,0.13855863604234417,1,mf,NAC,83990,BRIP1
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,1/18,226/18493,0.1986301814446929,0.23458017522179225,0.1456512432468623,1,bp,NAC,6772,STAT1
GO:0008237,metallopeptidase activity,1/18,189/17632,0.17640821767790893,0.23521095690387855,0.13976881989194823,1,mf,NAC,4316,MMP7
GO:0031669,cellular response to nutrient levels,1/18,228/18493,0.20020875967709106,0.235830318217041,0.1464274592306818,1,bp,NAC,83990,BRIP1
GO:0051607,defense response to virus,1/18,228/18493,0.20020875967709106,0.235830318217041,0.1464274592306818,1,bp,NAC,6772,STAT1
GO:0005244,voltage-gated ion channel activity,1/18,199/17632,0.1848699447322859,0.23632858914230362,0.14043294770765072,1,mf,NAC,27092,CACNG4
GO:0022832,voltage-gated channel activity,1/18,199/17632,0.1848699447322859,0.23632858914230362,0.14043294770765072,1,mf,NAC,27092,CACNG4
GO:0042393,histone binding,1/18,195/17632,0.18149515471534183,0.23632858914230362,0.14043294770765072,1,mf,NAC,6772,STAT1
GO:0060090,molecular adaptor activity,1/18,196/17632,0.18234008717018624,0.23632858914230362,0.14043294770765072,1,mf,NAC,1301,COL11A1
GO:0033157,regulation of intracellular protein transport,1/18,232/18493,0.20335710989543232,0.2392281435475449,0.14853717495263336,1,bp,NAC,2064,ERBB2
GO:0042593,glucose homeostasis,1/18,233/18493,0.2041423665638451,0.2398408374007869,0.14891759764338308,1,bp,NAC,2264,FGFR4
GO:0033500,carbohydrate homeostasis,1/18,234/18493,0.20492689216087945,0.24045108821464123,0.14929650344668144,1,bp,NAC,2264,FGFR4
GO:0006302,double-strand break repair,1/18,236/18493,0.2064937527027817,0.2407324340635257,0.14947119157893143,1,bp,NAC,83990,BRIP1
GO:0033002,muscle cell proliferation,1/18,236/18493,0.2064937527027817,0.2407324340635257,0.14947119157893143,1,bp,NAC,6772,STAT1
GO:0048705,skeletal system morphogenesis,1/18,236/18493,0.2064937527027817,0.2407324340635257,0.14947119157893143,1,bp,NAC,1301,COL11A1
GO:0071356,cellular response to tumor necrosis factor,1/18,235/18493,0.20571068732715936,0.2407324340635257,0.14947119157893143,1,bp,NAC,6772,STAT1
GO:0097237,cellular response to toxic substance,1/18,235/18493,0.20571068732715936,0.2407324340635257,0.14947119157893143,1,bp,NAC,2146,EZH2
GO:0032412,regulation of ion transmembrane transporter activity,1/18,238/18493,0.20805769663981244,0.2419337575029614,0.1502170954147094,1,bp,NAC,27092,CACNG4
GO:0034329,cell junction assembly,1/18,238/18493,0.20805769663981244,0.2419337575029614,0.1502170954147094,1,bp,NAC,2335,FN1
GO:0006839,mitochondrial transport,1/18,241/18493,0.21039815508763482,0.2434070493169449,0.15113186489243374,1,bp,NAC,1869,E2F1
GO:0007050,cell cycle arrest,1/18,241/18493,0.21039815508763482,0.2434070493169449,0.15113186489243374,1,bp,NAC,1869,E2F1
GO:0009755,hormone-mediated signaling pathway,1/18,240/18493,0.20961872908223722,0.2434070493169449,0.15113186489243374,1,bp,NAC,898,CCNE1
GO:0046474,glycerophospholipid biosynthetic process,1/18,241/18493,0.21039815508763482,0.2434070493169449,0.15113186489243374,1,bp,NAC,2264,FGFR4
GO:0019207,kinase regulator activity,1/18,208/17632,0.19241523564485163,0.24346417571389392,0.14467310950740725,1,mf,NAC,898,CCNE1
GO:0000775,"chromosome, centromeric region",1/18,194/19659,0.1635499147512267,0.24374186707571063,0.16755617070725543,1,cc,NAC,3070,HELLS
GO:0044798,nuclear transcription factor complex,1/18,198/19659,0.16663984789870012,0.24374186707571063,0.16755617070725543,1,cc,NAC,1869,E2F1
GO:0098858,actin-based cell projection,1/18,198/19659,0.16663984789870012,0.24374186707571063,0.16755617070725543,1,cc,NAC,8842,PROM1
GO:0022898,regulation of transmembrane transporter activity,1/18,245/18493,0.21350860585979958,0.24637697902651173,0.1529758994709961,1,bp,NAC,27092,CACNG4
GO:0031330,negative regulation of cellular catabolic process,1/18,245/18493,0.21350860585979958,0.24637697902651173,0.1529758994709961,1,bp,NAC,1869,E2F1
GO:0021537,telencephalon development,1/18,248/18493,0.2158338458176321,0.24842804334592933,0.1542494089132156,1,bp,NAC,2146,EZH2
GO:0045637,regulation of myeloid cell differentiation,1/18,248/18493,0.2158338458176321,0.24842804334592933,0.1542494089132156,1,bp,NAC,6772,STAT1
GO:0005125,cytokine activity,1/18,219/17632,0.20154768690092972,0.24845800860718423,0.14764058236420116,1,mf,NAC,6696,SPP1
GO:0008168,methyltransferase activity,1/18,216/17632,0.19906673896290017,0.24845800860718423,0.14764058236420116,1,mf,NAC,2146,EZH2
GO:0061134,peptidase regulator activity,1/18,220/17632,0.20237305539778716,0.24845800860718423,0.14764058236420116,1,mf,NAC,2335,FN1
GO:1901617,organic hydroxy compound biosynthetic process,1/18,251/18493,0.21815259211838,0.25077870855687034,0.15570894107575653,1,bp,NAC,2264,FGFR4
GO:0003007,heart morphogenesis,1/18,253/18493,0.21969482383002303,0.2522319053339631,0.1566112335097433,1,bp,NAC,1301,COL11A1
GO:0065004,protein-DNA complex assembly,1/18,254/18493,0.220464861832822,0.2527959920131094,0.15696147592063311,1,bp,NAC,3070,HELLS
GO:0007281,germ cell development,1/18,255/18493,0.22123418210734447,0.2530383394342515,0.1571119498605287,1,bp,NAC,83990,BRIP1
GO:0015850,organic hydroxy compound transport,1/18,255/18493,0.22123418210734447,0.2530383394342515,0.1571119498605287,1,bp,NAC,6696,SPP1
GO:0001818,negative regulation of cytokine production,1/18,256/18493,0.2220027852832448,0.25359764011574687,0.15745922063706214,1,bp,NAC,2335,FN1
GO:0007249,I-kappaB kinase/NF-kappaB signaling,1/18,258/18493,0.2235378428552114,0.2539036391729863,0.15764921598972634,1,bp,NAC,6772,STAT1
GO:0007411,axon guidance,1/18,259/18493,0.22430429850800038,0.2539036391729863,0.15764921598972634,1,bp,NAC,2064,ERBB2
GO:0031668,cellular response to extracellular stimulus,1/18,258/18493,0.2235378428552114,0.2539036391729863,0.15764921598972634,1,bp,NAC,83990,BRIP1
GO:0032409,regulation of transporter activity,1/18,260/18493,0.225070039575613,0.2539036391729863,0.15764921598972634,1,bp,NAC,27092,CACNG4
GO:0032868,response to insulin,1/18,259/18493,0.22430429850800038,0.2539036391729863,0.15764921598972634,1,bp,NAC,6772,STAT1
GO:0034612,response to tumor necrosis factor,1/18,257/18493,0.22277067198966027,0.2539036391729863,0.15764921598972634,1,bp,NAC,6772,STAT1
GO:0043270,positive regulation of ion transport,1/18,260/18493,0.225070039575613,0.2539036391729863,0.15764921598972634,1,bp,NAC,27092,CACNG4
GO:0045926,negative regulation of growth,1/18,260/18493,0.225070039575613,0.2539036391729863,0.15764921598972634,1,bp,NAC,6696,SPP1
GO:0071383,cellular response to steroid hormone stimulus,1/18,259/18493,0.22430429850800038,0.2539036391729863,0.15764921598972634,1,bp,NAC,898,CCNE1
GO:0097485,neuron projection guidance,1/18,260/18493,0.225070039575613,0.2539036391729863,0.15764921598972634,1,bp,NAC,2064,ERBB2
GO:0016741,"transferase activity, transferring one-carbon groups",1/18,228/17632,0.2089470553018229,0.254014067229667,0.1509421452128752,1,mf,NAC,2146,EZH2
GO:0046883,regulation of hormone secretion,1/18,261/18493,0.2258350666851202,0.2544501931470858,0.1579885723132257,1,bp,NAC,6696,SPP1
GO:0061448,connective tissue development,1/18,263/18493,0.22736298153551526,0.25585387624406,0.1588601216161691,1,bp,NAC,1301,COL11A1
GO:1903311,regulation of mRNA metabolic process,1/18,264/18493,0.22812587052796518,0.2563942559713314,0.159195644338957,1,bp,NAC,1869,E2F1
GO:0016323,basolateral plasma membrane,1/18,213/19659,0.17813135340913133,0.2567187152072775,0.17647688263443354,1,cc,NAC,2064,ERBB2
GO:0034703,cation channel complex,1/18,219/19659,0.18268591599991268,0.2594669531592963,0.17836611173141745,1,cc,NAC,27092,CACNG4
GO:0002440,production of molecular mediator of immune response,1/18,268/18493,0.23117031819031408,0.2594944042062065,0.1611205318288406,1,bp,NAC,4316,MMP7
hsa00310,Lysine degradation,1/17,59/7844,0.12057178368745569,0.2615776012191789,0.1733652717631985,1,kg,NAC,2146,EZH2
hsa01521,EGFR tyrosine kinase inhibitor resistance,1/17,79/7844,0.15823830197209587,0.2615776012191789,0.1733652717631985,1,kg,NAC,2064,ERBB2
hsa01524,Platinum drug resistance,1/17,73/7844,0.14710086681795942,0.2615776012191789,0.1733652717631985,1,kg,NAC,2064,ERBB2
hsa04115,p53 signaling pathway,1/17,72/7844,0.14523119753825686,0.2615776012191789,0.1733652717631985,1,kg,NAC,898,CCNE1
hsa04137,Mitophagy - animal,1/17,65/7844,0.13203509863024876,0.2615776012191789,0.1733652717631985,1,kg,NAC,1869,E2F1
hsa04260,Cardiac muscle contraction,1/17,78/7844,0.15639161867535167,0.2615776012191789,0.1733652717631985,1,kg,NAC,27092,CACNG4
hsa04520,Adherens junction,1/17,72/7844,0.14523119753825686,0.2615776012191789,0.1733652717631985,1,kg,NAC,2064,ERBB2
hsa04917,Prolactin signaling pathway,1/17,70/7844,0.14148028059145912,0.2615776012191789,0.1733652717631985,1,kg,NAC,6772,STAT1
hsa05100,Bacterial invasion of epithelial cells,1/17,74/7844,0.14896668656626655,0.2615776012191789,0.1733652717631985,1,kg,NAC,2335,FN1
hsa05140,Leishmaniasis,1/17,74/7844,0.14896668656626655,0.2615776012191789,0.1733652717631985,1,kg,NAC,6772,STAT1
hsa05213,Endometrial cancer,1/17,58/7844,0.11864743310471482,0.2615776012191789,0.1733652717631985,1,kg,NAC,2064,ERBB2
hsa05214,Glioma,1/17,75/7844,0.15082866421470598,0.2615776012191789,0.1733652717631985,1,kg,NAC,1869,E2F1
hsa05218,Melanoma,1/17,72/7844,0.14523119753825686,0.2615776012191789,0.1733652717631985,1,kg,NAC,1869,E2F1
hsa05220,Chronic myeloid leukemia,1/17,76/7844,0.1526868071814137,0.2615776012191789,0.1733652717631985,1,kg,NAC,1869,E2F1
hsa05230,Central carbon metabolism in cancer,1/17,65/7844,0.13203509863024876,0.2615776012191789,0.1733652717631985,1,kg,NAC,2064,ERBB2
hsa05321,Inflammatory bowel disease (IBD),1/17,65/7844,0.13203509863024876,0.2615776012191789,0.1733652717631985,1,kg,NAC,6772,STAT1
GO:0045017,glycerolipid biosynthetic process,1/18,273/18493,0.2349599308172864,0.26342232045893543,0.16355938193643646,1,bp,NAC,2264,FGFR4
GO:0007162,negative regulation of cell adhesion,1/18,276/18493,0.23722522318712636,0.26563367584039954,0.1649324163809131,1,bp,NAC,2064,ERBB2
GO:0051146,striated muscle cell differentiation,1/18,277/18493,0.23797891182864972,0.2661490419587981,0.16525240810997158,1,bp,NAC,2146,EZH2
GO:0050768,negative regulation of neurogenesis,1/18,279/18493,0.2394841795999445,0.26750264888811537,0.1660928650323701,1,bp,NAC,6696,SPP1
GO:0031503,protein-containing complex localization,1/18,280/18493,0.24023575996489444,0.26801209629539885,0.16640918182329062,1,bp,NAC,27092,CACNG4
GO:0006310,DNA recombination,1/18,282/18493,0.24173681673753344,0.2693553965367848,0.1672432393050309,1,bp,NAC,83990,BRIP1
GO:0008654,phospholipid biosynthetic process,1/18,284/18493,0.24323507234007524,0.2703605522211376,0.16786734223676503,1,bp,NAC,2264,FGFR4
GO:0048562,embryonic organ morphogenesis,1/18,284/18493,0.24323507234007524,0.2703605522211376,0.16786734223676503,1,bp,NAC,1301,COL11A1
GO:0009895,negative regulation of catabolic process,1/18,287/18493,0.24547721431112102,0.27185327641048446,0.1687941773105196,1,bp,NAC,1869,E2F1
GO:0034330,cell junction organization,1/18,287/18493,0.24547721431112102,0.27185327641048446,0.1687941773105196,1,bp,NAC,2335,FN1
GO:0097193,intrinsic apoptotic signaling pathway,1/18,287/18493,0.24547721431112102,0.27185327641048446,0.1687941773105196,1,bp,NAC,1869,E2F1
GO:0019058,viral life cycle,1/18,289/18493,0.24696848849745734,0.2728385128711252,0.16940591236122787,1,bp,NAC,3694,ITGB6
GO:0034599,cellular response to oxidative stress,1/18,289/18493,0.24696848849745734,0.2728385128711252,0.16940591236122787,1,bp,NAC,2146,EZH2
GO:0004252,serine-type endopeptidase activity,1/18,250/17632,0.22676270398858234,0.27299587664644864,0.16222165844865372,1,mf,NAC,4316,MMP7
GO:0071824,protein-DNA complex subunit organization,1/18,290/18493,0.24771308129063685,0.27332818093747885,0.16970994812458795,1,bp,NAC,3070,HELLS
hsa04012,ErbB signaling pathway,1/17,85/7844,0.16923875059608517,0.274166775965658,0.1817089743242178,1,kg,NAC,2064,ERBB2
GO:0072330,monocarboxylic acid biosynthetic process,1/18,293/18493,0.24994268980987622,0.27511895589509433,0.17082184344440954,1,bp,NAC,2264,FGFR4
GO:1903037,regulation of leukocyte cell-cell adhesion,1/18,293/18493,0.24994268980987622,0.27511895589509433,0.17082184344440954,1,bp,NAC,2064,ERBB2
GO:0051961,negative regulation of nervous system development,1/18,298/18493,0.2536448410894452,0.27885560105227486,0.17314193299247618,1,bp,NAC,6696,SPP1
GO:0043414,macromolecule methylation,1/18,300/18493,0.25512086378654864,0.2801387693152538,0.17393865442309614,1,bp,NAC,2146,EZH2
GO:0043010,camera-type eye development,1/18,302/18493,0.2565941293064865,0.2810759363296899,0.17452054307013767,1,bp,NAC,8842,PROM1
GO:0070588,calcium ion transmembrane transport,1/18,302/18493,0.2565941293064865,0.2810759363296899,0.17452054307013767,1,bp,NAC,27092,CACNG4
hsa04974,Protein digestion and absorption,1/17,90/7844,0.17830228960833516,0.2831859893779441,0.18768662064035282,1,kg,NAC,1301,COL11A1
hsa04658,Th1 and Th2 cell differentiation,1/17,92/7844,0.18190157957138176,0.28334669125542156,0.18779312870729695,1,kg,NAC,6772,STAT1
GO:0046879,hormone secretion,1/18,306/18493,0.25953240819853785,0.28395162151516745,0.17630606105798713,1,bp,NAC,6696,SPP1
GO:0006402,mRNA catabolic process,1/18,307/18493,0.2602652622510164,0.28441035284538785,0.1765908881474874,1,bp,NAC,1869,E2F1
GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1/18,267/17632,0.24026907361760075,0.28647466469790855,0.17023112503271312,1,mf,NAC,1869,E2F1
GO:0007568,aging,1/18,311/18493,0.2631898338761762,0.2872601435928903,0.1783603282332691,1,bp,NAC,4316,MMP7
GO:0001664,G protein-coupled receptor binding,1/18,274/17632,0.2457654957291061,0.28749925915480334,0.1708399672396964,1,mf,NAC,6772,STAT1
GO:0008236,serine-type peptidase activity,1/18,273/17632,0.24498259848691295,0.28749925915480334,0.1708399672396964,1,mf,NAC,4316,MMP7
GO:0017171,serine hydrolase activity,1/18,277/17632,0.2481095897800063,0.2875288703992596,0.17085756305558722,1,mf,NAC,4316,MMP7
GO:0005126,cytokine receptor binding,1/18,281/17632,0.2512243469521066,0.28844276872278907,0.17140062657551133,1,mf,NAC,6772,STAT1
hsa04066,HIF-1 signaling pathway,1/17,100/7844,0.19615088817866444,0.2888767625903967,0.19145828319831365,1,kg,NAC,2064,ERBB2
hsa04914,Progesterone-mediated oocyte maturation,1/17,99/7844,0.194382586561045,0.2888767625903967,0.19145828319831365,1,kg,NAC,9088,PKMYT1
hsa05146,Amoebiasis,1/17,96/7844,0.18905568964418462,0.2888767625903967,0.19145828319831365,1,kg,NAC,2335,FN1
GO:1904062,regulation of cation transmembrane transport,1/18,314/18493,0.2653760926301797,0.2892982163648714,0.1796257712008428,1,bp,NAC,27092,CACNG4
GO:0009615,response to virus,1/18,315/18493,0.2661034830439897,0.2897429281163249,0.17990189350923674,1,bp,NAC,6772,STAT1
GO:0009914,hormone transport,1/18,316/18493,0.2668301932049101,0.29018583361733025,0.18017689431355155,1,bp,NAC,6696,SPP1
GO:0042742,defense response to bacterium,1/18,319/18493,0.2690062481556724,0.2915037838437215,0.18099521192640983,1,bp,NAC,4316,MMP7
GO:0071214,cellular response to abiotic stimulus,1/18,319/18493,0.2690062481556724,0.2915037838437215,0.18099521192640983,1,bp,NAC,4316,MMP7
GO:0104004,cellular response to environmental stimulus,1/18,319/18493,0.2690062481556724,0.2915037838437215,0.18099521192640983,1,bp,NAC,4316,MMP7
GO:0016042,lipid catabolic process,1/18,321/18493,0.2704535611562163,0.29272241046382846,0.18175185933748994,1,bp,NAC,6696,SPP1
hsa04625,C-type lectin receptor signaling pathway,1/17,104/7844,0.2031876302049167,0.2938963936892545,0.19478513421899912,1,kg,NAC,6772,STAT1
hsa04659,Th17 cell differentiation,1/17,107/7844,0.20842709651856073,0.29618587400005997,0.1963025285770378,1,kg,NAC,6772,STAT1
GO:0010721,negative regulation of cell development,1/18,326/18493,0.2740600123927255,0.29627226607890583,0.18395597093044116,1,bp,NAC,6696,SPP1
GO:0007159,leukocyte cell-cell adhesion,1/18,327/18493,0.2747792791828908,0.29669619787962137,0.18421919093088546,1,bp,NAC,2064,ERBB2
GO:0061695,"transferase complex, transferring phosphorus-containing groups",1/18,259/19659,0.21244593204248818,0.29742430485948346,0.20445924286795855,1,cc,NAC,898,CCNE1
GO:0032102,negative regulation of response to external stimulus,1/18,329/18493,0.2762157940559603,0.2978926577987586,0.18496207499835882,1,bp,NAC,6696,SPP1
GO:0033044,regulation of chromosome organization,1/18,330/18493,0.27693304332412727,0.29831148491090664,0.18522212548869624,1,bp,NAC,990,CDC6
GO:0001101,response to acid chemical,1/18,332/18493,0.2783655284832163,0.2994988544890595,0.1859593653474692,1,bp,NAC,1869,E2F1
GO:0001077,"proximal promoter DNA-binding transcription activator activity, RNA polymerase II-specific",1/18,298/17632,0.2643266223765329,0.30054916263129733,0.17859457881316482,1,mf,NAC,1869,E2F1
GO:0044389,ubiquitin-like protein ligase binding,1/18,301/17632,0.26661619265679604,0.30054916263129733,0.17859457881316482,1,mf,NAC,6772,STAT1
GO:0006401,RNA catabolic process,1/18,340/18493,0.2840687106685569,0.30527289167817667,0.189544475190419,1,bp,NAC,1869,E2F1
hsa05145,Toxoplasmosis,1/17,113/7844,0.2188089027945871,0.3055779504545096,0.20252729659753071,1,kg,NAC,6772,STAT1
hsa04919,Thyroid hormone signaling pathway,1/17,116/7844,0.2239516184368534,0.3074590015827987,0.20377399715039296,1,kg,NAC,6772,STAT1
GO:0006898,receptor-mediated endocytosis,1/18,346/18493,0.2883181327001878,0.30947283592789393,0.19215222795963935,1,bp,NAC,27092,CACNG4
GO:0005667,transcription factor complex,1/18,356/19659,0.28042078454567954,0.31099257196111263,0.21378651563384757,1,cc,NAC,1869,E2F1
GO:0005819,spindle,1/18,333/19659,0.26482340701987805,0.31099257196111263,0.21378651563384757,1,cc,NAC,990,CDC6
GO:0009897,external side of plasma membrane,1/18,359/19659,0.2824320296381533,0.31099257196111263,0.21378651563384757,1,cc,NAC,3694,ITGB6
GO:0014069,postsynaptic density,1/18,316/19659,0.25309027547527174,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:0030139,endocytic vesicle,1/18,293/19659,0.23693432388311775,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:0031253,cell projection membrane,1/18,334/19659,0.26550814150573365,0.31099257196111263,0.21378651563384757,1,cc,NAC,8842,PROM1
GO:0031965,nuclear membrane,1/18,302/19659,0.24329513132313596,0.31099257196111263,0.21378651563384757,1,cc,NAC,83990,BRIP1
GO:0031983,vesicle lumen,1/18,339/19659,0.2689227885977319,0.31099257196111263,0.21378651563384757,1,cc,NAC,2335,FN1
GO:0032279,asymmetric synapse,1/18,320/19659,0.2558668168790489,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:0034702,ion channel complex,1/18,301/19659,0.24259085585073759,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:0034774,secretory granule lumen,1/18,321/19659,0.25655942752573035,0.31099257196111263,0.21378651563384757,1,cc,NAC,2335,FN1
GO:0045211,postsynaptic membrane,1/18,322/19659,0.2572514292996746,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:0060205,cytoplasmic vesicle lumen,1/18,338/19659,0.268241060897103,0.31099257196111263,0.21378651563384757,1,cc,NAC,2335,FN1
GO:0098687,chromosomal region,1/18,346/19659,0.27367811410663734,0.31099257196111263,0.21378651563384757,1,cc,NAC,3070,HELLS
GO:0098978,glutamatergic synapse,1/18,350/19659,0.2763823113929159,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:0098984,neuron to neuron synapse,1/18,342/19659,0.2709643745029503,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:0099572,postsynaptic specialization,1/18,340/19659,0.26960391643444215,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:1902495,transmembrane transporter complex,1/18,325/19659,0.2593237864211214,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:1990351,transporter complex,1/18,333/19659,0.26482340701987805,0.31099257196111263,0.21378651563384757,1,cc,NAC,27092,CACNG4
GO:0006959,humoral immune response,1/18,349/18493,0.29043389991635904,0.31137535132876787,0.1933335031171483,1,bp,NAC,4316,MMP7
GO:0003713,transcription coactivator activity,1/18,321/17632,0.2817088785515276,0.31189197268204844,0.18533478852074187,1,mf,NAC,898,CCNE1
GO:0005261,cation channel activity,1/18,320/17632,0.2809612643393109,0.31189197268204844,0.18533478852074187,1,mf,NAC,27092,CACNG4
GO:0001654,eye development,1/18,351/18493,0.29184110957546583,0.3121460924350796,0.19381205762521625,1,bp,NAC,8842,PROM1
GO:0009913,epidermal cell differentiation,1/18,351/18493,0.29184110957546583,0.3121460924350796,0.19381205762521625,1,bp,NAC,2146,EZH2
GO:0150063,visual system development,1/18,352/18493,0.2925437256060932,0.3125290449054494,0.1940498334873968,1,bp,NAC,8842,PROM1
GO:0035690,cellular response to drug,1/18,355/18493,0.2946476254755853,0.3140368934269752,0.19498605928559362,1,bp,NAC,2146,EZH2
GO:0062012,regulation of small molecule metabolic process,1/18,355/18493,0.2946476254755853,0.3140368934269752,0.19498605928559362,1,bp,NAC,2264,FGFR4
GO:0048880,sensory system development,1/18,357/18493,0.29604694100474505,0.3151579524545819,0.1956821268069417,1,bp,NAC,8842,PROM1
GO:0032259,methylation,1/18,358/18493,0.2967456151921024,0.3155313868455298,0.19591399287687394,1,bp,NAC,2146,EZH2
GO:0006869,lipid transport,1/18,359/18493,0.29744363443260635,0.31590325108943085,0.19614488403974412,1,bp,NAC,6696,SPP1
GO:0018205,peptidyl-lysine modification,1/18,361/18493,0.29883771038406903,0.3170126354600592,0.19683370274604733,1,bp,NAC,2146,EZH2
GO:0045088,regulation of innate immune response,1/18,365/18493,0.3016180283191603,0.3195882613148112,0.19843291336786864,1,bp,NAC,6772,STAT1
GO:0051098,regulation of binding,1/18,369/18493,0.3043879316564507,0.3221468541568271,0.20002154816213372,1,bp,NAC,1869,E2F1
GO:0043900,regulation of multi-organism process,1/18,371/18493,0.30576898933211305,0.3232313208907069,0.20069489546396824,1,bp,NAC,6772,STAT1
GO:0030133,transport vesicle,1/18,381/19659,0.297019758667304,0.3234215149932866,0.22233057958722172,1,cc,NAC,2264,FGFR4
GO:0042692,muscle cell differentiation,1/18,373/18493,0.30714745712056357,0.3239334228004083,0.20113083177417568,1,bp,NAC,2146,EZH2
GO:1903532,positive regulation of secretion by cell,1/18,373/18493,0.30714745712056357,0.3239334228004083,0.20113083177417568,1,bp,NAC,6696,SPP1
GO:0022839,ion gated channel activity,1/18,342/17632,0.2972402215259241,0.3261751103470317,0.19382222176818528,1,mf,NAC,27092,CACNG4
GO:0014706,striated muscle tissue development,1/18,379/18493,0.31126736684088685,0.32789721454667176,0.20359195703878533,1,bp,NAC,1301,COL11A1
hsa04380,Osteoclast differentiation,1/17,128/7844,0.24420556660079218,0.32967751491106945,0.21849971748491934,1,kg,NAC,6772,STAT1
GO:0022836,gated channel activity,1/18,351/17632,0.3037989418083499,0.33044797179153845,0.196361273560337,1,mf,NAC,27092,CACNG4
GO:0050808,synapse organization,1/18,384/18493,0.3146829396368255,0.3311107033069614,0.20558721786018033,1,bp,NAC,2064,ERBB2
GO:0005924,cell-substrate adherens junction,1/18,405/19659,0.3126140242787626,0.3321263095000051,0.22831454143931607,1,cc,NAC,3694,ITGB6
GO:0005925,focal adhesion,1/18,402/19659,0.3106827640767741,0.3321263095000051,0.22831454143931607,1,cc,NAC,3694,ITGB6
GO:0030055,cell-substrate junction,1/18,409/19659,0.31518108962755587,0.3321263095000051,0.22831454143931607,1,cc,NAC,3694,ITGB6
GO:0042623,"ATPase activity, coupled",1/18,357/17632,0.308139258575313,0.33225450489859837,0.1974347652198802,1,mf,NAC,83990,BRIP1
GO:0019216,regulation of lipid metabolic process,1/18,388/18493,0.31740387308667395,0.3332005936222376,0.20688483443149439,1,bp,NAC,2264,FGFR4
GO:0022407,regulation of cell-cell adhesion,1/18,388/18493,0.31740387308667395,0.3332005936222376,0.20688483443149439,1,bp,NAC,2064,ERBB2
GO:2001233,regulation of apoptotic signaling pathway,1/18,391/18493,0.3194378741157209,0.33494815239648423,0.20796989674707722,1,bp,NAC,1869,E2F1
GO:0010876,lipid localization,1/18,393/18493,0.3207906932258484,0.335978243367026,0.20860948204184868,1,bp,NAC,6696,SPP1
GO:0009100,glycoprotein metabolic process,1/18,394/18493,0.3214661499950161,0.336297344919815,0.20880761275703713,1,bp,NAC,1301,COL11A1
GO:0060537,muscle tissue development,1/18,395/18493,0.3221409723222215,0.33661504826757477,0.20900487532426448,1,bp,NAC,1301,COL11A1
GO:0006417,regulation of translation,1/18,402/18493,0.326847011294332,0.3407474014298381,0.21157066066844238,1,bp,NAC,2064,ERBB2
GO:0051222,positive regulation of protein transport,1/18,402/18493,0.326847011294332,0.3407474014298381,0.21157066066844238,1,bp,NAC,2064,ERBB2
GO:0007517,muscle organ development,1/18,403/18493,0.32751677823903935,0.3410536370411122,0.21176080289792265,1,bp,NAC,1301,COL11A1
GO:0051047,positive regulation of secretion,1/18,404/18493,0.32818591577312994,0.3413585156034734,0.21195010253334687,1,bp,NAC,6696,SPP1
GO:0030099,myeloid cell differentiation,1/18,405/18493,0.32885442445332713,0.34166204235872594,0.21213856282936042,1,bp,NAC,6772,STAT1
hsa04371,Apelin signaling pathway,1/17,137/7844,0.2590684000146163,0.34272626084025354,0.22714800913389127,1,kg,NAC,6696,SPP1
hsa04550,Signaling pathways regulating pluripotency of stem cells,1/17,139/7844,0.2623336811369842,0.34272626084025354,0.22714800913389127,1,kg,NAC,2264,FGFR4
GO:0005911,cell-cell junction,1/18,442/19659,0.33601659288820185,0.3430169385733727,0.23580111781628202,1,cc,NAC,2264,FGFR4
GO:0044441,ciliary part,1/18,441/19659,0.3353941084440343,0.3430169385733727,0.23580111781628202,1,cc,NAC,8842,PROM1
GO:0097060,synaptic membrane,1/18,431/19659,0.3291388759946331,0.3430169385733727,0.23580111781628202,1,cc,NAC,27092,CACNG4
GO:0006816,calcium ion transport,1/18,413/18493,0.33417992180935785,0.34600592360854743,0.2148356863350234,1,bp,NAC,27092,CACNG4
GO:0016053,organic acid biosynthetic process,1/18,413/18493,0.33417992180935785,0.34600592360854743,0.2148356863350234,1,bp,NAC,2264,FGFR4
GO:0046394,carboxylic acid biosynthetic process,1/18,412/18493,0.3335164239735924,0.34600592360854743,0.2148356863350234,1,bp,NAC,2264,FGFR4
GO:0005635,nuclear envelope,1/18,461/19659,0.3477396908981967,0.34835124864191147,0.23946809788488002,1,cc,NAC,83990,BRIP1
GO:0010008,endosome membrane,1/18,462/19659,0.34835124864191147,0.34835124864191147,0.23946809788488002,1,cc,NAC,2064,ERBB2
GO:0050804,modulation of chemical synaptic transmission,1/18,418/18493,0.3374880640620369,0.34903269567191275,0.21671501443100255,1,bp,NAC,27092,CACNG4
GO:0099177,regulation of trans-synaptic signaling,1/18,419/18493,0.33814782698579215,0.3493167187655051,0.2168913648691989,1,bp,NAC,27092,CACNG4
hsa04261,Adrenergic signaling in cardiomyocytes,1/17,145/7844,0.27204845246133036,0.3497765817359962,0.23182073643321383,1,kg,NAC,27092,CACNG4
GO:0001819,positive regulation of cytokine production,1/18,422/18493,0.340123394604656,0.350161088429538,0.21741563547821374,1,bp,NAC,6772,STAT1
GO:0032386,regulation of intracellular transport,1/18,422/18493,0.340123394604656,0.350161088429538,0.21741563547821374,1,bp,NAC,2064,ERBB2
GO:0048568,embryonic organ development,1/18,422/18493,0.340123394604656,0.350161088429538,0.21741563547821374,1,bp,NAC,1301,COL11A1
GO:0006605,protein targeting,1/18,424/18493,0.34143734421165695,0.3507176344280553,0.21776119586724266,1,bp,NAC,2064,ERBB2
GO:0042391,regulation of membrane potential,1/18,424/18493,0.34143734421165695,0.3507176344280553,0.21776119586724266,1,bp,NAC,27092,CACNG4
GO:0050727,regulation of inflammatory response,1/18,425/18493,0.3420933920175231,0.3509940119455808,0.21793279915381625,1,bp,NAC,2175,FANCA
GO:0048732,gland development,1/18,434/18493,0.3479701106768729,0.3566202151230776,0.22142611859902117,1,bp,NAC,2146,EZH2
GO:0002683,negative regulation of immune system process,1/18,437/18493,0.3499179747388603,0.35821174163447667,0.22241430020825745,1,bp,NAC,2064,ERBB2
GO:0050708,regulation of protein secretion,1/18,438/18493,0.3505660405593467,0.35847057360465334,0.22257500943363256,1,bp,NAC,2335,FN1
GO:0002697,regulation of immune effector process,1/18,439/18493,0.35121349618216235,0.3587281993662401,0.22273496972197357,1,bp,NAC,6772,STAT1
hsa04217,Necroptosis,1/17,162/7844,0.29892386038227514,0.36015536936775067,0.23869946507804138,1,kg,NAC,6772,STAT1
hsa04310,Wnt signaling pathway,1/17,158/7844,0.2926855870346118,0.36015536936775067,0.23869946507804138,1,kg,NAC,4316,MMP7
hsa04530,Tight junction,1/17,170/7844,0.31124538093509313,0.36015536936775067,0.23869946507804138,1,kg,NAC,2064,ERBB2
hsa04630,JAK-STAT signaling pathway,1/17,162/7844,0.29892386038227514,0.36015536936775067,0.23869946507804138,1,kg,NAC,6772,STAT1
hsa04921,Oxytocin signaling pathway,1/17,153/7844,0.28481426799918896,0.36015536936775067,0.23869946507804138,1,kg,NAC,27092,CACNG4
hsa05164,Influenza A,1/17,167/7844,0.30664889173425713,0.36015536936775067,0.23869946507804138,1,kg,NAC,6772,STAT1
hsa05225,Hepatocellular carcinoma,1/17,168/7844,0.3081842530525477,0.36015536936775067,0.23869946507804138,1,kg,NAC,1869,E2F1
GO:0052547,regulation of peptidase activity,1/18,442/18493,0.35315220727009244,0.3603026456625128,0.22371254619560654,1,bp,NAC,2335,FN1
hsa04621,NOD-like receptor signaling pathway,1/17,178/7844,0.3233628760150584,0.365471297739249,0.24222269245876152,1,kg,NAC,6772,STAT1
hsa05152,Tuberculosis,1/17,179/7844,0.32486337576822133,0.365471297739249,0.24222269245876152,1,kg,NAC,6772,STAT1
GO:0023061,signal release,1/18,453/18493,0.36021410616422134,0.3666825974084722,0.22767386945225168,1,bp,NAC,6696,SPP1
GO:0034248,regulation of cellular amide metabolic process,1/18,453/18493,0.36021410616422134,0.3666825974084722,0.22767386945225168,1,bp,NAC,2064,ERBB2
GO:0034765,regulation of ion transmembrane transport,1/18,454/18493,0.36085247346405747,0.3669206204393499,0.2278216583706287,1,bp,NAC,27092,CACNG4
GO:0003012,muscle system process,1/18,456/18493,0.362127403800402,0.3673932385312803,0.22811510777489122,1,bp,NAC,2146,EZH2
GO:0016570,histone modification,1/18,456/18493,0.362127403800402,0.3673932385312803,0.22811510777489122,1,bp,NAC,2146,EZH2
GO:0008544,epidermis development,1/18,458/18493,0.3633999320076108,0.36786131510145426,0.2284057373403099,1,bp,NAC,2146,EZH2
GO:0051346,negative regulation of hydrolase activity,1/18,458/18493,0.3633999320076108,0.36786131510145426,0.2284057373403099,1,bp,NAC,9088,PKMYT1
GO:0070838,divalent metal ion transport,1/18,459/18493,0.36403529664436485,0.36809366115545034,0.22855000141375956,1,bp,NAC,27092,CACNG4
hsa04020,Calcium signaling pathway,1/17,188/7844,0.3382276596925271,0.3684565732093819,0.24420123760465856,1,kg,NAC,2064,ERBB2
hsa04062,Chemokine signaling pathway,1/17,190/7844,0.34116349371239063,0.3684565732093819,0.24420123760465856,1,kg,NAC,6772,STAT1
hsa05202,Transcriptional misregulation in cancer,1/17,186/7844,0.3352795161102954,0.3684565732093819,0.24420123760465856,1,kg,NAC,8842,PROM1
GO:0072511,divalent inorganic cation transport,1/18,462/18493,0.3659377990681614,0.36960532712118305,0.22948859746977654,1,bp,NAC,27092,CACNG4
GO:0016055,Wnt signaling pathway,1/18,463/18493,0.3665707711505066,0.3698328024844377,0.22962983732278094,1,bp,NAC,898,CCNE1
GO:0002791,regulation of peptide secretion,1/18,465/18493,0.36783492540800566,0.37028443656499577,0.22991025771748708,1,bp,NAC,2335,FN1
GO:0198738,cell-cell signaling by wnt,1/18,465/18493,0.36783492540800566,0.37028443656499577,0.22991025771748708,1,bp,NAC,898,CCNE1
GO:0016311,dephosphorylation,1/18,475/18493,0.37412003594509413,0.3761938720645237,0.2335794366094356,1,bp,NAC,9088,PKMYT1
GO:0050900,leukocyte migration,1/18,478/18493,0.3759940307136219,0.37765956351855495,0.23448948701030223,1,bp,NAC,2335,FN1
GO:0002009,morphogenesis of an epithelium,1/18,479/18493,0.3766175171109106,0.37786735400397786,0.23461850448804988,1,bp,NAC,6772,STAT1
hsa05203,Viral carcinogenesis,1/17,201/7844,0.3570926923679115,0.3805856326552742,0.2522399904537879,1,kg,NAC,898,CCNE1
GO:0005216,ion channel activity,1/18,427/17632,0.3569241444310287,0.38153960266765136,0.2267213258636299,1,mf,NAC,27092,CACNG4
hsa04015,Rap1 signaling pathway,1/17,206/7844,0.36421276843574424,0.3831329122505881,0.25392824593606234,1,kg,NAC,2264,FGFR4
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",1/18,449/17632,0.3715729181056576,0.38395868204251293,0.22815880936312313,1,mf,NAC,1869,E2F1
GO:0016887,ATPase activity,1/18,445/17632,0.36893316501522877,0.38395868204251293,0.22815880936312313,1,mf,NAC,83990,BRIP1
GO:0022838,substrate-specific channel activity,1/18,442/17632,0.3669464813920621,0.38395868204251293,0.22815880936312313,1,mf,NAC,27092,CACNG4
GO:0046873,metal ion transmembrane transporter activity,1/18,444/17632,0.368271592328582,0.38395868204251293,0.22815880936312313,1,mf,NAC,27092,CACNG4
GO:0008015,blood circulation,1/18,492/18493,0.3846694865332724,0.3855195848460531,0.23936978807246378,1,bp,NAC,6772,STAT1
GO:0051051,negative regulation of transport,1/18,495/18493,0.38651363270125527,0.386940248189888,0.2402518804405386,1,bp,NAC,2335,FN1
GO:0003013,circulatory system process,1/18,500/18493,0.38957561490435877,0.38957561490435877,0.24188818426719894,1,bp,NAC,6772,STAT1
GO:0015267,channel activity,1/18,467/17632,0.38332328158423634,0.39026454630624097,0.23190592734666277,1,mf,NAC,27092,CACNG4
GO:0022803,passive transmembrane transporter activity,1/18,468/17632,0.3839699568496887,0.39026454630624097,0.23190592734666277,1,mf,NAC,27092,CACNG4
GO:0048018,receptor ligand activity,1/18,478/17632,0.3904015805530968,0.3935755771429594,0.23387343293724247,1,mf,NAC,6696,SPP1
GO:0048037,cofactor binding,1/18,495/17632,0.4011900268326344,0.4011900268326344,0.23839814837253318,1,mf,NAC,83990,BRIP1
hsa05163,Human cytomegalovirus infection,1/17,225/7844,0.3905979344076169,0.405620931884833,0.26883258643439223,1,kg,NAC,1869,E2F1
hsa04014,Ras signaling pathway,1/17,232/7844,0.40005631624310056,0.410184324249255,0.27185705700730356,1,kg,NAC,2264,FGFR4
hsa04144,Endocytosis,1/17,244/7844,0.41594999577930614,0.42114937072654746,0.27912433927295544,1,kg,NAC,2264,FGFR4
hsa05168,Herpes simplex virus 1 infection,1/17,492/7844,0.6679145139303395,0.6679145139303395,0.4426723874002251,1,kg,NAC,6772,STAT1
